name,title,company,location,email,linkedin,recent_publication,pub_date,journal,pmid,keywords,source
Arshdeep Singh,Researcher,Dayanand Medical College and Hospital,"Punjab, India. drarshdeepsingh@gmail.com.",arshdeep.singh@dayanandmedicalcollegeandhospital.com,linkedin.com/in/arshdeepsingh,Drug-induced liver injury in inflammatory bowel disease: Challenges in diagnosis and monitoring.,2024-01,World journal of hepatology,41479516,DILI,PubMed
Arshia Bhardwaj,Researcher,Dayanand Medical College and Hospital,"Punjab, India.",arshia.bhardwaj@dayanandmedicalcollegeandhospital.com,linkedin.com/in/arshiabhardwaj,Drug-induced liver injury in inflammatory bowel disease: Challenges in diagnosis and monitoring.,2024-01,World journal of hepatology,41479516,DILI,PubMed
Harmeet Kaur,Researcher,Dayanand Medical College and Hospital,"Punjab, India.",harmeet.kaur@dayanandmedicalcollegeandhospital.com,linkedin.com/in/harmeetkaur,Drug-induced liver injury in inflammatory bowel disease: Challenges in diagnosis and monitoring.,2024-01,World journal of hepatology,41479516,DILI,PubMed
Ashutosh Bawa,Researcher,Government Medical College,"Jammu and Kashmīr, India.",ashutosh.bawa@governmentmedicalcollege.com,linkedin.com/in/ashutoshbawa,Drug-induced liver injury in inflammatory bowel disease: Challenges in diagnosis and monitoring.,2024-01,World journal of hepatology,41479516,DILI,PubMed
Vandana Midha,Researcher,Dayanand Medical College and Hospital,"Punjab, India.",vandana.midha@dayanandmedicalcollegeandhospital.com,linkedin.com/in/vandanamidha,Drug-induced liver injury in inflammatory bowel disease: Challenges in diagnosis and monitoring.,2024-01,World journal of hepatology,41479516,DILI,PubMed
Ajit Sood,Researcher,Dayanand Medical College and Hospital,"Punjab, India.",ajit.sood@dayanandmedicalcollegeandhospital.com,linkedin.com/in/ajitsood,Drug-induced liver injury in inflammatory bowel disease: Challenges in diagnosis and monitoring.,2024-01,World journal of hepatology,41479516,DILI,PubMed
Ratikanta Tripathy,Researcher,KIMS,"Odisha, India.",ratikanta.tripathy@kims.com,linkedin.com/in/ratikantatripathy,Adverse Drug Reaction to First-Line Oral Antitubercular Drugs: An 8-Year Analysis from a Tertiary Ce,2026-01,The Nigerian postgraduate medical journal,41479182,DILI,PubMed
Pratima Singh,Researcher,KIMS,"Odisha, India.",pratima.singh@kims.com,linkedin.com/in/pratimasingh,Adverse Drug Reaction to First-Line Oral Antitubercular Drugs: An 8-Year Analysis from a Tertiary Ce,2026-01,The Nigerian postgraduate medical journal,41479182,DILI,PubMed
Debasis Behera,Researcher,KIMS,"Odisha, India.",debasis.behera@kims.com,linkedin.com/in/debasisbehera,Adverse Drug Reaction to First-Line Oral Antitubercular Drugs: An 8-Year Analysis from a Tertiary Ce,2026-01,The Nigerian postgraduate medical journal,41479182,DILI,PubMed
Elisha Paikray,Researcher,KIMS,"Odisha, India.",elisha.paikray@kims.com,linkedin.com/in/elishapaikray,Adverse Drug Reaction to First-Line Oral Antitubercular Drugs: An 8-Year Analysis from a Tertiary Ce,2026-01,The Nigerian postgraduate medical journal,41479182,DILI,PubMed
Saswat Subhankar,Researcher,KIMS,"Odisha, India.",saswat.subhankar@kims.com,linkedin.com/in/saswatsubhankar,Adverse Drug Reaction to First-Line Oral Antitubercular Drugs: An 8-Year Analysis from a Tertiary Ce,2026-01,The Nigerian postgraduate medical journal,41479182,DILI,PubMed
Mangala Charana Das,Researcher,KIMS,"Odisha, India.",mangala.das@kims.com,linkedin.com/in/mangalacharanadas,Adverse Drug Reaction to First-Line Oral Antitubercular Drugs: An 8-Year Analysis from a Tertiary Ce,2026-01,The Nigerian postgraduate medical journal,41479182,DILI,PubMed
Carolina Guimarães,Researcher,Unidade Local de Saúde São João,"Porto, PRT.",carolina.guimarães@unidadelocaldesaúdesãojoão.com,linkedin.com/in/carolinaguimarães,Acute Drug-Induced Hepatitis Associated With Vortioxetine: A Case Report.,2025-11,Cureus,41477396,DILI,PubMed
Rui Ribeiro,Researcher,Centro Hospitalar Universitário de São João - EPE,"Porto, PRT.",rui.ribeiro@centrohospitalaruniversitáriodesãojoão-epe.com,linkedin.com/in/ruiribeiro,Acute Drug-Induced Hepatitis Associated With Vortioxetine: A Case Report.,2025-11,Cureus,41477396,DILI,PubMed
Helena Hipólito Reis,Researcher,Unidade Local de Saúde São João,"Porto, PRT.",helena.reis@unidadelocaldesaúdesãojoão.com,linkedin.com/in/helenahipólitoreis,Acute Drug-Induced Hepatitis Associated With Vortioxetine: A Case Report.,2025-11,Cureus,41477396,DILI,PubMed
Ana Ribeiro,Researcher,Centro Hospitalar Universitário de São João - EPE,"Porto, PRT.",ana.ribeiro@centrohospitalaruniversitáriodesãojoão-epe.com,linkedin.com/in/anaribeiro,Acute Drug-Induced Hepatitis Associated With Vortioxetine: A Case Report.,2025-11,Cureus,41477396,DILI,PubMed
Jorge S Almeida,Researcher,Faculdade de Medicina da Universidade do Porto,"Porto, PRT.",jorge.almeida@faculdadedemedicinadauniversidadedoporto.com,linkedin.com/in/jorgesalmeida,Acute Drug-Induced Hepatitis Associated With Vortioxetine: A Case Report.,2025-11,Cureus,41477396,DILI,PubMed
Sen Liu,Researcher,Shenyang Pharmaceutical University,"Shenyang 110016, China.",sen.liu@shenyangpharmaceuticaledu.com,linkedin.com/in/senliu,Generation and applications of an expandable and mature hiPSC-derived liver organoid.,2025-09,Acta pharmaceutica Sinica. B,41477334,DILI,PubMed
Ze Wang,Researcher,Tianjin Institute of Pharmaceutical Research,"Tianjin 300301, China.",ze.wang@tianjinorgofpharmaceuticalresearch.com,linkedin.com/in/zewang,Generation and applications of an expandable and mature hiPSC-derived liver organoid.,2025-09,Acta pharmaceutica Sinica. B,41477334,DILI,PubMed
Liuyang Zhu,Researcher,Tianjin First Central Hospital,"Tianjin 300192, China.",liuyang.zhu@tianjinfirstcentralhospital.com,linkedin.com/in/liuyangzhu,Generation and applications of an expandable and mature hiPSC-derived liver organoid.,2025-09,Acta pharmaceutica Sinica. B,41477334,DILI,PubMed
Libo Wang,Researcher,Tianjin Institute of Pharmaceutical Research,"Tianjin 300301, China.",libo.wang@tianjinorgofpharmaceuticalresearch.com,linkedin.com/in/libowang,Generation and applications of an expandable and mature hiPSC-derived liver organoid.,2025-09,Acta pharmaceutica Sinica. B,41477334,DILI,PubMed
Tianyu Zhao,Researcher,Tianjin Institute of Pharmaceutical Research,"Tianjin 300301, China.",tianyu.zhao@tianjinorgofpharmaceuticalresearch.com,linkedin.com/in/tianyuzhao,Generation and applications of an expandable and mature hiPSC-derived liver organoid.,2025-09,Acta pharmaceutica Sinica. B,41477334,DILI,PubMed
Pinsheng Han,Researcher,Tianjin 300192,"Tianjin 300192, China.",pinsheng.han@tianjin300192.com,linkedin.com/in/pinshenghan,Generation and applications of an expandable and mature hiPSC-derived liver organoid.,2025-09,Acta pharmaceutica Sinica. B,41477334,DILI,PubMed
Yongdeng Xu,Researcher,Tianjin Institute of Pharmaceutical Research,"Tianjin 300301, China.",yongdeng.xu@tianjinorgofpharmaceuticalresearch.com,linkedin.com/in/yongdengxu,Generation and applications of an expandable and mature hiPSC-derived liver organoid.,2025-09,Acta pharmaceutica Sinica. B,41477334,DILI,PubMed
Long Yang,Researcher,Tianjin First Central Hospital,"Tianjin 300192, China.",long.yang@tianjinfirstcentralhospital.com,linkedin.com/in/longyang,Generation and applications of an expandable and mature hiPSC-derived liver organoid.,2025-09,Acta pharmaceutica Sinica. B,41477334,DILI,PubMed
Lei Hu,Researcher,Ltd.,"Tianjin 300301, China.",lei.hu@ltd.,linkedin.com/in/leihu,Generation and applications of an expandable and mature hiPSC-derived liver organoid.,2025-09,Acta pharmaceutica Sinica. B,41477334,DILI,PubMed
Fengying Yan,Researcher,Tianjin Institute of Pharmaceutical Research,"Tianjin 300301, China.",fengying.yan@tianjinorgofpharmaceuticalresearch.com,linkedin.com/in/fengyingyan,Generation and applications of an expandable and mature hiPSC-derived liver organoid.,2025-09,Acta pharmaceutica Sinica. B,41477334,DILI,PubMed
Xiaoliang Wang,Researcher,Tianjin Institute of Pharmaceutical Research,"Tianjin 300301, China.",xiaoliang.wang@tianjinorgofpharmaceuticalresearch.com,linkedin.com/in/xiaoliangwang,Generation and applications of an expandable and mature hiPSC-derived liver organoid.,2025-09,Acta pharmaceutica Sinica. B,41477334,DILI,PubMed
Tao Cui,Researcher,Tianjin Institute of Pharmaceutical Research,"Tianjin 300301, China.",tao.cui@tianjinorgofpharmaceuticalresearch.com,linkedin.com/in/taocui,Generation and applications of an expandable and mature hiPSC-derived liver organoid.,2025-09,Acta pharmaceutica Sinica. B,41477334,DILI,PubMed
Chunli Li,Researcher,Shenzhen Technology University,"Shenzhen 518118, China.",chunli.li@shenzhentechnologyedu.com,linkedin.com/in/chunlili,Generation and applications of an expandable and mature hiPSC-derived liver organoid.,2025-09,Acta pharmaceutica Sinica. B,41477334,DILI,PubMed
Baofeng Yang,Researcher,Shenyang Pharmaceutical University,"Shenyang 110016, China.",baofeng.yang@shenyangpharmaceuticaledu.com,linkedin.com/in/baofengyang,Generation and applications of an expandable and mature hiPSC-derived liver organoid.,2025-09,Acta pharmaceutica Sinica. B,41477334,DILI,PubMed
Yanqing Song,Researcher,Lequn Branch,"Changchun, China.",yanqing.song@lequnbranch.com,linkedin.com/in/yanqingsong,Drug-Induced Liver Injury Associated With Moxifloxacin: A Pharmacovigilance Analysis of the FDA Adve,2024-01,Basic & clinical pharmacology & toxicology,41474201,DILI,PubMed
Chunzi Li,Researcher,Lequn Branch,"Changchun, China.",chunzi.li@lequnbranch.com,linkedin.com/in/chunzili,Drug-Induced Liver Injury Associated With Moxifloxacin: A Pharmacovigilance Analysis of the FDA Adve,2024-01,Basic & clinical pharmacology & toxicology,41474201,DILI,PubMed
Xiaoyue Liu,Researcher,the First Hospital of Jilin University,"Changchun, China.",xiaoyue.liu@thefirsthospitalofjilinedu.com,linkedin.com/in/xiaoyueliu,Drug-Induced Liver Injury Associated With Moxifloxacin: A Pharmacovigilance Analysis of the FDA Adve,2024-01,Basic & clinical pharmacology & toxicology,41474201,DILI,PubMed
Huan Gao,Researcher,the First Hospital of Jilin University,"Changchun, China.",huan.gao@thefirsthospitalofjilinedu.com,linkedin.com/in/huangao,Drug-Induced Liver Injury Associated With Moxifloxacin: A Pharmacovigilance Analysis of the FDA Adve,2024-01,Basic & clinical pharmacology & toxicology,41474201,DILI,PubMed
Xiaoya Mao,Researcher,The Affiliated People's Hospital of Ningbo University,"Ningbo, China.",xiaoya.mao@theaffiliatedpeople'shospitalofningboedu.com,linkedin.com/in/xiaoyamao,"Gut microbiota-metabolite interactions in drug-induced liver injury: mechanisms, biomarkers, and the",2025-12,Frontiers in cellular and infection microbiology,41473771,DILI,PubMed
Xujiao Hu,Researcher,The Affiliated People's Hospital of Ningbo University,"Ningbo, China.",xujiao.hu@theaffiliatedpeople'shospitalofningboedu.com,linkedin.com/in/xujiaohu,"Gut microbiota-metabolite interactions in drug-induced liver injury: mechanisms, biomarkers, and the",2025-12,Frontiers in cellular and infection microbiology,41473771,DILI,PubMed
Jingjing Fang,Researcher,The Affiliated People's Hospital of Ningbo University,"Ningbo, China.",jingjing.fang@theaffiliatedpeople'shospitalofningboedu.com,linkedin.com/in/jingjingfang,"Gut microbiota-metabolite interactions in drug-induced liver injury: mechanisms, biomarkers, and the",2025-12,Frontiers in cellular and infection microbiology,41473771,DILI,PubMed
Minami Shibata,Researcher,School of Pharmaceutical Sciences,"422-8526, Japan.",minami.shibata@schoolofpharmaceuticalsciences.com,linkedin.com/in/minamishibata,Cytochrome P450 inhibition correlates with hepatotoxicity of pesticides: Analysis using repeated-dos,2025-10,Drug metabolism and pharmacokinetics,41468647,DILI,PubMed
Nana Uchida,Researcher,School of Pharmaceutical Sciences,"422-8526, Japan.",nana.uchida@schoolofpharmaceuticalsciences.com,linkedin.com/in/nanauchida,Cytochrome P450 inhibition correlates with hepatotoxicity of pesticides: Analysis using repeated-dos,2025-10,Drug metabolism and pharmacokinetics,41468647,DILI,PubMed
Akira Ooka,Researcher,School of Pharmaceutical Sciences,"422-8526, Japan.",akira.ooka@schoolofpharmaceuticalsciences.com,linkedin.com/in/akiraooka,Cytochrome P450 inhibition correlates with hepatotoxicity of pesticides: Analysis using repeated-dos,2025-10,Drug metabolism and pharmacokinetics,41468647,DILI,PubMed
Ryota Shizu,Researcher,School of Pharmaceutical Sciences,"422-8526, Japan.",ryota.shizu@schoolofpharmaceuticalsciences.com,linkedin.com/in/ryotashizu,Cytochrome P450 inhibition correlates with hepatotoxicity of pesticides: Analysis using repeated-dos,2025-10,Drug metabolism and pharmacokinetics,41468647,DILI,PubMed
Kouichi Yoshinari,Researcher,School of Pharmaceutical Sciences,"422-8526, Japan. Electronic address: yoshinari@u-shizuoka-ken.ac.jp.",kouichi.yoshinari@schoolofpharmaceuticalsciences.com,linkedin.com/in/kouichiyoshinari,Cytochrome P450 inhibition correlates with hepatotoxicity of pesticides: Analysis using repeated-dos,2025-10,Drug metabolism and pharmacokinetics,41468647,DILI,PubMed
Rajamathanky Hariharan,Researcher,KMCH College of Pharmacy,"Tamil Nadu, India.",rajamathanky.hariharan@kmchcollegeofpharmacy.com,linkedin.com/in/rajamathankyhariharan,Molecular docking analysis of PI3K/AKT with betulin from <i>Impatiens henslowiana</i>.,2025-09,Bioinformation,41466686,DILI,PubMed
Rajasekaran Aiyalu,Researcher,KMCH College of Pharmacy,"Tamil Nadu, India.",rajasekaran.aiyalu@kmchcollegeofpharmacy.com,linkedin.com/in/rajasekaranaiyalu,Molecular docking analysis of PI3K/AKT with betulin from <i>Impatiens henslowiana</i>.,2025-09,Bioinformation,41466686,DILI,PubMed
Wei Jiang,Researcher,China Three Gorges University,"Yichang 443002, China.",wei.jiang@chinathreegorgesedu.com,linkedin.com/in/weijiang,Genistein Ameliorates Rifampicin-Undermined Hepatic Cholesterol Efflux via the CH25H-LXRα-ABCA Pathw,2025-12,Journal of agricultural and food chemistry,41459645,DILI,PubMed
Ding Zhang,Researcher,China Three Gorges University,"Yichang 443002, China.",ding.zhang@chinathreegorgesedu.com,linkedin.com/in/dingzhang,Genistein Ameliorates Rifampicin-Undermined Hepatic Cholesterol Efflux via the CH25H-LXRα-ABCA Pathw,2025-12,Journal of agricultural and food chemistry,41459645,DILI,PubMed
Jinsheng Shen,Researcher,China Three Gorges University,"Yichang 443002, China.",jinsheng.shen@chinathreegorgesedu.com,linkedin.com/in/jinshengshen,Genistein Ameliorates Rifampicin-Undermined Hepatic Cholesterol Efflux via the CH25H-LXRα-ABCA Pathw,2025-12,Journal of agricultural and food chemistry,41459645,DILI,PubMed
Xionghong Hu,Researcher,The Third People's Hospital of Yichang,"Yichang 443000, China.",xionghong.hu@thethirdpeople'shospitalofyichang.com,linkedin.com/in/xionghonghu,Genistein Ameliorates Rifampicin-Undermined Hepatic Cholesterol Efflux via the CH25H-LXRα-ABCA Pathw,2025-12,Journal of agricultural and food chemistry,41459645,DILI,PubMed
Xueli Jin,Researcher,China Three Gorges University,"Yichang 443002, China.",xueli.jin@chinathreegorgesedu.com,linkedin.com/in/xuelijin,Genistein Ameliorates Rifampicin-Undermined Hepatic Cholesterol Efflux via the CH25H-LXRα-ABCA Pathw,2025-12,Journal of agricultural and food chemistry,41459645,DILI,PubMed
Shelly Tan,Researcher,Purdue University,"Indiana 47906, United States of America.",shelly.tan@purdueedu.com,linkedin.com/in/shellytan,Genistein Ameliorates Rifampicin-Undermined Hepatic Cholesterol Efflux via the CH25H-LXRα-ABCA Pathw,2025-12,Journal of agricultural and food chemistry,41459645,DILI,PubMed
Li Zeng,Researcher,China Three Gorges University,"Yichang 443002, China.",li.zeng@chinathreegorgesedu.com,linkedin.com/in/lizeng,Genistein Ameliorates Rifampicin-Undermined Hepatic Cholesterol Efflux via the CH25H-LXRα-ABCA Pathw,2025-12,Journal of agricultural and food chemistry,41459645,DILI,PubMed
Hankun Wang,Researcher,China Three Gorges University,"Yichang 443002, China.",hankun.wang@chinathreegorgesedu.com,linkedin.com/in/hankunwang,Genistein Ameliorates Rifampicin-Undermined Hepatic Cholesterol Efflux via the CH25H-LXRα-ABCA Pathw,2025-12,Journal of agricultural and food chemistry,41459645,DILI,PubMed
Shanshan Han,Researcher,China Three Gorges University,"Yichang 443002, China.",shanshan.han@chinathreegorgesedu.com,linkedin.com/in/shanshanhan,Genistein Ameliorates Rifampicin-Undermined Hepatic Cholesterol Efflux via the CH25H-LXRα-ABCA Pathw,2025-12,Journal of agricultural and food chemistry,41459645,DILI,PubMed
Jin Chao,Researcher,China Three Gorges University,"Yichang 443002, China.",jin.chao@chinathreegorgesedu.com,linkedin.com/in/jinchao,Genistein Ameliorates Rifampicin-Undermined Hepatic Cholesterol Efflux via the CH25H-LXRα-ABCA Pathw,2025-12,Journal of agricultural and food chemistry,41459645,DILI,PubMed
Qiuping Peng,Researcher,The Third People's Hospital of Yichang,"Yichang 443000, China.",qiuping.peng@thethirdpeople'shospitalofyichang.com,linkedin.com/in/qiupingpeng,Genistein Ameliorates Rifampicin-Undermined Hepatic Cholesterol Efflux via the CH25H-LXRα-ABCA Pathw,2025-12,Journal of agricultural and food chemistry,41459645,DILI,PubMed
Zhaoyang Liu,Researcher,China Three Gorges University,"Yichang 443002, China.",zhaoyang.liu@chinathreegorgesedu.com,linkedin.com/in/zhaoyangliu,Genistein Ameliorates Rifampicin-Undermined Hepatic Cholesterol Efflux via the CH25H-LXRα-ABCA Pathw,2025-12,Journal of agricultural and food chemistry,41459645,DILI,PubMed
Qing-Ao Xiao,Researcher,Yichang Central People's Hospital,"Yichang 443003, China.",qing-ao.xiao@yichangcentralpeople'shospital.com,linkedin.com/in/qing-aoxiao,Genistein Ameliorates Rifampicin-Undermined Hepatic Cholesterol Efflux via the CH25H-LXRα-ABCA Pathw,2025-12,Journal of agricultural and food chemistry,41459645,DILI,PubMed
Lin Han,Researcher,Yichang Center People's Hospital,"Yichang 443000, China.",lin.han@yichangcenterpeople'shospital.com,linkedin.com/in/linhan,Genistein Ameliorates Rifampicin-Undermined Hepatic Cholesterol Efflux via the CH25H-LXRα-ABCA Pathw,2025-12,Journal of agricultural and food chemistry,41459645,DILI,PubMed
Yiling Huang,Researcher,China Three Gorges University,"Yichang 443002, China.",yiling.huang@chinathreegorgesedu.com,linkedin.com/in/yilinghuang,Genistein Ameliorates Rifampicin-Undermined Hepatic Cholesterol Efflux via the CH25H-LXRα-ABCA Pathw,2025-12,Journal of agricultural and food chemistry,41459645,DILI,PubMed
Xiaochen Zhang,Researcher,China Three Gorges University,"Yichang 443002, China.",xiaochen.zhang@chinathreegorgesedu.com,linkedin.com/in/xiaochenzhang,Genistein Ameliorates Rifampicin-Undermined Hepatic Cholesterol Efflux via the CH25H-LXRα-ABCA Pathw,2025-12,Journal of agricultural and food chemistry,41459645,DILI,PubMed
Bo Yu,Researcher,Yichang Center People's Hospital,"Yichang 443000, China.",bo.yu@yichangcenterpeople'shospital.com,linkedin.com/in/boyu,Genistein Ameliorates Rifampicin-Undermined Hepatic Cholesterol Efflux via the CH25H-LXRα-ABCA Pathw,2025-12,Journal of agricultural and food chemistry,41459645,DILI,PubMed
Yincheng Zhu,Researcher,Yichang 443100,"Yichang 443100, China.",yincheng.zhu@yichang443100.com,linkedin.com/in/yinchengzhu,Genistein Ameliorates Rifampicin-Undermined Hepatic Cholesterol Efflux via the CH25H-LXRα-ABCA Pathw,2025-12,Journal of agricultural and food chemistry,41459645,DILI,PubMed
Wei Liu,Researcher,The First College of Clinical Medical Science,"Yichang 443003, China.",wei.liu@thefirstcollegeofclinicalmedicalscience.com,linkedin.com/in/weiliu,Genistein Ameliorates Rifampicin-Undermined Hepatic Cholesterol Efflux via the CH25H-LXRα-ABCA Pathw,2025-12,Journal of agricultural and food chemistry,41459645,DILI,PubMed
Xiaofei Huang,Researcher,China Three Gorges University,"Yichang 443002, China.",xiaofei.huang@chinathreegorgesedu.com,linkedin.com/in/xiaofeihuang,Genistein Ameliorates Rifampicin-Undermined Hepatic Cholesterol Efflux via the CH25H-LXRα-ABCA Pathw,2025-12,Journal of agricultural and food chemistry,41459645,DILI,PubMed
Xuan Xia,Researcher,China Three Gorges University,"Yichang 443002, China.",xuan.xia@chinathreegorgesedu.com,linkedin.com/in/xuanxia,Genistein Ameliorates Rifampicin-Undermined Hepatic Cholesterol Efflux via the CH25H-LXRα-ABCA Pathw,2025-12,Journal of agricultural and food chemistry,41459645,DILI,PubMed
Decheng Wang,Researcher,China Three Gorges University,"Yichang 443002, China.",decheng.wang@chinathreegorgesedu.com,linkedin.com/in/dechengwang,Genistein Ameliorates Rifampicin-Undermined Hepatic Cholesterol Efflux via the CH25H-LXRα-ABCA Pathw,2025-12,Journal of agricultural and food chemistry,41459645,DILI,PubMed
Xuying Ding,Researcher,Beihua University,"132013, PR China.",xuying.ding@beihuaedu.com,linkedin.com/in/xuyingding,From traditional tonic herb to molecular therapy: The natural peptide G-6-Y from Eleutherococcus ses,2025-12,Journal of ethnopharmacology,41448365,DILI,PubMed
Siya Wang,Researcher,Beihua University,"132013, PR China.",siya.wang@beihuaedu.com,linkedin.com/in/siyawang,From traditional tonic herb to molecular therapy: The natural peptide G-6-Y from Eleutherococcus ses,2025-12,Journal of ethnopharmacology,41448365,DILI,PubMed
Miao Yu,Researcher,Beihua University,"132013, PR China.",miao.yu@beihuaedu.com,linkedin.com/in/miaoyu,From traditional tonic herb to molecular therapy: The natural peptide G-6-Y from Eleutherococcus ses,2025-12,Journal of ethnopharmacology,41448365,DILI,PubMed
Leiyi Wang,Researcher,Changchun Institute of Applied Chemistry,"130022, PR China.",leiyi.wang@changchunorgofappliedchemistry.com,linkedin.com/in/leiyiwang,From traditional tonic herb to molecular therapy: The natural peptide G-6-Y from Eleutherococcus ses,2025-12,Journal of ethnopharmacology,41448365,DILI,PubMed
Qucheng Huang,Researcher,Beihua University,"132013, PR China.",qucheng.huang@beihuaedu.com,linkedin.com/in/quchenghuang,From traditional tonic herb to molecular therapy: The natural peptide G-6-Y from Eleutherococcus ses,2025-12,Journal of ethnopharmacology,41448365,DILI,PubMed
Jiaxin Zheng,Researcher,Beihua University,"132013, PR China.",jiaxin.zheng@beihuaedu.com,linkedin.com/in/jiaxinzheng,From traditional tonic herb to molecular therapy: The natural peptide G-6-Y from Eleutherococcus ses,2025-12,Journal of ethnopharmacology,41448365,DILI,PubMed
Yuanyuan Zuo,Researcher,Beihua University,"132013, PR China.",yuanyuan.zuo@beihuaedu.com,linkedin.com/in/yuanyuanzuo,From traditional tonic herb to molecular therapy: The natural peptide G-6-Y from Eleutherococcus ses,2025-12,Journal of ethnopharmacology,41448365,DILI,PubMed
Chang Liu,Researcher,Beihua University,"132013, PR China. Electronic address: liuchangbhu@163.com.",chang.liu@beihuaedu.com,linkedin.com/in/changliu,From traditional tonic herb to molecular therapy: The natural peptide G-6-Y from Eleutherococcus ses,2025-12,Journal of ethnopharmacology,41448365,DILI,PubMed
John Hellgren,Researcher,Clinical Pharmacology & Safety Sciences,"Gothenburg, Sweden.",john.hellgren@clinicalpharmacology&safetysciences.com,linkedin.com/in/johnhellgren,Apoptotic signatures allow early and rapid screening of drug-induced liver injury to accelerate drug,2025-12,Communications medicine,41444459,DILI,PubMed
Bhavik Chouhan,Researcher,Clinical Pharmacology & Safety Sciences,"Gothenburg, Sweden.",bhavik.chouhan@clinicalpharmacology&safetysciences.com,linkedin.com/in/bhavikchouhan,Apoptotic signatures allow early and rapid screening of drug-induced liver injury to accelerate drug,2025-12,Communications medicine,41444459,DILI,PubMed
Aydar Uatay,Researcher,Clinical Pharmacology & Safety Sciences,"Cambridge, MA",aydar.uatay@clinicalpharmacology&safetysciences.com,linkedin.com/in/aydaruatay,Apoptotic signatures allow early and rapid screening of drug-induced liver injury to accelerate drug,2025-12,Communications medicine,41444459,DILI,PubMed
Ramy Elgendy,Researcher,Centre for Genomics Research,"Gothenburg, Sweden.",ramy.elgendy@centreforgenomicsresearch.com,linkedin.com/in/ramyelgendy,Apoptotic signatures allow early and rapid screening of drug-induced liver injury to accelerate drug,2025-12,Communications medicine,41444459,DILI,PubMed
Julia Lindgren,Researcher,Centre for Genomics Research,"Gothenburg, Sweden.",julia.lindgren@centreforgenomicsresearch.com,linkedin.com/in/julialindgren,Apoptotic signatures allow early and rapid screening of drug-induced liver injury to accelerate drug,2025-12,Communications medicine,41444459,DILI,PubMed
Naoko Toki,Researcher,Centre for Genomics Research,"Gothenburg, Sweden.",naoko.toki@centreforgenomicsresearch.com,linkedin.com/in/naokotoki,Apoptotic signatures allow early and rapid screening of drug-induced liver injury to accelerate drug,2025-12,Communications medicine,41444459,DILI,PubMed
Alessandro Bonetti,Researcher,Centre for Genomics Research,"Gothenburg, Sweden.",alessandro.bonetti@centreforgenomicsresearch.com,linkedin.com/in/alessandrobonetti,Apoptotic signatures allow early and rapid screening of drug-induced liver injury to accelerate drug,2025-12,Communications medicine,41444459,DILI,PubMed
Aditi Chaudhari,Researcher,Discovery Sciences,"Gothenburg, Sweden.",aditi.chaudhari@discoverysciences.com,linkedin.com/in/aditichaudhari,Apoptotic signatures allow early and rapid screening of drug-induced liver injury to accelerate drug,2025-12,Communications medicine,41444459,DILI,PubMed
Kenneth Pryde,Researcher,Clinical Pharmacology & Safety Sciences,"MA, USA.",kenneth.pryde@clinicalpharmacology&safetysciences.com,linkedin.com/in/kennethpryde,Apoptotic signatures allow early and rapid screening of drug-induced liver injury to accelerate drug,2025-12,Communications medicine,41444459,DILI,PubMed
Patrik Andersson,Researcher,Clinical Pharmacology & Safety Sciences,"Gothenburg, Sweden.",patrik.andersson@clinicalpharmacology&safetysciences.com,linkedin.com/in/patrikandersson,Apoptotic signatures allow early and rapid screening of drug-induced liver injury to accelerate drug,2025-12,Communications medicine,41444459,DILI,PubMed
Marie Kalm,Researcher,Clinical Pharmacology & Safety Sciences,"Gothenburg, Sweden.",marie.kalm@clinicalpharmacology&safetysciences.com,linkedin.com/in/mariekalm,Apoptotic signatures allow early and rapid screening of drug-induced liver injury to accelerate drug,2025-12,Communications medicine,41444459,DILI,PubMed
Fredrik Karlsson,Researcher,Discovery Sciences,"Gothenburg, Sweden.",fredrik.karlsson@discoverysciences.com,linkedin.com/in/fredrikkarlsson,Apoptotic signatures allow early and rapid screening of drug-induced liver injury to accelerate drug,2025-12,Communications medicine,41444459,DILI,PubMed
Johanna Sagemark,Researcher,Clinical Pharmacology & Safety Sciences,"Gothenburg, Sweden.",johanna.sagemark@clinicalpharmacology&safetysciences.com,linkedin.com/in/johannasagemark,Apoptotic signatures allow early and rapid screening of drug-induced liver injury to accelerate drug,2025-12,Communications medicine,41444459,DILI,PubMed
Dominic P Williams,Researcher,Clinical Pharmacology & Safety Sciences,"Cambridge, MA",dominic.williams@clinicalpharmacology&safetysciences.com,linkedin.com/in/dominicpwilliams,Apoptotic signatures allow early and rapid screening of drug-induced liver injury to accelerate drug,2025-12,Communications medicine,41444459,DILI,PubMed
Jennifer Y Tan,Researcher,Clinical Pharmacology & Safety Sciences,"Cambridge, MA",jennifer.tan@clinicalpharmacology&safetysciences.com,linkedin.com/in/jenniferytan,Apoptotic signatures allow early and rapid screening of drug-induced liver injury to accelerate drug,2025-12,Communications medicine,41444459,DILI,PubMed
Bino John,Researcher,Clinical Pharmacology & Safety Sciences,"Boston, MA",bino.john@clinicalpharmacology&safetysciences.com,linkedin.com/in/binojohn,Apoptotic signatures allow early and rapid screening of drug-induced liver injury to accelerate drug,2025-12,Communications medicine,41444459,DILI,PubMed
John Gallon,Researcher,Clinical Pharmacology & Safety Sciences,"Cambridge, MA",john.gallon@clinicalpharmacology&safetysciences.com,linkedin.com/in/johngallon,Apoptotic signatures allow early and rapid screening of drug-induced liver injury to accelerate drug,2025-12,Communications medicine,41444459,DILI,PubMed
Zijin Xu,Researcher,Zhejiang University of Technology,"Shangrao 334000, China.",zijin.xu@zhejiangeduoftechnology.com,linkedin.com/in/zijinxu,A comparative study of the hepatoprotective effects of the three processed products of Tetrastigma h,2025-12,Fitoterapia,41443516,DILI,PubMed
Shaoxian Wang,Researcher,Zhejiang University of Technology,"Hangzhou 310014, China.",shaoxian.wang@zhejiangeduoftechnology.com,linkedin.com/in/shaoxianwang,A comparative study of the hepatoprotective effects of the three processed products of Tetrastigma h,2025-12,Fitoterapia,41443516,DILI,PubMed
Hao Chen,Researcher,Yichun University,"Yichun 336000, China.",hao.chen@yichunedu.com,linkedin.com/in/haochen,A comparative study of the hepatoprotective effects of the three processed products of Tetrastigma h,2025-12,Fitoterapia,41443516,DILI,PubMed
Tao Lv,Researcher,Zhejiang University of Technology,"Hangzhou 310014, China.",tao.lv@zhejiangeduoftechnology.com,linkedin.com/in/taolv,A comparative study of the hepatoprotective effects of the three processed products of Tetrastigma h,2025-12,Fitoterapia,41443516,DILI,PubMed
Zhiwen Zhang,Researcher,Jiangxi Medical College,"Shangrao 334000, China.",zhiwen.zhang@jiangximedicalcollege.com,linkedin.com/in/zhiwenzhang,A comparative study of the hepatoprotective effects of the three processed products of Tetrastigma h,2025-12,Fitoterapia,41443516,DILI,PubMed
Faxiang Pu,Researcher,LTD,"Suichang 323300, China.",faxiang.pu@ltd.com,linkedin.com/in/faxiangpu,A comparative study of the hepatoprotective effects of the three processed products of Tetrastigma h,2025-12,Fitoterapia,41443516,DILI,PubMed
Zhangfu Xie,Researcher,LTD,"Suichang 323300, China.",zhangfu.xie@ltd.com,linkedin.com/in/zhangfuxie,A comparative study of the hepatoprotective effects of the three processed products of Tetrastigma h,2025-12,Fitoterapia,41443516,DILI,PubMed
Longfei Feng,Researcher,Yichun University,"Yichun 336000, China. Electronic address: fenglongfei@163.com.",longfei.feng@yichunedu.com,linkedin.com/in/longfeifeng,A comparative study of the hepatoprotective effects of the three processed products of Tetrastigma h,2025-12,Fitoterapia,41443516,DILI,PubMed
Ping Wang,Researcher,Zhejiang University of Technology,"Jinhua 321000, China. Electronic address: wangping45@aliyun.com.",ping.wang@zhejiangeduoftechnology.com,linkedin.com/in/pingwang,A comparative study of the hepatoprotective effects of the three processed products of Tetrastigma h,2025-12,Fitoterapia,41443516,DILI,PubMed
Yichen Fan,Researcher,Prevention and Treatment of High Incidence Diseases in Central Asia,"Xinjiang, China.",yichen.fan@preventionandtreatmentofhighincidencediseasesincentralasia.com,linkedin.com/in/yichenfan,Molecular mechanisms and therapeutic strategies of cGAS-STING pathway in liver disease: the quest co,2025-12,Frontiers in immunology,41438738,DILI,PubMed
Zihao Dong,Researcher,Urumqi,"Xinjiang, China.",zihao.dong@urumqi.com,linkedin.com/in/zihaodong,Molecular mechanisms and therapeutic strategies of cGAS-STING pathway in liver disease: the quest co,2025-12,Frontiers in immunology,41438738,DILI,PubMed
Yufeng Wu,Researcher,Urumqi,"Xinjiang, China.",yufeng.wu@urumqi.com,linkedin.com/in/yufengwu,Molecular mechanisms and therapeutic strategies of cGAS-STING pathway in liver disease: the quest co,2025-12,Frontiers in immunology,41438738,DILI,PubMed
Hao Wen,Researcher,Prevention and Treatment of High Incidence Diseases in Central Asia,"Xinjiang, China.",hao.wen@preventionandtreatmentofhighincidencediseasesincentralasia.com,linkedin.com/in/haowen,Molecular mechanisms and therapeutic strategies of cGAS-STING pathway in liver disease: the quest co,2025-12,Frontiers in immunology,41438738,DILI,PubMed
Lin Yang,Researcher,Shenzhen People's Hospital (The First Affiliated Hospital,"Shenzhen, People's Republic of China.",lin.yang@shenzhenpeople'shospital(thefirstaffiliatedhospital.com,linkedin.com/in/linyang,Recurrent Disseminated <i>Talaromycosis</i> Mimicking Liver Disease in a STAT3-Mutated HIES Patient:,2025-12,Infection and drug resistance,41426281,DILI,PubMed
Yiying Zhang,Researcher,Shenzhen Nanshan People's Hospital,"Shenzhen, People's Republic of China.",yiying.zhang@shenzhennanshanpeople'shospital.com,linkedin.com/in/yiyingzhang,Recurrent Disseminated <i>Talaromycosis</i> Mimicking Liver Disease in a STAT3-Mutated HIES Patient:,2025-12,Infection and drug resistance,41426281,DILI,PubMed
Minna Wu,Researcher,Shenzhen People's Hospital (The First Affiliated Hospital,"Shenzhen, People's Republic of China.",minna.wu@shenzhenpeople'shospital(thefirstaffiliatedhospital.com,linkedin.com/in/minnawu,Recurrent Disseminated <i>Talaromycosis</i> Mimicking Liver Disease in a STAT3-Mutated HIES Patient:,2025-12,Infection and drug resistance,41426281,DILI,PubMed
Furong Zeng,Researcher,Shenzhen People's Hospital (The First Affiliated Hospital,"Shenzhen, People's Republic of China.",furong.zeng@shenzhenpeople'shospital(thefirstaffiliatedhospital.com,linkedin.com/in/furongzeng,Recurrent Disseminated <i>Talaromycosis</i> Mimicking Liver Disease in a STAT3-Mutated HIES Patient:,2025-12,Infection and drug resistance,41426281,DILI,PubMed
Hongtao Chen,Researcher,Shenzhen People's Hospital (The First Affiliated Hospital,"Shenzhen, People's Republic of China.",hongtao.chen@shenzhenpeople'shospital(thefirstaffiliatedhospital.com,linkedin.com/in/hongtaochen,Recurrent Disseminated <i>Talaromycosis</i> Mimicking Liver Disease in a STAT3-Mutated HIES Patient:,2025-12,Infection and drug resistance,41426281,DILI,PubMed
Dongyuan Xie,Researcher,Shenzhen People's Hospital (The First Affiliated Hospital,"Shenzhen, People's Republic of China.",dongyuan.xie@shenzhenpeople'shospital(thefirstaffiliatedhospital.com,linkedin.com/in/dongyuanxie,Recurrent Disseminated <i>Talaromycosis</i> Mimicking Liver Disease in a STAT3-Mutated HIES Patient:,2025-12,Infection and drug resistance,41426281,DILI,PubMed
Fei Shi,Researcher,Shenzhen People's Hospital (The First Affiliated Hospital,"Shenzhen, People's Republic of China.",fei.shi@shenzhenpeople'shospital(thefirstaffiliatedhospital.com,linkedin.com/in/feishi,Recurrent Disseminated <i>Talaromycosis</i> Mimicking Liver Disease in a STAT3-Mutated HIES Patient:,2025-12,Infection and drug resistance,41426281,DILI,PubMed
Yajun Xiong,Researcher,Shanxi University of Chinese Medicine,"030000, China.",yajun.xiong@shanxieduofchinesemedicine.com,linkedin.com/in/yajunxiong,Xiaoyao powder attenuates acetaminophen-induced liver injury through modulating gut microbiota and u,2025-12,Journal of ethnopharmacology,41423158,DILI,PubMed
Dan Wang,Researcher,Shanxi University of Chinese Medicine,"030000, China.",dan.wang@shanxieduofchinesemedicine.com,linkedin.com/in/danwang,Xiaoyao powder attenuates acetaminophen-induced liver injury through modulating gut microbiota and u,2025-12,Journal of ethnopharmacology,41423158,DILI,PubMed
Xinli Shi,Researcher,Shanxi University of Chinese Medicine,"030000, China. Electronic address: sxlsunshine@sina.com.",xinli.shi@shanxieduofchinesemedicine.com,linkedin.com/in/xinlishi,Xiaoyao powder attenuates acetaminophen-induced liver injury through modulating gut microbiota and u,2025-12,Journal of ethnopharmacology,41423158,DILI,PubMed
Xiaoyong Song,Researcher,Shanxi University of Chinese Medicine,"030000, China.",xiaoyong.song@shanxieduofchinesemedicine.com,linkedin.com/in/xiaoyongsong,Xiaoyao powder attenuates acetaminophen-induced liver injury through modulating gut microbiota and u,2025-12,Journal of ethnopharmacology,41423158,DILI,PubMed
Zhihan Liu,Researcher,Shanxi University of Chinese Medicine,"030000, China.",zhihan.liu@shanxieduofchinesemedicine.com,linkedin.com/in/zhihanliu,Xiaoyao powder attenuates acetaminophen-induced liver injury through modulating gut microbiota and u,2025-12,Journal of ethnopharmacology,41423158,DILI,PubMed
Yanguang Yang,Researcher,Shanxi University of Chinese Medicine,"030000, China.",yanguang.yang@shanxieduofchinesemedicine.com,linkedin.com/in/yanguangyang,Xiaoyao powder attenuates acetaminophen-induced liver injury through modulating gut microbiota and u,2025-12,Journal of ethnopharmacology,41423158,DILI,PubMed
Yuting Gao,Researcher,Shanxi University of Chinese Medicine,"030000, China.",yuting.gao@shanxieduofchinesemedicine.com,linkedin.com/in/yutinggao,Xiaoyao powder attenuates acetaminophen-induced liver injury through modulating gut microbiota and u,2025-12,Journal of ethnopharmacology,41423158,DILI,PubMed
Yi Gong,Researcher,Shanxi University of Chinese Medicine,"030000, China.",yi.gong@shanxieduofchinesemedicine.com,linkedin.com/in/yigong,Xiaoyao powder attenuates acetaminophen-induced liver injury through modulating gut microbiota and u,2025-12,Journal of ethnopharmacology,41423158,DILI,PubMed
Junlan Lu,Researcher,Shanxi University of Chinese Medicine,"030000, China.",junlan.lu@shanxieduofchinesemedicine.com,linkedin.com/in/junlanlu,Xiaoyao powder attenuates acetaminophen-induced liver injury through modulating gut microbiota and u,2025-12,Journal of ethnopharmacology,41423158,DILI,PubMed
Yu Ding,Researcher,Shanxi University of Chinese Medicine,"030000, China.",yu.ding@shanxieduofchinesemedicine.com,linkedin.com/in/yuding,Xiaoyao powder attenuates acetaminophen-induced liver injury through modulating gut microbiota and u,2025-12,Journal of ethnopharmacology,41423158,DILI,PubMed
Yanli Gong,Researcher,Shanxi University of Chinese Medicine,"030000, China.",yanli.gong@shanxieduofchinesemedicine.com,linkedin.com/in/yanligong,Xiaoyao powder attenuates acetaminophen-induced liver injury through modulating gut microbiota and u,2025-12,Journal of ethnopharmacology,41423158,DILI,PubMed
Yuman Zhang,Researcher,Shanxi University of Chinese Medicine,"030000, China.",yuman.zhang@shanxieduofchinesemedicine.com,linkedin.com/in/yumanzhang,Xiaoyao powder attenuates acetaminophen-induced liver injury through modulating gut microbiota and u,2025-12,Journal of ethnopharmacology,41423158,DILI,PubMed
Gauri Kulkarni,Researcher,Boston,"Boston, MA",gauri.kulkarni@boston.com,linkedin.com/in/gaurikulkarni,A scalable human liver-on-a-chip platform for predictive safety assessment.,2025-12,Toxicology,41422937,DILI,PubMed
Lizao Chen,Researcher,L'Oréal Research & Innovation China,"Shanghai 201206, China.",lizao.chen@l'oréalresearch&innovationchina.com,linkedin.com/in/lizaochen,A scalable human liver-on-a-chip platform for predictive safety assessment.,2025-12,Toxicology,41422937,DILI,PubMed
Jing Sang,Researcher,NMPA Key Laboratory for Animal Alternative Testing Technology of Cosmetics,"Hangzhou 310035, China.",jing.sang@nmpakeylaboratoryforanimalalternativetestingtechnologyofcosmetics.com,linkedin.com/in/jingsang,A scalable human liver-on-a-chip platform for predictive safety assessment.,2025-12,Toxicology,41422937,DILI,PubMed
Ji Hye Seo,Researcher,Boston,"Boston, MA",ji.seo@boston.com,linkedin.com/in/jihyeseo,A scalable human liver-on-a-chip platform for predictive safety assessment.,2025-12,Toxicology,41422937,DILI,PubMed
Romain Grall,Researcher,1 Avenue Eugène Schueller,"Aulnay-Sous-Bois 93600, France.",romain.grall@1avenueeugèneschueller.com,linkedin.com/in/romaingrall,A scalable human liver-on-a-chip platform for predictive safety assessment.,2025-12,Toxicology,41422937,DILI,PubMed
Yunfang Wang,Researcher,Beijing Tsinghua Changgung Hospital,"Beijing, China.",yunfang.wang@beijingtsinghuachanggunghospital.com,linkedin.com/in/yunfangwang,A scalable human liver-on-a-chip platform for predictive safety assessment.,2025-12,Toxicology,41422937,DILI,PubMed
Paige Gilbride,Researcher,Boston,"Boston, MA",paige.gilbride@boston.com,linkedin.com/in/paigegilbride,A scalable human liver-on-a-chip platform for predictive safety assessment.,2025-12,Toxicology,41422937,DILI,PubMed
Yu-Chieh Yuan,Researcher,Boston,"Boston, MA",yu-chieh.yuan@boston.com,linkedin.com/in/yu-chiehyuan,A scalable human liver-on-a-chip platform for predictive safety assessment.,2025-12,Toxicology,41422937,DILI,PubMed
Matthew Albaum-Getzen,Researcher,Boston,"Boston, MA",matthew.albaum-getzen@boston.com,linkedin.com/in/matthewalbaum-getzen,A scalable human liver-on-a-chip platform for predictive safety assessment.,2025-12,Toxicology,41422937,DILI,PubMed
Jenna McCormack,Researcher,Boston,"Boston, MA",jenna.mccormack@boston.com,linkedin.com/in/jennamccormack,A scalable human liver-on-a-chip platform for predictive safety assessment.,2025-12,Toxicology,41422937,DILI,PubMed
Jingzhe Ma,Researcher,Boston,"Boston, MA",jingzhe.ma@boston.com,linkedin.com/in/jingzhema,A scalable human liver-on-a-chip platform for predictive safety assessment.,2025-12,Toxicology,41422937,DILI,PubMed
Alyssa Fanelli,Researcher,Boston,"Boston, MA",alyssa.fanelli@boston.com,linkedin.com/in/alyssafanelli,A scalable human liver-on-a-chip platform for predictive safety assessment.,2025-12,Toxicology,41422937,DILI,PubMed
Lingjun Meng,Researcher,Boston,"Boston, MA",lingjun.meng@boston.com,linkedin.com/in/lingjunmeng,A scalable human liver-on-a-chip platform for predictive safety assessment.,2025-12,Toxicology,41422937,DILI,PubMed
Beibei Xu,Researcher,Shenzhen Institute of Synthetic Biology,"Shenzhen, China.",beibei.xu@shenzhenorgofsyntheticbiology.com,linkedin.com/in/beibeixu,A scalable human liver-on-a-chip platform for predictive safety assessment.,2025-12,Toxicology,41422937,DILI,PubMed
XuHai Huang,Researcher,Boston,"Boston, MA",xuhai.huang@boston.com,linkedin.com/in/xuhaihuang,A scalable human liver-on-a-chip platform for predictive safety assessment.,2025-12,Toxicology,41422937,DILI,PubMed
Thomas Marshall,Researcher,Boston,"Boston, MA",thomas.marshall@boston.com,linkedin.com/in/thomasmarshall,A scalable human liver-on-a-chip platform for predictive safety assessment.,2025-12,Toxicology,41422937,DILI,PubMed
Hardeep Singh,Researcher,Boston,"Boston, MA",hardeep.singh@boston.com,linkedin.com/in/hardeepsingh,A scalable human liver-on-a-chip platform for predictive safety assessment.,2025-12,Toxicology,41422937,DILI,PubMed
Xiaohua Qian,Researcher,Boston,"Boston, MA",xiaohua.qian@boston.com,linkedin.com/in/xiaohuaqian,A scalable human liver-on-a-chip platform for predictive safety assessment.,2025-12,Toxicology,41422937,DILI,PubMed
Zhiyong Xie,Researcher,Boston,"Boston, MA",zhiyong.xie@boston.com,linkedin.com/in/zhiyongxie,A scalable human liver-on-a-chip platform for predictive safety assessment.,2025-12,Toxicology,41422937,DILI,PubMed
Hui Bai,Researcher,Beijing Tsinghua Changgung Hospital,"Beijing, China.",hui.bai@beijingtsinghuachanggunghospital.com,linkedin.com/in/huibai,A scalable human liver-on-a-chip platform for predictive safety assessment.,2025-12,Toxicology,41422937,DILI,PubMed
Longlong Si,Researcher,Shenzhen Institute of Synthetic Biology,"Beijing 100049, China.",longlong.si@shenzhenorgofsyntheticbiology.com,linkedin.com/in/longlongsi,A scalable human liver-on-a-chip platform for predictive safety assessment.,2025-12,Toxicology,41422937,DILI,PubMed
Chunmei Ding,Researcher,L'Oréal Research & Innovation China,"Shanghai 201206, China.",chunmei.ding@l'oréalresearch&innovationchina.com,linkedin.com/in/chunmeiding,A scalable human liver-on-a-chip platform for predictive safety assessment.,2025-12,Toxicology,41422937,DILI,PubMed
Gladys Ouedraogo,Researcher,1 Avenue Eugène Schueller,"Aulnay-Sous-Bois 93600, France. Electronic address: gladys.ouedraogo@loreal.com.",gladys.ouedraogo@1avenueeugèneschueller.com,linkedin.com/in/gladysouedraogo,A scalable human liver-on-a-chip platform for predictive safety assessment.,2025-12,Toxicology,41422937,DILI,PubMed
Rong Kuang,Researcher,NMPA Key Laboratory for Animal Alternative Testing Technology of Cosmetics,"Hangzhou 310035, China. Electronic address: kuangrong@zjyj.org.cn.",rong.kuang@nmpakeylaboratoryforanimalalternativetestingtechnologyofcosmetics.com,linkedin.com/in/rongkuang,A scalable human liver-on-a-chip platform for predictive safety assessment.,2025-12,Toxicology,41422937,DILI,PubMed
Xin Xie,Researcher,Boston,"Boston, MA",xin.xie@boston.com,linkedin.com/in/xinxie,A scalable human liver-on-a-chip platform for predictive safety assessment.,2025-12,Toxicology,41422937,DILI,PubMed
Haiqing Bai,Researcher,Boston,"Boston, MA",haiqing.bai@boston.com,linkedin.com/in/haiqingbai,A scalable human liver-on-a-chip platform for predictive safety assessment.,2025-12,Toxicology,41422937,DILI,PubMed
Mina Komuta,Researcher,International University of Health and Welfare,"Chiba, Japan.",mina.komuta@internationaleduofhealthandwelfare.com,linkedin.com/in/minakomuta,Autoimmune Hepatitis: Histopathological Diversity and Its Clinical Implications.,2025-12,Hepatology research : the official journal of the Japan Society of Hepatology,41417598,DILI,PubMed
Kenichi Harada,Researcher,Graduate School of Medicine Sciences,"Kanazawa, Japan.",kenichi.harada@graduateschoolofmedicinesciences.com,linkedin.com/in/kenichiharada,Autoimmune Hepatitis: Histopathological Diversity and Its Clinical Implications.,2025-12,Hepatology research : the official journal of the Japan Society of Hepatology,41417598,DILI,PubMed
Zhun Xiao,Researcher,The First Affiliated Hospital of Henan University of Chinese Medicine,"Zhengzhou, China.",zhun.xiao@thefirstaffiliatedhospitalofhenaneduofchinesemedicine.com,linkedin.com/in/zhunxiao,Drug-induced liver injury highly probable due to goserelin: a case report evaluated with the updated,2025-12,Frontiers in medicine,41416092,DILI,PubMed
Xiqian Zhang,Researcher,The Second Affiliated Hospital of Henan University of Chinese Medicine (Henan Province Hospital of Traditional Chinese Medicine),"Zhengzhou, China.",xiqian.zhang@thesecondaffiliatedhospitalofhenaneduofchinesemedicine(henanprovincehospitaloftraditionalchinesemedicine).com,linkedin.com/in/xiqianzhang,Drug-induced liver injury highly probable due to goserelin: a case report evaluated with the updated,2025-12,Frontiers in medicine,41416092,DILI,PubMed
Longfei Zhang,Researcher,The First Affiliated Hospital of Henan University of Chinese Medicine,"Zhengzhou, China.",longfei.zhang@thefirstaffiliatedhospitalofhenaneduofchinesemedicine.com,linkedin.com/in/longfeizhang,Drug-induced liver injury highly probable due to goserelin: a case report evaluated with the updated,2025-12,Frontiers in medicine,41416092,DILI,PubMed
Yanmin Li,Researcher,The First Affiliated Hospital of Henan University of Chinese Medicine,"Zhengzhou, China.",yanmin.li@thefirstaffiliatedhospitalofhenaneduofchinesemedicine.com,linkedin.com/in/yanminli,Drug-induced liver injury highly probable due to goserelin: a case report evaluated with the updated,2025-12,Frontiers in medicine,41416092,DILI,PubMed
Suping Ma,Researcher,The First Affiliated Hospital of Henan University of Chinese Medicine,"Zhengzhou, China.",suping.ma@thefirstaffiliatedhospitalofhenaneduofchinesemedicine.com,linkedin.com/in/supingma,Drug-induced liver injury highly probable due to goserelin: a case report evaluated with the updated,2025-12,Frontiers in medicine,41416092,DILI,PubMed
Zhikun Wang,Researcher,The Second Affiliated Hospital,"Jiangxi, China.",zhikun.wang@thesecondaffiliatedhospital.com,linkedin.com/in/zhikunwang,Evaluating the accuracy of the histological diagnosis in unexplained liver injury: A retrospective s,2025-12,Clinics and research in hepatology and gastroenterology,41412480,DILI,PubMed
Linqian Wu,Researcher,The Second Affiliated Hospital,"Jiangxi, China.",linqian.wu@thesecondaffiliatedhospital.com,linkedin.com/in/linqianwu,Evaluating the accuracy of the histological diagnosis in unexplained liver injury: A retrospective s,2025-12,Clinics and research in hepatology and gastroenterology,41412480,DILI,PubMed
Ke Bai,Researcher,The Second Affiliated Hospital,"Jiangxi, China.",ke.bai@thesecondaffiliatedhospital.com,linkedin.com/in/kebai,Evaluating the accuracy of the histological diagnosis in unexplained liver injury: A retrospective s,2025-12,Clinics and research in hepatology and gastroenterology,41412480,DILI,PubMed
Mengru Qiu,Researcher,The Second Affiliated Hospital,"Jiangxi, China.",mengru.qiu@thesecondaffiliatedhospital.com,linkedin.com/in/mengruqiu,Evaluating the accuracy of the histological diagnosis in unexplained liver injury: A retrospective s,2025-12,Clinics and research in hepatology and gastroenterology,41412480,DILI,PubMed
Qing Li,Researcher,The Second Affiliated Hospital,"Jiangxi, China.",qing.li@thesecondaffiliatedhospital.com,linkedin.com/in/qingli,Evaluating the accuracy of the histological diagnosis in unexplained liver injury: A retrospective s,2025-12,Clinics and research in hepatology and gastroenterology,41412480,DILI,PubMed
Liangtao Zeng,Researcher,The Second Affiliated Hospital,"Jiangxi, China.",liangtao.zeng@thesecondaffiliatedhospital.com,linkedin.com/in/liangtaozeng,Evaluating the accuracy of the histological diagnosis in unexplained liver injury: A retrospective s,2025-12,Clinics and research in hepatology and gastroenterology,41412480,DILI,PubMed
Yipeng Wan,Researcher,The Second Affiliated Hospital,"Jiangxi, China.",yipeng.wan@thesecondaffiliatedhospital.com,linkedin.com/in/yipengwan,Evaluating the accuracy of the histological diagnosis in unexplained liver injury: A retrospective s,2025-12,Clinics and research in hepatology and gastroenterology,41412480,DILI,PubMed
Hui Zhu,Researcher,The Second Affiliated Hospital,"Jiangxi, China.",hui.zhu@thesecondaffiliatedhospital.com,linkedin.com/in/huizhu,Evaluating the accuracy of the histological diagnosis in unexplained liver injury: A retrospective s,2025-12,Clinics and research in hepatology and gastroenterology,41412480,DILI,PubMed
Lifang Chen,Researcher,The Second Affiliated Hospital,"Jiangxi, China.",lifang.chen@thesecondaffiliatedhospital.com,linkedin.com/in/lifangchen,Evaluating the accuracy of the histological diagnosis in unexplained liver injury: A retrospective s,2025-12,Clinics and research in hepatology and gastroenterology,41412480,DILI,PubMed
Zhili Wen,Researcher,The Second Affiliated Hospital,"Jiangxi, China.",zhili.wen@thesecondaffiliatedhospital.com,linkedin.com/in/zhiliwen,Evaluating the accuracy of the histological diagnosis in unexplained liver injury: A retrospective s,2025-12,Clinics and research in hepatology and gastroenterology,41412480,DILI,PubMed
Lingling Yang,Researcher,The Second Affiliated Hospital,"Jiangxi, China. Electronic address: eleanyang2008@163.com.",lingling.yang@thesecondaffiliatedhospital.com,linkedin.com/in/linglingyang,Evaluating the accuracy of the histological diagnosis in unexplained liver injury: A retrospective s,2025-12,Clinics and research in hepatology and gastroenterology,41412480,DILI,PubMed
Yongqing Zhou,Researcher,University of Jinan,"250022, P. R. China.",yongqing.zhou@eduofjinan.com,linkedin.com/in/yongqingzhou,Investigating Mitochondrial Viscosity in Ferroptosis-Mediated Drug-Induced Liver Injury using a Doub,2025-12,"Advanced science (Weinheim, Baden-Wurttemberg, Germany)",41400087,DILI,PubMed
Yan Wang,Researcher,University of Jinan,"250022, P. R. China.",yan.wang@eduofjinan.com,linkedin.com/in/yanwang,Investigating Mitochondrial Viscosity in Ferroptosis-Mediated Drug-Induced Liver Injury using a Doub,2025-12,"Advanced science (Weinheim, Baden-Wurttemberg, Germany)",41400087,DILI,PubMed
Bing Huang,Researcher,University of Jinan,"250022, P. R. China.",bing.huang@eduofjinan.com,linkedin.com/in/binghuang,Investigating Mitochondrial Viscosity in Ferroptosis-Mediated Drug-Induced Liver Injury using a Doub,2025-12,"Advanced science (Weinheim, Baden-Wurttemberg, Germany)",41400087,DILI,PubMed
Hosoowi Lee,Researcher,Ewha Womans University,"03760, South Korea.",hosoowi.lee@ewhawomansedu.com,linkedin.com/in/hosoowilee,Investigating Mitochondrial Viscosity in Ferroptosis-Mediated Drug-Induced Liver Injury using a Doub,2025-12,"Advanced science (Weinheim, Baden-Wurttemberg, Germany)",41400087,DILI,PubMed
Mei Yan,Researcher,University of Jinan,"250022, P. R. China.",mei.yan@eduofjinan.com,linkedin.com/in/meiyan,Investigating Mitochondrial Viscosity in Ferroptosis-Mediated Drug-Induced Liver Injury using a Doub,2025-12,"Advanced science (Weinheim, Baden-Wurttemberg, Germany)",41400087,DILI,PubMed
Juyoung Yoon,Researcher,Ewha Womans University,"03760, South Korea.",juyoung.yoon@ewhawomansedu.com,linkedin.com/in/juyoungyoon,Investigating Mitochondrial Viscosity in Ferroptosis-Mediated Drug-Induced Liver Injury using a Doub,2025-12,"Advanced science (Weinheim, Baden-Wurttemberg, Germany)",41400087,DILI,PubMed
Kevan English,Researcher,University of Nebraska Medical Center,"NE 68198, United States. keenglish@unmc.edu.",kevan.english@eduofnebraskamedicalcenter.com,linkedin.com/in/kevanenglish,Drug-induced liver injury from high-dose intravenous methylprednisolone: A rare but known adverse ef,2024-01,World journal of gastrointestinal pathophysiology,41479865,drug-induced liver injury,PubMed
Meng-Jiao Xu,Researcher,Beijing Ditan Hospital,"Beijing 100015, China.",meng-jiao.xu@beijingditanhospital.com,linkedin.com/in/meng-jiaoxu,Severe hyperlipidemia associated with drug-induced cholestatic liver disease: A case report.,2024-01,World journal of hepatology,41479512,drug-induced liver injury,PubMed
Xin Wei,Researcher,Beijing Ditan Hospital,"Beijing 100015, China.",xin.wei@beijingditanhospital.com,linkedin.com/in/xinwei,Severe hyperlipidemia associated with drug-induced cholestatic liver disease: A case report.,2024-01,World journal of hepatology,41479512,drug-induced liver injury,PubMed
Yao Lu,Researcher,Beijing Ditan Hospital,"Beijing 100015, China.",yao.lu@beijingditanhospital.com,linkedin.com/in/yaolu,Severe hyperlipidemia associated with drug-induced cholestatic liver disease: A case report.,2024-01,World journal of hepatology,41479512,drug-induced liver injury,PubMed
Lei Sun,Researcher,Beijing Ditan Hospital,"Beijing 100015, China.",lei.sun@beijingditanhospital.com,linkedin.com/in/leisun,Severe hyperlipidemia associated with drug-induced cholestatic liver disease: A case report.,2024-01,World journal of hepatology,41479512,drug-induced liver injury,PubMed
Yao Xie,Researcher,Beijing Ditan Hospital,"Beijing 100015, China.",yao.xie@beijingditanhospital.com,linkedin.com/in/yaoxie,Severe hyperlipidemia associated with drug-induced cholestatic liver disease: A case report.,2024-01,World journal of hepatology,41479512,drug-induced liver injury,PubMed
Ming-Hui Li,Researcher,Beijing Ditan Hospital,"Beijing 100015, China.",ming-hui.li@beijingditanhospital.com,linkedin.com/in/ming-huili,Severe hyperlipidemia associated with drug-induced cholestatic liver disease: A case report.,2024-01,World journal of hepatology,41479512,drug-induced liver injury,PubMed
Sahan Withanage,Researcher,Barwon Health,"Australia, barwonhealth.org.au.",sahan.withanage@barwonhealth.com,linkedin.com/in/sahanwithanage,Kava Herb-Induced Liver Injury as Verified by the Updated RUCAM.,2025-12,Case reports in gastrointestinal medicine,41477654,drug-induced liver injury,PubMed
Carl Cosgrave,Researcher,Barwon Health,"Australia, barwonhealth.org.au.",carl.cosgrave@barwonhealth.com,linkedin.com/in/carlcosgrave,Kava Herb-Induced Liver Injury as Verified by the Updated RUCAM.,2025-12,Case reports in gastrointestinal medicine,41477654,drug-induced liver injury,PubMed
Shoa Zafir,Researcher,Geelong,"3220, Australia.",shoa.zafir@geelong.com,linkedin.com/in/shoazafir,Kava Herb-Induced Liver Injury as Verified by the Updated RUCAM.,2025-12,Case reports in gastrointestinal medicine,41477654,drug-induced liver injury,PubMed
Eliza Flanagan,Researcher,Barwon Health,"Australia, barwonhealth.org.au.",eliza.flanagan@barwonhealth.com,linkedin.com/in/elizaflanagan,Kava Herb-Induced Liver Injury as Verified by the Updated RUCAM.,2025-12,Case reports in gastrointestinal medicine,41477654,drug-induced liver injury,PubMed
Phillip Te,Researcher,Barwon Health,"Australia, barwonhealth.org.au.",phillip.te@barwonhealth.com,linkedin.com/in/phillipte,Kava Herb-Induced Liver Injury as Verified by the Updated RUCAM.,2025-12,Case reports in gastrointestinal medicine,41477654,drug-induced liver injury,PubMed
Samuel Hall,Researcher,Barwon Health,"Australia, barwonhealth.org.au.",samuel.hall@barwonhealth.com,linkedin.com/in/samuelhall,Kava Herb-Induced Liver Injury as Verified by the Updated RUCAM.,2025-12,Case reports in gastrointestinal medicine,41477654,drug-induced liver injury,PubMed
Isabel Conde Amiel,Researcher,Valencia,"Valencia, Spain.",isabel.amiel@valencia.com,linkedin.com/in/isabelcondeamiel,Trends in Liver Transplantation for Acute Liver Failure in a Spanish Multicenter Cohort.,2025-12,Transplant international : official journal of the European Society for Organ Transplantation,41477112,drug-induced liver injury,PubMed
Sara Martínez Delgado,Researcher,Valencia,"Valencia, Spain.",sara.delgado@valencia.com,linkedin.com/in/saramartínezdelgado,Trends in Liver Transplantation for Acute Liver Failure in a Spanish Multicenter Cohort.,2025-12,Transplant international : official journal of the European Society for Organ Transplantation,41477112,drug-induced liver injury,PubMed
Andrea Bosca Robledo,Researcher,Valencia,"Valencia, Spain.",andrea.robledo@valencia.com,linkedin.com/in/andreaboscarobledo,Trends in Liver Transplantation for Acute Liver Failure in a Spanish Multicenter Cohort.,2025-12,Transplant international : official journal of the European Society for Organ Transplantation,41477112,drug-induced liver injury,PubMed
María Senosiáin Labiano,Researcher,Bilbao,"Bilbao, Spain.",maría.labiano@bilbao.com,linkedin.com/in/maríasenosiáinlabiano,Trends in Liver Transplantation for Acute Liver Failure in a Spanish Multicenter Cohort.,2025-12,Transplant international : official journal of the European Society for Organ Transplantation,41477112,drug-induced liver injury,PubMed
Rosa María Martín Mateos,Researcher,Instituto Carlos III,"Madrid, Spain.",rosa.mateos@institutocarlosiii.com,linkedin.com/in/rosamaríamartínmateos,Trends in Liver Transplantation for Acute Liver Failure in a Spanish Multicenter Cohort.,2025-12,Transplant international : official journal of the European Society for Organ Transplantation,41477112,drug-induced liver injury,PubMed
Carolina Almohalla Álvarez,Researcher,Valladolid,"Valladolid, Spain.",carolina.álvarez@valladolid.com,linkedin.com/in/carolinaalmohallaálvarez,Trends in Liver Transplantation for Acute Liver Failure in a Spanish Multicenter Cohort.,2025-12,Transplant international : official journal of the European Society for Organ Transplantation,41477112,drug-induced liver injury,PubMed
María Luisa González Diéguez,Researcher,Oviedo,"Oviedo, Spain.",maría.diéguez@oviedo.com,linkedin.com/in/maríaluisagonzálezdiéguez,Trends in Liver Transplantation for Acute Liver Failure in a Spanish Multicenter Cohort.,2025-12,Transplant international : official journal of the European Society for Organ Transplantation,41477112,drug-induced liver injury,PubMed
Sara Lorente Pérez,Researcher,Zaragoza,"Zaragoza, Spain.",sara.pérez@zaragoza.com,linkedin.com/in/saralorentepérez,Trends in Liver Transplantation for Acute Liver Failure in a Spanish Multicenter Cohort.,2025-12,Transplant international : official journal of the European Society for Organ Transplantation,41477112,drug-induced liver injury,PubMed
Alejandra Otero Ferreiro,Researcher,A Coruña,"A Coruña, Spain.",alejandra.ferreiro@acoruña.com,linkedin.com/in/alejandraoteroferreiro,Trends in Liver Transplantation for Acute Liver Failure in a Spanish Multicenter Cohort.,2025-12,Transplant international : official journal of the European Society for Organ Transplantation,41477112,drug-induced liver injury,PubMed
María Rodríguez-Soler,Researcher,Alicante,"Alicante, Spain.",maría.rodríguez-soler@alicante.com,linkedin.com/in/maríarodríguez-soler,Trends in Liver Transplantation for Acute Liver Failure in a Spanish Multicenter Cohort.,2025-12,Transplant international : official journal of the European Society for Organ Transplantation,41477112,drug-induced liver injury,PubMed
José Ignacio Herrero,Researcher,Instituto Carlos III,"Madrid, Spain.",josé.herrero@institutocarlosiii.com,linkedin.com/in/joséignacioherrero,Trends in Liver Transplantation for Acute Liver Failure in a Spanish Multicenter Cohort.,2025-12,Transplant international : official journal of the European Society for Organ Transplantation,41477112,drug-induced liver injury,PubMed
Laia Aceituno,Researcher,Barcelona,"Barcelona, Spain.",laia.aceituno@barcelona.com,linkedin.com/in/laiaaceituno,Trends in Liver Transplantation for Acute Liver Failure in a Spanish Multicenter Cohort.,2025-12,Transplant international : official journal of the European Society for Organ Transplantation,41477112,drug-induced liver injury,PubMed
Ainhoa Fernández Yunquera,Researcher,Madrid,"Madrid, Spain.",ainhoa.yunquera@madrid.com,linkedin.com/in/ainhoafernándezyunquera,Trends in Liver Transplantation for Acute Liver Failure in a Spanish Multicenter Cohort.,2025-12,Transplant international : official journal of the European Society for Organ Transplantation,41477112,drug-induced liver injury,PubMed
Marina Berenguer,Researcher,Valencia,"Valencia, Spain.",marina.berenguer@valencia.com,linkedin.com/in/marinaberenguer,Trends in Liver Transplantation for Acute Liver Failure in a Spanish Multicenter Cohort.,2025-12,Transplant international : official journal of the European Society for Organ Transplantation,41477112,drug-induced liver injury,PubMed
Victoria Aguilera Sancho-Tello,Researcher,Valencia,"Valencia, Spain.",victoria.sancho-tello@valencia.com,linkedin.com/in/victoriaaguilerasancho-tello,Trends in Liver Transplantation for Acute Liver Failure in a Spanish Multicenter Cohort.,2025-12,Transplant international : official journal of the European Society for Organ Transplantation,41477112,drug-induced liver injury,PubMed
Sydney Lovrien,Researcher,Sanford School of Medicine,"USA, sdstate.edu.",sydney.lovrien@sanfordschoolofmedicine.com,linkedin.com/in/sydneylovrien,Deciphering Hepatic Dilemmas: A Case of Acute Hepatitis Following Malaria Treatment.,2025-12,Case reports in gastrointestinal medicine,41466773,drug-induced liver injury,PubMed
Erin Quist,Researcher,Sanford School of Medicine,"USA, sdstate.edu.",erin.quist@sanfordschoolofmedicine.com,linkedin.com/in/erinquist,Deciphering Hepatic Dilemmas: A Case of Acute Hepatitis Following Malaria Treatment.,2025-12,Case reports in gastrointestinal medicine,41466773,drug-induced liver injury,PubMed
Dayana Maita Coronel,Researcher,Avera McKennan Hospital & University Health Center,"USA, avera.org.",dayana.coronel@averamckennanhospital&eduhealthcenter.com,linkedin.com/in/dayanamaitacoronel,Deciphering Hepatic Dilemmas: A Case of Acute Hepatitis Following Malaria Treatment.,2025-12,Case reports in gastrointestinal medicine,41466773,drug-induced liver injury,PubMed
Ashwani K Singal,Researcher,University of Louisville School of Medicine,"USA, louisville.edu.",ashwani.singal@eduoflouisvilleschoolofmedicine.com,linkedin.com/in/ashwaniksingal,Deciphering Hepatic Dilemmas: A Case of Acute Hepatitis Following Malaria Treatment.,2025-12,Case reports in gastrointestinal medicine,41466773,drug-induced liver injury,PubMed
Chencheng Xie,Researcher,Roy J. and Lucille A. Carver College of Medicine,"USA, uiowa.edu.",chencheng.xie@royj.andlucillea.carvercollegeofmedicine,linkedin.com/in/chenchengxie,Deciphering Hepatic Dilemmas: A Case of Acute Hepatitis Following Malaria Treatment.,2025-12,Case reports in gastrointestinal medicine,41466773,drug-induced liver injury,PubMed
Chizuka Obara,Researcher,Department of Biology,"Chiba, Japan.",chizuka.obara@departmentofbiology.com,linkedin.com/in/chizukaobara,Development of a CYP2D6-enhanced HepaRG cell model with improved CYP2D6 metabolic capacity.,2025-12,PloS one,41460788,drug-induced liver injury,PubMed
Yohei Iizaka,Researcher,Faculty of Pharmaceutical Sciences,"Toho University, Japan.",yohei.iizaka@facultyofpharmaceuticalsciences.com,linkedin.com/in/yoheiiizaka,Development of a CYP2D6-enhanced HepaRG cell model with improved CYP2D6 metabolic capacity.,2025-12,PloS one,41460788,drug-induced liver injury,PubMed
Akari Mine,Researcher,Department of Biology,"Chiba, Japan.",akari.mine@departmentofbiology.com,linkedin.com/in/akarimine,Development of a CYP2D6-enhanced HepaRG cell model with improved CYP2D6 metabolic capacity.,2025-12,PloS one,41460788,drug-induced liver injury,PubMed
Yojiro Anzai,Researcher,Faculty of Pharmaceutical Sciences,"Toho University, Japan.",yojiro.anzai@facultyofpharmaceuticalsciences.com,linkedin.com/in/yojiroanzai,Development of a CYP2D6-enhanced HepaRG cell model with improved CYP2D6 metabolic capacity.,2025-12,PloS one,41460788,drug-induced liver injury,PubMed
Masako Tada,Researcher,Department of Biology,"Chiba, Japan.",masako.tada@departmentofbiology.com,linkedin.com/in/masakotada,Development of a CYP2D6-enhanced HepaRG cell model with improved CYP2D6 metabolic capacity.,2025-12,PloS one,41460788,drug-induced liver injury,PubMed
Shinpei Yamaguchi,Researcher,Department of Biology,"Chiba, Japan.",shinpei.yamaguchi@departmentofbiology.com,linkedin.com/in/shinpeiyamaguchi,Development of a CYP2D6-enhanced HepaRG cell model with improved CYP2D6 metabolic capacity.,2025-12,PloS one,41460788,drug-induced liver injury,PubMed
Eunbyul Cho,Researcher,Korea Institute of Oriental Medicine,"Iksan 54538, the Republic of Korea.",eunbyul.cho@koreaorgoforientalmedicine.com,linkedin.com/in/eunbyulcho,Safety of herbal medicines in Korean medicine clinics in Republic of Korea: A nationwide retrospecti,2025-12,Journal of integrative medicine,41455671,drug-induced liver injury,PubMed
Mi Mi Ko,Researcher,Korea Institute of Oriental Medicine,"Daejeon 34054, the Republic of Korea.",mi.ko@koreaorgoforientalmedicine.com,linkedin.com/in/mimiko,Safety of herbal medicines in Korean medicine clinics in Republic of Korea: A nationwide retrospecti,2025-12,Journal of integrative medicine,41455671,drug-induced liver injury,PubMed
Changsop Yang,Researcher,Korea Institute of Oriental Medicine,"Daejeon 34054, the Republic of Korea.",changsop.yang@koreaorgoforientalmedicine.com,linkedin.com/in/changsopyang,Safety of herbal medicines in Korean medicine clinics in Republic of Korea: A nationwide retrospecti,2025-12,Journal of integrative medicine,41455671,drug-induced liver injury,PubMed
Sungha Kim,Researcher,Korea Institute of Oriental Medicine,"Daejeon 34054, the Republic of Korea. Electronic address: bozzol@kiom.re.kr.",sungha.kim@koreaorgoforientalmedicine.com,linkedin.com/in/sunghakim,Safety of herbal medicines in Korean medicine clinics in Republic of Korea: A nationwide retrospecti,2025-12,Journal of integrative medicine,41455671,drug-induced liver injury,PubMed
Juan Li,Researcher,University of Jinan,"Jinan 250022, People's Republic of China.",juan.li@eduofjinan.com,linkedin.com/in/juanli,Near-Infrared Ratiometric Fluorescent Probe for Monitoring Hypochlorous Acid in Ferroptosis Models.,2025-12,Analytical chemistry,41451512,drug-induced liver injury,PubMed
Chuanchen Wu,Researcher,School of Medicine,"Shandong, People's Republic of China.",chuanchen.wu@schoolofmedicine.com,linkedin.com/in/chuanchenwu,Near-Infrared Ratiometric Fluorescent Probe for Monitoring Hypochlorous Acid in Ferroptosis Models.,2025-12,Analytical chemistry,41451512,drug-induced liver injury,PubMed
Chaewoon Cho,Researcher,Ewha Womans University,"Seoul 03760, Korea.",chaewoon.cho@ewhawomansedu.com,linkedin.com/in/chaewooncho,Near-Infrared Ratiometric Fluorescent Probe for Monitoring Hypochlorous Acid in Ferroptosis Models.,2025-12,Analytical chemistry,41451512,drug-induced liver injury,PubMed
Bola Reyad,Researcher,St. Mary's Hospital,"Isle of Wight, GBR.",bola.reyad@st.mary'shospital,linkedin.com/in/bolareyad,Severe Hepatitis in a Patient With Undifferentiated Connective Tissue Disease: Diagnostic Uncertaint,2025-11,Cureus,41446487,drug-induced liver injury,PubMed
Percy J Vásquez-Paredes,Researcher,EsSalud,"Cusco, Peru.",percy.vásquez-paredes@essalud.com,linkedin.com/in/percyjvásquez-paredes,Ketoconazole for Cutaneous Leishmaniasis in the Context of Drug Shortages: A Case Report from Madre ,2025-12,The Yale journal of biology and medicine,41477461,hepatotoxicity,PubMed
Talat M Hashem,Researcher,Makkah Regional Laboratory Ministry of Health Makkah Saudi Arabia.,Unknown,talat.hashem@makkahregionallaboratoryministryofhealthmakkahsaudiarabia.,linkedin.com/in/talatmhashem,Gastroprotective and Antiulcerogenic Impacts of Pomegranates (<i>Punica granatum</i>) Peel Extract: ,2025-12,Food science & nutrition,41476712,hepatotoxicity,PubMed
Manal A Almughamisi,Researcher,Faculty of Applied Medical Sciences Taibah University Medina Saudi Arabia.,"Department of Clinical Nutrition, Faculty of Applied Medical Sciences Taibah University Medina Saudi Arabia.",manal.almughamisi@facultyofappliedmedicalsciencestaibahedumedinasaudiarabia.,linkedin.com/in/manalaalmughamisi,Gastroprotective and Antiulcerogenic Impacts of Pomegranates (<i>Punica granatum</i>) Peel Extract: ,2025-12,Food science & nutrition,41476712,hepatotoxicity,PubMed
Ameerah M Almaski,Researcher,Faculty of Applied Medical Sciences Taibah University Medina Saudi Arabia.,"Department of Clinical Nutrition, Faculty of Applied Medical Sciences Taibah University Medina Saudi Arabia.",ameerah.almaski@facultyofappliedmedicalsciencestaibahedumedinasaudiarabia.,linkedin.com/in/ameerahmalmaski,Gastroprotective and Antiulcerogenic Impacts of Pomegranates (<i>Punica granatum</i>) Peel Extract: ,2025-12,Food science & nutrition,41476712,hepatotoxicity,PubMed
Suha H Abduljawad,Researcher,Faculty of Applied Medical Sciences Taibah University Medina Saudi Arabia.,"Department of Clinical Nutrition, Faculty of Applied Medical Sciences Taibah University Medina Saudi Arabia.",suha.abduljawad@facultyofappliedmedicalsciencestaibahedumedinasaudiarabia.,linkedin.com/in/suhahabduljawad,Gastroprotective and Antiulcerogenic Impacts of Pomegranates (<i>Punica granatum</i>) Peel Extract: ,2025-12,Food science & nutrition,41476712,hepatotoxicity,PubMed
Adel A Hassan,Researcher,Makkah Regional Laboratory Ministry of Health Makkah Saudi Arabia.,Unknown,adel.hassan@makkahregionallaboratoryministryofhealthmakkahsaudiarabia.,linkedin.com/in/adelahassan,Gastroprotective and Antiulcerogenic Impacts of Pomegranates (<i>Punica granatum</i>) Peel Extract: ,2025-12,Food science & nutrition,41476712,hepatotoxicity,PubMed
Gianluca Gazzaniga,Researcher,Sapienza University of Rome,"Rome, Italy.",gianluca.gazzaniga@sapienzaeduofrome.com,linkedin.com/in/gianlucagazzaniga,Drug-related hepatotoxicity risk in elderly patients with atrial fibrillation: insights from the nat,2025-12,Scientific reports,41476074,hepatotoxicity,PubMed
Danilo Menichelli,Researcher,Sapienza University of Rome,"Rome, Italy.",danilo.menichelli@sapienzaeduofrome.com,linkedin.com/in/danilomenichelli,Drug-related hepatotoxicity risk in elderly patients with atrial fibrillation: insights from the nat,2025-12,Scientific reports,41476074,hepatotoxicity,PubMed
Daniela Poli,Researcher,Thrombosis Centre,"Firenze, Italy.",daniela.poli@thrombosiscentre.com,linkedin.com/in/danielapoli,Drug-related hepatotoxicity risk in elderly patients with atrial fibrillation: insights from the nat,2025-12,Scientific reports,41476074,hepatotoxicity,PubMed
Gualtiero Palareti,Researcher,Bologna,"Bologna, Italy.",gualtiero.palareti@bologna.com,linkedin.com/in/gualtieropalareti,Drug-related hepatotoxicity risk in elderly patients with atrial fibrillation: insights from the nat,2025-12,Scientific reports,41476074,hepatotoxicity,PubMed
Emilia Antonucci,Researcher,Bologna,"Bologna, Italy.",emilia.antonucci@bologna.com,linkedin.com/in/emiliaantonucci,Drug-related hepatotoxicity risk in elderly patients with atrial fibrillation: insights from the nat,2025-12,Scientific reports,41476074,hepatotoxicity,PubMed
Arianna Pani,Researcher,University of Milan,"Milan, Italy.",arianna.pani@eduofmilan.com,linkedin.com/in/ariannapani,Drug-related hepatotoxicity risk in elderly patients with atrial fibrillation: insights from the nat,2025-12,Scientific reports,41476074,hepatotoxicity,PubMed
Pasquale Pignatelli,Researcher,Sapienza University of Rome,"Rome, Italy.",pasquale.pignatelli@sapienzaeduofrome.com,linkedin.com/in/pasqualepignatelli,Drug-related hepatotoxicity risk in elderly patients with atrial fibrillation: insights from the nat,2025-12,Scientific reports,41476074,hepatotoxicity,PubMed
Daniele Pastori,Researcher,Sapienza University of Rome,"Rome, Italy. daniele.pastori@uniroma1.it.",daniele.pastori@sapienzaeduofrome.com,linkedin.com/in/danielepastori,Drug-related hepatotoxicity risk in elderly patients with atrial fibrillation: insights from the nat,2025-12,Scientific reports,41476074,hepatotoxicity,PubMed
Christina Kotoula,Researcher,Department of General Internal Medicine,"Bern, Switzerland.",christina.kotoula@departmentofgeneralinternalmedicine.com,linkedin.com/in/christinakotoula,Efficacy of paracetamol added to WHO step III opioids in chronic pain control: study protocol for a ,2025-12,BMJ open,41475826,hepatotoxicity,PubMed
Maria M Wertli,Researcher,Inselspital,"Bern, Switzerland.",maria.wertli@inselspital.com,linkedin.com/in/mariamwertli,Efficacy of paracetamol added to WHO step III opioids in chronic pain control: study protocol for a ,2025-12,BMJ open,41475826,hepatotoxicity,PubMed
Konrad Streitberger,Researcher,Inselspital,"Bern, Switzerland.",konrad.streitberger@inselspital.com,linkedin.com/in/konradstreitberger,Efficacy of paracetamol added to WHO step III opioids in chronic pain control: study protocol for a ,2025-12,BMJ open,41475826,hepatotoxicity,PubMed
Sacha I Rothschild,Researcher,Cantonal Hospital Baden,"Baden, Switzerland.",sacha.rothschild@cantonalhospitalbaden.com,linkedin.com/in/sachairothschild,Efficacy of paracetamol added to WHO step III opioids in chronic pain control: study protocol for a ,2025-12,BMJ open,41475826,hepatotoxicity,PubMed
Andreas Limacher,Researcher,Inselspital,"Bern, Switzerland.",andreas.limacher@inselspital.com,linkedin.com/in/andreaslimacher,Efficacy of paracetamol added to WHO step III opioids in chronic pain control: study protocol for a ,2025-12,BMJ open,41475826,hepatotoxicity,PubMed
Felix Hammann,Researcher,Department of General Internal Medicine,"Bern, Switzerland.",felix.hammann@departmentofgeneralinternalmedicine.com,linkedin.com/in/felixhammann,Efficacy of paracetamol added to WHO step III opioids in chronic pain control: study protocol for a ,2025-12,BMJ open,41475826,hepatotoxicity,PubMed
Stephan Krähenbühl,Researcher,University Hospital Basel,"Basel, Switzerland",stephan.krähenbühl@eduhospitalbasel.com,linkedin.com/in/stephankrähenbühl,Efficacy of paracetamol added to WHO step III opioids in chronic pain control: study protocol for a ,2025-12,BMJ open,41475826,hepatotoxicity,PubMed
Manuel Haschke,Researcher,Department of General Internal Medicine,"Bern, Switzerland.",manuel.haschke@departmentofgeneralinternalmedicine.com,linkedin.com/in/manuelhaschke,Efficacy of paracetamol added to WHO step III opioids in chronic pain control: study protocol for a ,2025-12,BMJ open,41475826,hepatotoxicity,PubMed
Evangelia Liakoni,Researcher,Department of General Internal Medicine,"Bern, Switzerland evangelia.liakoni@insel.ch.",evangelia.liakoni@departmentofgeneralinternalmedicine.com,linkedin.com/in/evangelialiakoni,Efficacy of paracetamol added to WHO step III opioids in chronic pain control: study protocol for a ,2025-12,BMJ open,41475826,hepatotoxicity,PubMed
Ruoting Ding,Researcher,The Key Laboratory of Pharmacology and Toxicology for New Drugs,"Hebei, PR China.",ruoting.ding@thekeylaboratoryofpharmacologyandtoxicologyfornewdrugs.com,linkedin.com/in/ruotingding,M1 macrophage activation via TLR4/NF-κB/mincle is essential for triptolide-induced hepatotoxicity.,2025-12,Journal of ethnopharmacology,41475624,hepatotoxicity,PubMed
Qingfeng Miao,Researcher,The Key Laboratory of Pharmacology and Toxicology for New Drugs,"Shijiazhuang, PR China.",qingfeng.miao@thekeylaboratoryofpharmacologyandtoxicologyfornewdrugs.com,linkedin.com/in/qingfengmiao,M1 macrophage activation via TLR4/NF-κB/mincle is essential for triptolide-induced hepatotoxicity.,2025-12,Journal of ethnopharmacology,41475624,hepatotoxicity,PubMed
Xindi Ma,Researcher,The First Hospital of Hebei Medical University,"Shijiazhuang 050000, PR China.",xindi.ma@thefirsthospitalofhebeimedicaledu.com,linkedin.com/in/xindima,M1 macrophage activation via TLR4/NF-κB/mincle is essential for triptolide-induced hepatotoxicity.,2025-12,Journal of ethnopharmacology,41475624,hepatotoxicity,PubMed
Lin Zhou,Researcher,The Key Laboratory of Pharmacology and Toxicology for New Drugs,"Shijiazhuang, PR China.",lin.zhou@thekeylaboratoryofpharmacologyandtoxicologyfornewdrugs.com,linkedin.com/in/linzhou,M1 macrophage activation via TLR4/NF-κB/mincle is essential for triptolide-induced hepatotoxicity.,2025-12,Journal of ethnopharmacology,41475624,hepatotoxicity,PubMed
Jiarui Liu,Researcher,The Key Laboratory of Pharmacology and Toxicology for New Drugs,"050017, PR China.",jiarui.liu@thekeylaboratoryofpharmacologyandtoxicologyfornewdrugs.com,linkedin.com/in/jiaruiliu,M1 macrophage activation via TLR4/NF-κB/mincle is essential for triptolide-induced hepatotoxicity.,2025-12,Journal of ethnopharmacology,41475624,hepatotoxicity,PubMed
Junru Cui,Researcher,The Key Laboratory of Pharmacology and Toxicology for New Drugs,"Shijiazhuang, PR China.",junru.cui@thekeylaboratoryofpharmacologyandtoxicologyfornewdrugs.com,linkedin.com/in/junrucui,M1 macrophage activation via TLR4/NF-κB/mincle is essential for triptolide-induced hepatotoxicity.,2025-12,Journal of ethnopharmacology,41475624,hepatotoxicity,PubMed
Shanshan Ding,Researcher,The Key Laboratory of Pharmacology and Toxicology for New Drugs,"Shijiazhuang, PR China.",shanshan.ding@thekeylaboratoryofpharmacologyandtoxicologyfornewdrugs.com,linkedin.com/in/shanshanding,M1 macrophage activation via TLR4/NF-κB/mincle is essential for triptolide-induced hepatotoxicity.,2025-12,Journal of ethnopharmacology,41475624,hepatotoxicity,PubMed
Ziwei Song,Researcher,The Key Laboratory of Pharmacology and Toxicology for New Drugs,"Shijiazhuang, PR China.",ziwei.song@thekeylaboratoryofpharmacologyandtoxicologyfornewdrugs.com,linkedin.com/in/ziweisong,M1 macrophage activation via TLR4/NF-κB/mincle is essential for triptolide-induced hepatotoxicity.,2025-12,Journal of ethnopharmacology,41475624,hepatotoxicity,PubMed
Feifei Mou,Researcher,Shijiazhuang Medical College,"Hebei, PR China.",feifei.mou@shijiazhuangmedicalcollege.com,linkedin.com/in/feifeimou,M1 macrophage activation via TLR4/NF-κB/mincle is essential for triptolide-induced hepatotoxicity.,2025-12,Journal of ethnopharmacology,41475624,hepatotoxicity,PubMed
Chuchu Wang,Researcher,The Key Laboratory of Pharmacology and Toxicology for New Drugs,"Shijiazhuang, PR China.",chuchu.wang@thekeylaboratoryofpharmacologyandtoxicologyfornewdrugs.com,linkedin.com/in/chuchuwang,M1 macrophage activation via TLR4/NF-κB/mincle is essential for triptolide-induced hepatotoxicity.,2025-12,Journal of ethnopharmacology,41475624,hepatotoxicity,PubMed
Yumei Ma,Researcher,Hebei Provincial Hospital of Chinese Medicine,"Shijiazhuang, PR China.",yumei.ma@hebeiprovincialhospitalofchinesemedicine.com,linkedin.com/in/yumeima,M1 macrophage activation via TLR4/NF-κB/mincle is essential for triptolide-induced hepatotoxicity.,2025-12,Journal of ethnopharmacology,41475624,hepatotoxicity,PubMed
Qiao Wang,Researcher,Hebei Medical University,"Shijiazhuang, PR China.",qiao.wang@hebeimedicaledu.com,linkedin.com/in/qiaowang,M1 macrophage activation via TLR4/NF-κB/mincle is essential for triptolide-induced hepatotoxicity.,2025-12,Journal of ethnopharmacology,41475624,hepatotoxicity,PubMed
Suwen Su,Researcher,The Key Laboratory of Pharmacology and Toxicology for New Drugs,"Shijiazhuang, PR China. Electronic address: suswmk@hebmu.edu.cn.",suwen.su@thekeylaboratoryofpharmacologyandtoxicologyfornewdrugs.com,linkedin.com/in/suwensu,M1 macrophage activation via TLR4/NF-κB/mincle is essential for triptolide-induced hepatotoxicity.,2025-12,Journal of ethnopharmacology,41475624,hepatotoxicity,PubMed
Xueyan Chen,Researcher,The Key Laboratory of Pharmacology and Toxicology for New Drugs,"Shijiazhuang, PR China. Electronic address: 17800677@hebmu.edu.cn.",xueyan.chen@thekeylaboratoryofpharmacologyandtoxicologyfornewdrugs.com,linkedin.com/in/xueyanchen,M1 macrophage activation via TLR4/NF-κB/mincle is essential for triptolide-induced hepatotoxicity.,2025-12,Journal of ethnopharmacology,41475624,hepatotoxicity,PubMed
Akash Kumar Jha,Researcher,Indian Institute of Technology Bombay,"400076, India.",akash.jha@indianorgoftechnologybombay.com,linkedin.com/in/akashkumarjha,Mechanistic insight into the role of lipoglycopeptide drugs in hepatotoxicity.,2025-12,Biochimica et biophysica acta. Biomembranes,41475485,hepatotoxicity,PubMed
Vetriselvan Subramaniyan,Researcher,Sir Jeffrey Cheah Sunway Medical School,"Selangor Darul Ehsan, Malaysia.",vetriselvan.subramaniyan@sirjeffreycheahsunwaymedicalschool.com,linkedin.com/in/vetriselvansubramaniyan,Mechanistic insight into the role of lipoglycopeptide drugs in hepatotoxicity.,2025-12,Biochimica et biophysica acta. Biomembranes,41475485,hepatotoxicity,PubMed
Raj Gupta,Researcher,Indian Institute of Technology Bombay,"400076, India.",raj.gupta@indianorgoftechnologybombay.com,linkedin.com/in/rajgupta,Mechanistic insight into the role of lipoglycopeptide drugs in hepatotoxicity.,2025-12,Biochimica et biophysica acta. Biomembranes,41475485,hepatotoxicity,PubMed
Arabinda Saha,Researcher,Indian Institute of Technology Bombay,"400076, India.",arabinda.saha@indianorgoftechnologybombay.com,linkedin.com/in/arabindasaha,Mechanistic insight into the role of lipoglycopeptide drugs in hepatotoxicity.,2025-12,Biochimica et biophysica acta. Biomembranes,41475485,hepatotoxicity,PubMed
Ashutosh Kumar,Researcher,Indian Institute of Technology Bombay,"400076, India. Electronic address: ashutoshk@iitb.ac.in.",ashutosh.kumar@indianorgoftechnologybombay.com,linkedin.com/in/ashutoshkumar,Mechanistic insight into the role of lipoglycopeptide drugs in hepatotoxicity.,2025-12,Biochimica et biophysica acta. Biomembranes,41475485,hepatotoxicity,PubMed
Yuechen Xing,Researcher,School of Public Health,"Heilongjiang Province, China.",yuechen.xing@schoolofpublichealth.com,linkedin.com/in/yuechenxing,Schisandrin B Alleviates Sulfolane-Induced Liver Injury via the APOA1/ROS/NF-κB Signaling Pathway.,2025-12,The Journal of nutritional biochemistry,41475466,hepatotoxicity,PubMed
Bo Zhang,Researcher,School of Public Health,"Heilongjiang Province, China.",bo.zhang@schoolofpublichealth.com,linkedin.com/in/bozhang,Schisandrin B Alleviates Sulfolane-Induced Liver Injury via the APOA1/ROS/NF-κB Signaling Pathway.,2025-12,The Journal of nutritional biochemistry,41475466,hepatotoxicity,PubMed
Shuo Jin,Researcher,School of Public Health,"Heilongjiang Province, China.",shuo.jin@schoolofpublichealth.com,linkedin.com/in/shuojin,Schisandrin B Alleviates Sulfolane-Induced Liver Injury via the APOA1/ROS/NF-κB Signaling Pathway.,2025-12,The Journal of nutritional biochemistry,41475466,hepatotoxicity,PubMed
Youtong Guo,Researcher,School of Public Health,"Heilongjiang Province, China.",youtong.guo@schoolofpublichealth.com,linkedin.com/in/youtongguo,Schisandrin B Alleviates Sulfolane-Induced Liver Injury via the APOA1/ROS/NF-κB Signaling Pathway.,2025-12,The Journal of nutritional biochemistry,41475466,hepatotoxicity,PubMed
Yueru Chen,Researcher,School of Public Health,"Heilongjiang Province, China.",yueru.chen@schoolofpublichealth.com,linkedin.com/in/yueruchen,Schisandrin B Alleviates Sulfolane-Induced Liver Injury via the APOA1/ROS/NF-κB Signaling Pathway.,2025-12,The Journal of nutritional biochemistry,41475466,hepatotoxicity,PubMed
Lili Chen,Researcher,School of Public Health,"Heilongjiang Province, China.",lili.chen@schoolofpublichealth.com,linkedin.com/in/lilichen,Schisandrin B Alleviates Sulfolane-Induced Liver Injury via the APOA1/ROS/NF-κB Signaling Pathway.,2025-12,The Journal of nutritional biochemistry,41475466,hepatotoxicity,PubMed
Yue Wang,Researcher,School of Public Health,"Heilongjiang Province, China. Electronic address: wangyue@hrbmu.edu.cn.",yue.wang@schoolofpublichealth.com,linkedin.com/in/yuewang,Schisandrin B Alleviates Sulfolane-Induced Liver Injury via the APOA1/ROS/NF-κB Signaling Pathway.,2025-12,The Journal of nutritional biochemistry,41475466,hepatotoxicity,PubMed
Xinlei Liu,Researcher,School of Medicine,"Chongqing 400044, China.",xinlei.liu@schoolofmedicine.com,linkedin.com/in/xinleiliu,Cyp7a1 and Cyp8b1 Downregulation Characterizes Concanavalin-A-Induced Acute Liver Injury: Insights f,2025-12,Journal of proteome research,41474043,hepatotoxicity,PubMed
Rui Liu,Researcher,Chongqing Medical University,"Chongqing 400016, China.",rui.liu@chongqingmedicaledu.com,linkedin.com/in/ruiliu,Cyp7a1 and Cyp8b1 Downregulation Characterizes Concanavalin-A-Induced Acute Liver Injury: Insights f,2025-12,Journal of proteome research,41474043,hepatotoxicity,PubMed
Meng Zhang,Researcher,Chongqing Medical University,"Chongqing 400016, China.",meng.zhang@chongqingmedicaledu.com,linkedin.com/in/mengzhang,Cyp7a1 and Cyp8b1 Downregulation Characterizes Concanavalin-A-Induced Acute Liver Injury: Insights f,2025-12,Journal of proteome research,41474043,hepatotoxicity,PubMed
Di Ma,Researcher,Chongqing Medical University,"Chongqing 400016, China.",di.ma@chongqingmedicaledu.com,linkedin.com/in/dima,Cyp7a1 and Cyp8b1 Downregulation Characterizes Concanavalin-A-Induced Acute Liver Injury: Insights f,2025-12,Journal of proteome research,41474043,hepatotoxicity,PubMed
Yingming Tian,Researcher,Chongqing Medical University,"Chongqing 400016, China.",yingming.tian@chongqingmedicaledu.com,linkedin.com/in/yingmingtian,Cyp7a1 and Cyp8b1 Downregulation Characterizes Concanavalin-A-Induced Acute Liver Injury: Insights f,2025-12,Journal of proteome research,41474043,hepatotoxicity,PubMed
Yancheng Wang,Researcher,School of Electrical Engineering,"Chongqing 400044, China.",yancheng.wang@schoolofelectricalengineering.com,linkedin.com/in/yanchengwang,Cyp7a1 and Cyp8b1 Downregulation Characterizes Concanavalin-A-Induced Acute Liver Injury: Insights f,2025-12,Journal of proteome research,41474043,hepatotoxicity,PubMed
Qi Rao,Researcher,Freie Universität Berlin,"Berlin, Germany.",qi.rao@freieuniversitätberlin.com,linkedin.com/in/qirao,Engineering liver disease models in vitro: emerging trends and innovations.,2025-11,eGastroenterology,41473895,hepatotoxicity,PubMed
Lei Wang,Researcher,Freie Universität Berlin,"Berlin, Germany.",lei.wang@freieuniversitätberlin.com,linkedin.com/in/leiwang,Engineering liver disease models in vitro: emerging trends and innovations.,2025-11,eGastroenterology,41473895,hepatotoxicity,PubMed
Frank Tacke,Researcher,Charité - Universitätsmedizin Berlin,"Berlin, Germany.",frank.tacke@charité-universitätsmedizinberlin.com,linkedin.com/in/franktacke,Engineering liver disease models in vitro: emerging trends and innovations.,2025-11,eGastroenterology,41473895,hepatotoxicity,PubMed
Adrien Guillot,Researcher,Charité - Universitätsmedizin Berlin,"Berlin, Germany.",adrien.guillot@charité-universitätsmedizinberlin.com,linkedin.com/in/adrienguillot,Engineering liver disease models in vitro: emerging trends and innovations.,2025-11,eGastroenterology,41473895,hepatotoxicity,PubMed
Nan Ma,Researcher,Freie Universität Berlin,"Berlin, Germany.",nan.ma@freieuniversitätberlin.com,linkedin.com/in/nanma,Engineering liver disease models in vitro: emerging trends and innovations.,2025-11,eGastroenterology,41473895,hepatotoxicity,PubMed
HaoChun Tang,Researcher,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital and Shenzhen Hospital,"Shenzhen, China.",haochun.tang@nationalcancercenter/nationalclinicalresearchcenterforcancer/cancerhospitalandshenzhenhospital.com,linkedin.com/in/haochuntang,The effect of dosing sequence of programmed death receptor-1 inhibitors combined with chemotherapy o,2025-12,Frontiers in oncology,41473433,hepatotoxicity,PubMed
Ziyuan Zhou,Researcher,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital and Shenzhen Hospital,"Shenzhen, China.",ziyuan.zhou@nationalcancercenter/nationalclinicalresearchcenterforcancer/cancerhospitalandshenzhenhospital.com,linkedin.com/in/ziyuanzhou,The effect of dosing sequence of programmed death receptor-1 inhibitors combined with chemotherapy o,2025-12,Frontiers in oncology,41473433,hepatotoxicity,PubMed
Yuelin Zhang,Researcher,Guangdong Medical University,"Guangdong, China.",yuelin.zhang@guangdongmedicaledu.com,linkedin.com/in/yuelinzhang,The effect of dosing sequence of programmed death receptor-1 inhibitors combined with chemotherapy o,2025-12,Frontiers in oncology,41473433,hepatotoxicity,PubMed
Jun Pan,Researcher,Peking University,"Guangdong, China.",jun.pan@pekingedu.com,linkedin.com/in/junpan,The effect of dosing sequence of programmed death receptor-1 inhibitors combined with chemotherapy o,2025-12,Frontiers in oncology,41473433,hepatotoxicity,PubMed
Jun Meng,Researcher,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital and Shenzhen Hospital,"Shenzhen, China.",jun.meng@nationalcancercenter/nationalclinicalresearchcenterforcancer/cancerhospitalandshenzhenhospital.com,linkedin.com/in/junmeng,The effect of dosing sequence of programmed death receptor-1 inhibitors combined with chemotherapy o,2025-12,Frontiers in oncology,41473433,hepatotoxicity,PubMed
Areej M Abdelwahab,Researcher,Faculty of Pharmacy,"New Assuit City 71515, Egypt.",areej.abdelwahab@facultyofpharmacy.com,linkedin.com/in/areejmabdelwahab,"Modulation of SIRT-1, NF-κB/TNF-α/IL-6, and ERK/Caspase-3 by Lutein Mitigates Methotrexate-Induced H",2025-11,"Pharmaceuticals (Basel, Switzerland)",41471276,hepatotoxicity,PubMed
Heba A Habib,Researcher,Faculty of Pharmacy,"Minia 61519, Egypt.",heba.habib@facultyofpharmacy.com,linkedin.com/in/hebaahabib,"Modulation of SIRT-1, NF-κB/TNF-α/IL-6, and ERK/Caspase-3 by Lutein Mitigates Methotrexate-Induced H",2025-11,"Pharmaceuticals (Basel, Switzerland)",41471276,hepatotoxicity,PubMed
Mostafa A Darwish,Researcher,Faculty of Pharmacy,"New Assuit City 71515, Egypt.",mostafa.darwish@facultyofpharmacy.com,linkedin.com/in/mostafaadarwish,"Modulation of SIRT-1, NF-κB/TNF-α/IL-6, and ERK/Caspase-3 by Lutein Mitigates Methotrexate-Induced H",2025-11,"Pharmaceuticals (Basel, Switzerland)",41471276,hepatotoxicity,PubMed
Yousef A Bin Jardan,Researcher,College of Pharmacy,"Riyadh 11451, Saudi Arabia.",yousef.jardan@collegeofpharmacy.com,linkedin.com/in/yousefabinjardan,"Modulation of SIRT-1, NF-κB/TNF-α/IL-6, and ERK/Caspase-3 by Lutein Mitigates Methotrexate-Induced H",2025-11,"Pharmaceuticals (Basel, Switzerland)",41471276,hepatotoxicity,PubMed
Gehan H Heeba,Researcher,Faculty of Pharmacy,"Minia 61519, Egypt.",gehan.heeba@facultyofpharmacy.com,linkedin.com/in/gehanhheeba,"Modulation of SIRT-1, NF-κB/TNF-α/IL-6, and ERK/Caspase-3 by Lutein Mitigates Methotrexate-Induced H",2025-11,"Pharmaceuticals (Basel, Switzerland)",41471276,hepatotoxicity,PubMed
Zitong Xiong,Researcher,Affiliated Hospital of Southwest Medical University,"646600, People's Republic of China.",zitong.xiong@affiliatedhospitalofsouthwestmedicaledu.com,linkedin.com/in/zitongxiong,Matrine and Its Derivatives: Multi-Pathway Regulation in Cancer Therapy.,2025-12,Cancer management and research,41467103,hepatotoxicity,PubMed
Jiangtao Pu,Researcher,Affiliated Hospital of Southwest Medical University,"646600, People's Republic of China.",jiangtao.pu@affiliatedhospitalofsouthwestmedicaledu.com,linkedin.com/in/jiangtaopu,Matrine and Its Derivatives: Multi-Pathway Regulation in Cancer Therapy.,2025-12,Cancer management and research,41467103,hepatotoxicity,PubMed
Ayenew A Wolie,Researcher,College of Health Sciences,"Addis Ababa University, Ethiopia.",ayenew.wolie@collegeofhealthsciences.com,linkedin.com/in/ayenewawolie,Overlapping Hepatic and Neurological Toxicity Following Intentional Multidrug Poisoning with Acetami,2025-12,Clinical medicine insights. Case reports,41467082,hepatotoxicity,PubMed
Biruk T Mengistie,Researcher,College of Health Sciences,"Addis Ababa University, Ethiopia.",biruk.mengistie@collegeofhealthsciences.com,linkedin.com/in/biruktmengistie,Overlapping Hepatic and Neurological Toxicity Following Intentional Multidrug Poisoning with Acetami,2025-12,Clinical medicine insights. Case reports,41467082,hepatotoxicity,PubMed
Chernet T Mengistie,Researcher,College of Health Sciences,"Addis Ababa University, Ethiopia.",chernet.mengistie@collegeofhealthsciences.com,linkedin.com/in/chernettmengistie,Overlapping Hepatic and Neurological Toxicity Following Intentional Multidrug Poisoning with Acetami,2025-12,Clinical medicine insights. Case reports,41467082,hepatotoxicity,PubMed
Ayenew Genet,Researcher,College of Health Sciences,"Addis Ababa University, Ethiopia.",ayenew.genet@collegeofhealthsciences.com,linkedin.com/in/ayenewgenet,Overlapping Hepatic and Neurological Toxicity Following Intentional Multidrug Poisoning with Acetami,2025-12,Clinical medicine insights. Case reports,41467082,hepatotoxicity,PubMed
Sabontu A Wakie,Researcher,College of Health Sciences,"Addis Ababa University, Ethiopia.",sabontu.wakie@collegeofhealthsciences.com,linkedin.com/in/sabontuawakie,Overlapping Hepatic and Neurological Toxicity Following Intentional Multidrug Poisoning with Acetami,2025-12,Clinical medicine insights. Case reports,41467082,hepatotoxicity,PubMed
Elsabet A Alebachew,Researcher,College of Health Sciences,"Addis Ababa University, Ethiopia.",elsabet.alebachew@collegeofhealthsciences.com,linkedin.com/in/elsabetaalebachew,Overlapping Hepatic and Neurological Toxicity Following Intentional Multidrug Poisoning with Acetami,2025-12,Clinical medicine insights. Case reports,41467082,hepatotoxicity,PubMed
Selamawit M Bonus,Researcher,College of Health Sciences,"Addis Ababa University, Ethiopia.",selamawit.bonus@collegeofhealthsciences.com,linkedin.com/in/selamawitmbonus,Overlapping Hepatic and Neurological Toxicity Following Intentional Multidrug Poisoning with Acetami,2025-12,Clinical medicine insights. Case reports,41467082,hepatotoxicity,PubMed
Mone't Sawyer,Researcher,Boise State University,"Idaho 83725, United States.",mone't.sawyer@boisestateedu.com,linkedin.com/in/mone'tsawyer,Additively Manufactured Bioreactors for Scaffold-Coupled Electrical Stimulation.,2026-01,ACS applied bio materials,41480786,3D cell culture,PubMed
Hailey Burgoyne,Researcher,Boise State University,"Idaho 83725, United States.",hailey.burgoyne@boisestateedu.com,linkedin.com/in/haileyburgoyne,Additively Manufactured Bioreactors for Scaffold-Coupled Electrical Stimulation.,2026-01,ACS applied bio materials,41480786,3D cell culture,PubMed
Enrique Lopez,Researcher,College of Idaho,"Idaho 83605, United States.",enrique.lopez@collegeofidaho.com,linkedin.com/in/enriquelopez,Additively Manufactured Bioreactors for Scaffold-Coupled Electrical Stimulation.,2026-01,ACS applied bio materials,41480786,3D cell culture,PubMed
Felix White,Researcher,Boise State University,"Idaho 83725, United States.",felix.white@boisestateedu.com,linkedin.com/in/felixwhite,Additively Manufactured Bioreactors for Scaffold-Coupled Electrical Stimulation.,2026-01,ACS applied bio materials,41480786,3D cell culture,PubMed
Olivia Maryon,Researcher,Boise State University,"Idaho 83725, United States.",olivia.maryon@boisestateedu.com,linkedin.com/in/oliviamaryon,Additively Manufactured Bioreactors for Scaffold-Coupled Electrical Stimulation.,2026-01,ACS applied bio materials,41480786,3D cell culture,PubMed
Allyssa Bateman,Researcher,Boise State University,"Idaho 83725, United States.",allyssa.bateman@boisestateedu.com,linkedin.com/in/allyssabateman,Additively Manufactured Bioreactors for Scaffold-Coupled Electrical Stimulation.,2026-01,ACS applied bio materials,41480786,3D cell culture,PubMed
Miranda L Nelson,Researcher,Boise State University,"Idaho 83725, United States.",miranda.nelson@boisestateedu.com,linkedin.com/in/mirandalnelson,Additively Manufactured Bioreactors for Scaffold-Coupled Electrical Stimulation.,2026-01,ACS applied bio materials,41480786,3D cell culture,PubMed
Michael Eppel,Researcher,Boise State University,"Idaho 83725, United States.",michael.eppel@boisestateedu.com,linkedin.com/in/michaeleppel,Additively Manufactured Bioreactors for Scaffold-Coupled Electrical Stimulation.,2026-01,ACS applied bio materials,41480786,3D cell culture,PubMed
Olivia Nielson,Researcher,University of Idaho,"Idaho 83844, United States.",olivia.nielson@eduofidaho.com,linkedin.com/in/olivianielson,Additively Manufactured Bioreactors for Scaffold-Coupled Electrical Stimulation.,2026-01,ACS applied bio materials,41480786,3D cell culture,PubMed
Raquel Montenegro-Brown,Researcher,Boise State University,"Idaho 83725, United States.",raquel.montenegro-brown@boisestateedu.com,linkedin.com/in/raquelmontenegro-brown,Additively Manufactured Bioreactors for Scaffold-Coupled Electrical Stimulation.,2026-01,ACS applied bio materials,41480786,3D cell culture,PubMed
Josh Eixenberger,Researcher,Boise State University,"Idaho 83725, United States.",josh.eixenberger@boisestateedu.com,linkedin.com/in/josheixenberger,Additively Manufactured Bioreactors for Scaffold-Coupled Electrical Stimulation.,2026-01,ACS applied bio materials,41480786,3D cell culture,PubMed
Brian Jaques,Researcher,Boise State University,"Idaho 83725, United States.",brian.jaques@boisestateedu.com,linkedin.com/in/brianjaques,Additively Manufactured Bioreactors for Scaffold-Coupled Electrical Stimulation.,2026-01,ACS applied bio materials,41480786,3D cell culture,PubMed
Mike Hurley,Researcher,Boise State University,"Idaho 83725, United States.",mike.hurley@boisestateedu.com,linkedin.com/in/mikehurley,Additively Manufactured Bioreactors for Scaffold-Coupled Electrical Stimulation.,2026-01,ACS applied bio materials,41480786,3D cell culture,PubMed
David Estrada,Researcher,Boise State University,"Idaho 83725, United States.",david.estrada@boisestateedu.com,linkedin.com/in/davidestrada,Additively Manufactured Bioreactors for Scaffold-Coupled Electrical Stimulation.,2026-01,ACS applied bio materials,41480786,3D cell culture,PubMed
Asja Guzman,Researcher,Columbia University,"NY, USA.",asja.guzman@columbiaedu.com,linkedin.com/in/asjaguzman,Use of Biomimetic Hydrogels and 3D Cancer Models for Biochemical and Cell Biological Assays.,2024-01,"Methods in molecular biology (Clifton, N.J.)",41478973,3D cell culture,PubMed
Bijaya Gaire,Researcher,The Tisch Cancer Institute,"NY, USA. bijaya.gaire@mssm.edu.",bijaya.gaire@thetischcancerorg.com,linkedin.com/in/bijayagaire,Analysis of IFNγ-Induced Invasion of Ovarian Cancer Cells Using 3D Spheroids.,2024-01,"Methods in molecular biology (Clifton, N.J.)",41478972,3D cell culture,PubMed
Ivana Vancurova,Researcher,St. John's University,"NY, USA.",ivana.vancurova@st.john'sedu,linkedin.com/in/ivanavancurova,Analysis of IFNγ-Induced Invasion of Ovarian Cancer Cells Using 3D Spheroids.,2024-01,"Methods in molecular biology (Clifton, N.J.)",41478972,3D cell culture,PubMed
Devi Wahyuningtyas,Researcher,Academia Sinica,"Taipei 11529, Taiwan.",devi.wahyuningtyas@academiasinica.com,linkedin.com/in/deviwahyuningtyas,Self-Assembled Hydrogel from Pyrene-Modified Peptide as 3D Matrices for Neuronal Cell.,2025-12,ACS applied bio materials,41467555,3D cell culture,PubMed
Yoyo Cheng-Ting Yu,Researcher,Academia Sinica,"Taipei 11529, Taiwan.",yoyo.yu@academiasinica.com,linkedin.com/in/yoyocheng-tingyu,Self-Assembled Hydrogel from Pyrene-Modified Peptide as 3D Matrices for Neuronal Cell.,2025-12,ACS applied bio materials,41467555,3D cell culture,PubMed
Chin-Yun Hsieh,Researcher,Academia Sinica,"Taipei 11529, Taiwan.",chin-yun.hsieh@academiasinica.com,linkedin.com/in/chin-yunhsieh,Self-Assembled Hydrogel from Pyrene-Modified Peptide as 3D Matrices for Neuronal Cell.,2025-12,ACS applied bio materials,41467555,3D cell culture,PubMed
Yung-An Huang,Researcher,Academia Sinica,"Taipei 11529, Taiwan.",yung-an.huang@academiasinica.com,linkedin.com/in/yung-anhuang,Self-Assembled Hydrogel from Pyrene-Modified Peptide as 3D Matrices for Neuronal Cell.,2025-12,ACS applied bio materials,41467555,3D cell culture,PubMed
Ruei-Yu He,Researcher,Academia Sinica,"Taipei 11529, Taiwan.",ruei-yu.he@academiasinica.com,linkedin.com/in/ruei-yuhe,Self-Assembled Hydrogel from Pyrene-Modified Peptide as 3D Matrices for Neuronal Cell.,2025-12,ACS applied bio materials,41467555,3D cell culture,PubMed
Tzu-Hung Teng,Researcher,Academia Sinica,"Taipei 11529, Taiwan.",tzu-hung.teng@academiasinica.com,linkedin.com/in/tzu-hungteng,Self-Assembled Hydrogel from Pyrene-Modified Peptide as 3D Matrices for Neuronal Cell.,2025-12,ACS applied bio materials,41467555,3D cell culture,PubMed
Bryan Po-Wen Chen,Researcher,Academia Sinica,"Taipei 11529, Taiwan.",bryan.chen@academiasinica.com,linkedin.com/in/bryanpo-wenchen,Self-Assembled Hydrogel from Pyrene-Modified Peptide as 3D Matrices for Neuronal Cell.,2025-12,ACS applied bio materials,41467555,3D cell culture,PubMed
Jung-Ren Huang,Researcher,Academia Sinica,"Taipei 11529, Taiwan.",jung-ren.huang@academiasinica.com,linkedin.com/in/jung-renhuang,Self-Assembled Hydrogel from Pyrene-Modified Peptide as 3D Matrices for Neuronal Cell.,2025-12,ACS applied bio materials,41467555,3D cell culture,PubMed
David T Wu,Researcher,Academia Sinica,"Taipei 11529, Taiwan.",david.wu@academiasinica.com,linkedin.com/in/davidtwu,Self-Assembled Hydrogel from Pyrene-Modified Peptide as 3D Matrices for Neuronal Cell.,2025-12,ACS applied bio materials,41467555,3D cell culture,PubMed
Joseph Jen-Tse Huang,Researcher,Academia Sinica,"Taipei 11529, Taiwan.",joseph.huang@academiasinica.com,linkedin.com/in/josephjen-tsehuang,Self-Assembled Hydrogel from Pyrene-Modified Peptide as 3D Matrices for Neuronal Cell.,2025-12,ACS applied bio materials,41467555,3D cell culture,PubMed
Piotr Stasiak,Researcher,University of Zielona Góra,"65-417 Zielona Góra, Poland.",piotr.stasiak@eduofzielonagóra.com,linkedin.com/in/piotrstasiak,Elacridar Reverses P-gp-Mediated Drug Resistance in Ovarian Cancer Cells in 2D and 3D Culture Models,2025-12,International journal of molecular sciences,41465532,3D cell culture,PubMed
Justyna Sopel,Researcher,Collegium Medicum,"65-417 Zielona Góra, Poland.",justyna.sopel@collegiummedicum.com,linkedin.com/in/justynasopel,Elacridar Reverses P-gp-Mediated Drug Resistance in Ovarian Cancer Cells in 2D and 3D Culture Models,2025-12,International journal of molecular sciences,41465532,3D cell culture,PubMed
Julia Maria Lipowicz,Researcher,Doctoral School,"61-701 Poznań, Poland.",julia.lipowicz@doctoralschool.com,linkedin.com/in/juliamarialipowicz,Elacridar Reverses P-gp-Mediated Drug Resistance in Ovarian Cancer Cells in 2D and 3D Culture Models,2025-12,International journal of molecular sciences,41465532,3D cell culture,PubMed
Agnieszka Anna Rawłuszko-Wieczorek,Researcher,Poznan University of Medical Sciences,"61-701 Poznań, Poland.",agnieszka.rawłuszko-wieczorek@poznaneduofmedicalsciences.com,linkedin.com/in/agnieszkaannarawłuszko-wieczorek,Elacridar Reverses P-gp-Mediated Drug Resistance in Ovarian Cancer Cells in 2D and 3D Culture Models,2025-12,International journal of molecular sciences,41465532,3D cell culture,PubMed
Karolina Sterzyńska,Researcher,Poznan University of Medical Sciences,"61-701 Poznań, Poland.",karolina.sterzyńska@poznaneduofmedicalsciences.com,linkedin.com/in/karolinasterzyńska,Elacridar Reverses P-gp-Mediated Drug Resistance in Ovarian Cancer Cells in 2D and 3D Culture Models,2025-12,International journal of molecular sciences,41465532,3D cell culture,PubMed
Jan Korbecki,Researcher,Collegium Medicum,"65-417 Zielona Góra, Poland.",jan.korbecki@collegiummedicum.com,linkedin.com/in/jankorbecki,Elacridar Reverses P-gp-Mediated Drug Resistance in Ovarian Cancer Cells in 2D and 3D Culture Models,2025-12,International journal of molecular sciences,41465532,3D cell culture,PubMed
Radosław Januchowski,Researcher,Collegium Medicum,"65-417 Zielona Góra, Poland.",radosław.januchowski@collegiummedicum.com,linkedin.com/in/radosławjanuchowski,Elacridar Reverses P-gp-Mediated Drug Resistance in Ovarian Cancer Cells in 2D and 3D Culture Models,2025-12,International journal of molecular sciences,41465532,3D cell culture,PubMed
Yulia Goltseva,Researcher,Federal State Budgetary Institution National Medical Research Center of Cardiology Named after Academician E.I. Chazov,"121552 Moscow, Russia.",yulia.goltseva@federalstatebudgetaryinstitutionnationalmedicalresearchcenterofcardiologynamedafteracademiciane.i.chazov,linkedin.com/in/yuliagoltseva,The 3D World of Spheroids: Searching for an Optimal Method of Fabricating Pro-Reparative Cardiospher,2025-12,International journal of molecular sciences,41465452,3D cell culture,PubMed
Zoya Tsokolaeva,Researcher,Federal State Budgetary Institution National Medical Research Center of Cardiology Named after Academician E.I. Chazov,"121552 Moscow, Russia.",zoya.tsokolaeva@federalstatebudgetaryinstitutionnationalmedicalresearchcenterofcardiologynamedafteracademiciane.i.chazov,linkedin.com/in/zoyatsokolaeva,The 3D World of Spheroids: Searching for an Optimal Method of Fabricating Pro-Reparative Cardiospher,2025-12,International journal of molecular sciences,41465452,3D cell culture,PubMed
Irina Iarushkina,Researcher,Federal State Budgetary Institution National Medical Research Center of Cardiology Named after Academician E.I. Chazov,"121552 Moscow, Russia.",irina.iarushkina@federalstatebudgetaryinstitutionnationalmedicalresearchcenterofcardiologynamedafteracademiciane.i.chazov,linkedin.com/in/irinaiarushkina,The 3D World of Spheroids: Searching for an Optimal Method of Fabricating Pro-Reparative Cardiospher,2025-12,International journal of molecular sciences,41465452,3D cell culture,PubMed
Irina Beloglazova,Researcher,Federal State Budgetary Institution National Medical Research Center of Cardiology Named after Academician E.I. Chazov,"121552 Moscow, Russia.",irina.beloglazova@federalstatebudgetaryinstitutionnationalmedicalresearchcenterofcardiologynamedafteracademiciane.i.chazov,linkedin.com/in/irinabeloglazova,The 3D World of Spheroids: Searching for an Optimal Method of Fabricating Pro-Reparative Cardiospher,2025-12,International journal of molecular sciences,41465452,3D cell culture,PubMed
Maria Boldyreva,Researcher,Federal State Budgetary Institution National Medical Research Center of Cardiology Named after Academician E.I. Chazov,"121552 Moscow, Russia.",maria.boldyreva@federalstatebudgetaryinstitutionnationalmedicalresearchcenterofcardiologynamedafteracademiciane.i.chazov,linkedin.com/in/mariaboldyreva,The 3D World of Spheroids: Searching for an Optimal Method of Fabricating Pro-Reparative Cardiospher,2025-12,International journal of molecular sciences,41465452,3D cell culture,PubMed
Elizaveta Ratner,Researcher,Federal State Budgetary Institution National Medical Research Center of Cardiology Named after Academician E.I. Chazov,"121552 Moscow, Russia.",elizaveta.ratner@federalstatebudgetaryinstitutionnationalmedicalresearchcenterofcardiologynamedafteracademiciane.i.chazov,linkedin.com/in/elizavetaratner,The 3D World of Spheroids: Searching for an Optimal Method of Fabricating Pro-Reparative Cardiospher,2025-12,International journal of molecular sciences,41465452,3D cell culture,PubMed
Yelena Parfyonova,Researcher,Federal State Budgetary Institution National Medical Research Center of Cardiology Named after Academician E.I. Chazov,"121552 Moscow, Russia.",yelena.parfyonova@federalstatebudgetaryinstitutionnationalmedicalresearchcenterofcardiologynamedafteracademiciane.i.chazov,linkedin.com/in/yelenaparfyonova,The 3D World of Spheroids: Searching for an Optimal Method of Fabricating Pro-Reparative Cardiospher,2025-12,International journal of molecular sciences,41465452,3D cell culture,PubMed
Konstantin Dergilev,Researcher,Federal State Budgetary Institution National Medical Research Center of Cardiology Named after Academician E.I. Chazov,"121552 Moscow, Russia.",konstantin.dergilev@federalstatebudgetaryinstitutionnationalmedicalresearchcenterofcardiologynamedafteracademiciane.i.chazov,linkedin.com/in/konstantindergilev,The 3D World of Spheroids: Searching for an Optimal Method of Fabricating Pro-Reparative Cardiospher,2025-12,International journal of molecular sciences,41465452,3D cell culture,PubMed
Brendon Roets,Researcher,Faculty of Health Science,"Johannesburg 2028, South Africa.",brendon.roets@facultyofhealthscience.com,linkedin.com/in/brendonroets,Photobiomodulation-Driven Tenogenic Differentiation of MSCs in Hydrogel Culture.,2025-12,International journal of molecular sciences,41465392,3D cell culture,PubMed
Heidi Abrahamse,Researcher,Faculty of Health Science,"Johannesburg 2028, South Africa.",heidi.abrahamse@facultyofhealthscience.com,linkedin.com/in/heidiabrahamse,Photobiomodulation-Driven Tenogenic Differentiation of MSCs in Hydrogel Culture.,2025-12,International journal of molecular sciences,41465392,3D cell culture,PubMed
Anine Crous,Researcher,Faculty of Health Science,"Johannesburg 2028, South Africa.",anine.crous@facultyofhealthscience.com,linkedin.com/in/aninecrous,Photobiomodulation-Driven Tenogenic Differentiation of MSCs in Hydrogel Culture.,2025-12,International journal of molecular sciences,41465392,3D cell culture,PubMed
Pietro Arnaldi,Researcher,MorphoLAB,"16132 Genoa, Italy.",pietro.arnaldi@morpholab.com,linkedin.com/in/pietroarnaldi,3D Breast Cancer Spheroids Reveal Architecture-Dependent HER2 Expression and Signaling.,2025-11,Biology,41463429,3D cell culture,PubMed
Valentina Delli Zotti,Researcher,University of Genoa,"16132 Genoa, Italy.",valentina.zotti@eduofgenoa.com,linkedin.com/in/valentinadellizotti,3D Breast Cancer Spheroids Reveal Architecture-Dependent HER2 Expression and Signaling.,2025-11,Biology,41463429,3D cell culture,PubMed
Grazia Bellese,Researcher,MorphoLAB,"16132 Genoa, Italy.",grazia.bellese@morpholab.com,linkedin.com/in/graziabellese,3D Breast Cancer Spheroids Reveal Architecture-Dependent HER2 Expression and Signaling.,2025-11,Biology,41463429,3D cell culture,PubMed
Maria Cristina Gagliani,Researcher,MorphoLAB,"16132 Genoa, Italy.",maria.gagliani@morpholab.com,linkedin.com/in/mariacristinagagliani,3D Breast Cancer Spheroids Reveal Architecture-Dependent HER2 Expression and Signaling.,2025-11,Biology,41463429,3D cell culture,PubMed
Paola Orecchia,Researcher,16132 Genova,"16132 Genova, Italy.",paola.orecchia@16132genova.com,linkedin.com/in/paolaorecchia,3D Breast Cancer Spheroids Reveal Architecture-Dependent HER2 Expression and Signaling.,2025-11,Biology,41463429,3D cell culture,PubMed
Patrizio Castagnola,Researcher,16132 Genova,"16132 Genova, Italy.",patrizio.castagnola@16132genova.com,linkedin.com/in/patriziocastagnola,3D Breast Cancer Spheroids Reveal Architecture-Dependent HER2 Expression and Signaling.,2025-11,Biology,41463429,3D cell culture,PubMed
Katia Cortese,Researcher,MorphoLAB,"16132 Genoa, Italy.",katia.cortese@morpholab.com,linkedin.com/in/katiacortese,3D Breast Cancer Spheroids Reveal Architecture-Dependent HER2 Expression and Signaling.,2025-11,Biology,41463429,3D cell culture,PubMed
Carolina Epifânio,Researcher,Universidade Federal Do Rio de Janeiro,"RJ, Brazil.",carolina.epifânio@universidadefederaldoriodejaneiro.com,linkedin.com/in/carolinaepifânio,Toxoplasma gondii infection inhibits myotube formation in a 3D model of chicken muscle cell culture.,2025-12,BMC microbiology,41462081,3D cell culture,PubMed
Kayo Moreira Bagri,Researcher,Universidade Federal Do Rio de Janeiro,"RJ, Brazil.",kayo.bagri@universidadefederaldoriodejaneiro.com,linkedin.com/in/kayomoreirabagri,Toxoplasma gondii infection inhibits myotube formation in a 3D model of chicken muscle cell culture.,2025-12,BMC microbiology,41462081,3D cell culture,PubMed
Paloma de Carvalho Vieira,Researcher,Universidade Federal Do Rio de Janeiro,"RJ, Brazil.",paloma.vieira@universidadefederaldoriodejaneiro.com,linkedin.com/in/palomadecarvalhovieira,Toxoplasma gondii infection inhibits myotube formation in a 3D model of chicken muscle cell culture.,2025-12,BMC microbiology,41462081,3D cell culture,PubMed
José Raphael Monteiro-Neto,Researcher,Avenida Brasil,"21040-360, Brazil.",josé.monteiro-neto@avenidabrasil.com,linkedin.com/in/joséraphaelmonteiro-neto,Toxoplasma gondii infection inhibits myotube formation in a 3D model of chicken muscle cell culture.,2025-12,BMC microbiology,41462081,3D cell culture,PubMed
Manoel Luis Costa,Researcher,Universidade Federal Do Rio de Janeiro,"RJ, Brazil.",manoel.costa@universidadefederaldoriodejaneiro.com,linkedin.com/in/manoelluiscosta,Toxoplasma gondii infection inhibits myotube formation in a 3D model of chicken muscle cell culture.,2025-12,BMC microbiology,41462081,3D cell culture,PubMed
Claudia Mermelstein,Researcher,Universidade Federal Do Rio de Janeiro,"RJ, Brazil.",claudia.mermelstein@universidadefederaldoriodejaneiro.com,linkedin.com/in/claudiamermelstein,Toxoplasma gondii infection inhibits myotube formation in a 3D model of chicken muscle cell culture.,2025-12,BMC microbiology,41462081,3D cell culture,PubMed
Daniel Adesse,Researcher,Avenida Brasil,"21040-360, Brazil. adesse@ioc.fiocruz.br.",daniel.adesse@avenidabrasil.com,linkedin.com/in/danieladesse,Toxoplasma gondii infection inhibits myotube formation in a 3D model of chicken muscle cell culture.,2025-12,BMC microbiology,41462081,3D cell culture,PubMed
Rebecca Wißmann,Researcher,University Hospital of Tübingen,"D-72076 Tübingen, Germany.",rebecca.wißmann@eduhospitaloftübingen.com,linkedin.com/in/rebeccawißmann,Properties of 3-Dimensional Cell Cultivation Matrices and Scaffolds in Magnetic Resonance Imaging at,2025-11,Journal of functional biomaterials,41440617,3D cell culture,PubMed
Petros Martirosian,Researcher,University Hospital of Tübingen,"D-72076 Tübingen, Germany.",petros.martirosian@eduhospitaloftübingen.com,linkedin.com/in/petrosmartirosian,Properties of 3-Dimensional Cell Cultivation Matrices and Scaffolds in Magnetic Resonance Imaging at,2025-11,Journal of functional biomaterials,41440617,3D cell culture,PubMed
Marina Danalache,Researcher,University Hospital of Tübingen,"D-72076 Tübingen, Germany.",marina.danalache@eduhospitaloftübingen.com,linkedin.com/in/marinadanalache,Properties of 3-Dimensional Cell Cultivation Matrices and Scaffolds in Magnetic Resonance Imaging at,2025-11,Journal of functional biomaterials,41440617,3D cell culture,PubMed
Stefanie Elser,Researcher,University Hospital of Tübingen,"D-72076 Tübingen, Germany.",stefanie.elser@eduhospitaloftübingen.com,linkedin.com/in/stefanieelser,Properties of 3-Dimensional Cell Cultivation Matrices and Scaffolds in Magnetic Resonance Imaging at,2025-11,Journal of functional biomaterials,41440617,3D cell culture,PubMed
Jürgen Machann,Researcher,University Hospital of Tübingen,"D-72076 Tübingen, Germany.",jürgen.machann@eduhospitaloftübingen.com,linkedin.com/in/jürgenmachann,Properties of 3-Dimensional Cell Cultivation Matrices and Scaffolds in Magnetic Resonance Imaging at,2025-11,Journal of functional biomaterials,41440617,3D cell culture,PubMed
Fritz Schick,Researcher,University Hospital of Tübingen,"D-72076 Tübingen, Germany.",fritz.schick@eduhospitaloftübingen.com,linkedin.com/in/fritzschick,Properties of 3-Dimensional Cell Cultivation Matrices and Scaffolds in Magnetic Resonance Imaging at,2025-11,Journal of functional biomaterials,41440617,3D cell culture,PubMed
Giulia Gramigna,Researcher,National Research Council,"00133 Roma, Italy.",giulia.gramigna@nationalresearchcouncil.com,linkedin.com/in/giuliagramigna,A Fluid Dynamics-Model System for Advancing Tissue Engineering and Cancer Research Studies: Biologic,2025-12,"Biomimetics (Basel, Switzerland)",41439917,3D cell culture,PubMed
Federica Liguori,Researcher,Piazzale delle Belle Arti 2,"00196 Roma, Italy.",federica.liguori@piazzaledellebellearti2.com,linkedin.com/in/federicaliguori,A Fluid Dynamics-Model System for Advancing Tissue Engineering and Cancer Research Studies: Biologic,2025-12,"Biomimetics (Basel, Switzerland)",41439917,3D cell culture,PubMed
Ludovica Filippini,Researcher,Piazzale delle Belle Arti 2,"00196 Roma, Italy.",ludovica.filippini@piazzaledellebellearti2.com,linkedin.com/in/ludovicafilippini,A Fluid Dynamics-Model System for Advancing Tissue Engineering and Cancer Research Studies: Biologic,2025-12,"Biomimetics (Basel, Switzerland)",41439917,3D cell culture,PubMed
Maurizio Mastantuono,Researcher,Piazzale delle Belle Arti 2,"00196 Roma, Italy.",maurizio.mastantuono@piazzaledellebellearti2.com,linkedin.com/in/mauriziomastantuono,A Fluid Dynamics-Model System for Advancing Tissue Engineering and Cancer Research Studies: Biologic,2025-12,"Biomimetics (Basel, Switzerland)",41439917,3D cell culture,PubMed
Michele Pistillo,Researcher,Piazzale delle Belle Arti 2,"00196 Roma, Italy.",michele.pistillo@piazzaledellebellearti2.com,linkedin.com/in/michelepistillo,A Fluid Dynamics-Model System for Advancing Tissue Engineering and Cancer Research Studies: Biologic,2025-12,"Biomimetics (Basel, Switzerland)",41439917,3D cell culture,PubMed
Margherita Scamarcio,Researcher,Piazzale delle Belle Arti 2,"00196 Roma, Italy.",margherita.scamarcio@piazzaledellebellearti2.com,linkedin.com/in/margheritascamarcio,A Fluid Dynamics-Model System for Advancing Tissue Engineering and Cancer Research Studies: Biologic,2025-12,"Biomimetics (Basel, Switzerland)",41439917,3D cell culture,PubMed
Alessia Mengoni,Researcher,National Research Council,"00133 Roma, Italy.",alessia.mengoni@nationalresearchcouncil.com,linkedin.com/in/alessiamengoni,A Fluid Dynamics-Model System for Advancing Tissue Engineering and Cancer Research Studies: Biologic,2025-12,"Biomimetics (Basel, Switzerland)",41439917,3D cell culture,PubMed
Antonella Lisi,Researcher,National Research Council,"00133 Roma, Italy.",antonella.lisi@nationalresearchcouncil.com,linkedin.com/in/antonellalisi,A Fluid Dynamics-Model System for Advancing Tissue Engineering and Cancer Research Studies: Biologic,2025-12,"Biomimetics (Basel, Switzerland)",41439917,3D cell culture,PubMed
Giuseppe Falvo D'Urso Labate,Researcher,Piazzale delle Belle Arti 2,"00196 Roma, Italy.",giuseppe.labate@piazzaledellebellearti2.com,linkedin.com/in/giuseppefalvod'ursolabate,A Fluid Dynamics-Model System for Advancing Tissue Engineering and Cancer Research Studies: Biologic,2025-12,"Biomimetics (Basel, Switzerland)",41439917,3D cell culture,PubMed
Mario Ledda,Researcher,National Research Council,"00133 Roma, Italy.",mario.ledda@nationalresearchcouncil.com,linkedin.com/in/marioledda,A Fluid Dynamics-Model System for Advancing Tissue Engineering and Cancer Research Studies: Biologic,2025-12,"Biomimetics (Basel, Switzerland)",41439917,3D cell culture,PubMed
Yiying Chen,Researcher,East China University of Science and Technology,"Shanghai 200237, China.",yiying.chen@eastchinaeduofscienceandtechnology.com,linkedin.com/in/yiyingchen,Design and evaluation of ionically crosslinked multifunctional ELP-SA composite hydrogels for 3D cel,2025-11,Regenerative biomaterials,41439199,3D cell culture,PubMed
Yangmin Wang,Researcher,East China University of Science and Technology,"Shanghai 200237, China.",yangmin.wang@eastchinaeduofscienceandtechnology.com,linkedin.com/in/yangminwang,Design and evaluation of ionically crosslinked multifunctional ELP-SA composite hydrogels for 3D cel,2025-11,Regenerative biomaterials,41439199,3D cell culture,PubMed
Yuxi Li,Researcher,East China University of Science and Technology,"Shanghai 200237, China.",yuxi.li@eastchinaeduofscienceandtechnology.com,linkedin.com/in/yuxili,Design and evaluation of ionically crosslinked multifunctional ELP-SA composite hydrogels for 3D cel,2025-11,Regenerative biomaterials,41439199,3D cell culture,PubMed
Xingyang Chen,Researcher,Shanghai Key Laboratory of New Drug Design,"Shanghai 200237, China.",xingyang.chen@shanghaikeylaboratoryofnewdrugdesign.com,linkedin.com/in/xingyangchen,Design and evaluation of ionically crosslinked multifunctional ELP-SA composite hydrogels for 3D cel,2025-11,Regenerative biomaterials,41439199,3D cell culture,PubMed
Wenyun Zheng,Researcher,Shanghai Key Laboratory of New Drug Design,"Shanghai 200237, China.",wenyun.zheng@shanghaikeylaboratoryofnewdrugdesign.com,linkedin.com/in/wenyunzheng,Design and evaluation of ionically crosslinked multifunctional ELP-SA composite hydrogels for 3D cel,2025-11,Regenerative biomaterials,41439199,3D cell culture,PubMed
Tianwen Wang,Researcher,Wuhu 241000,"Wuhu 241000, China.",tianwen.wang@wuhu241000.com,linkedin.com/in/tianwenwang,Design and evaluation of ionically crosslinked multifunctional ELP-SA composite hydrogels for 3D cel,2025-11,Regenerative biomaterials,41439199,3D cell culture,PubMed
Hao Jia,Researcher,Department of Biochemistry & Molecular Cellular Biology,"Shanghai 200025, China.",hao.jia@departmentofbiochemistry&molecularcellularbiology.com,linkedin.com/in/haojia,Design and evaluation of ionically crosslinked multifunctional ELP-SA composite hydrogels for 3D cel,2025-11,Regenerative biomaterials,41439199,3D cell culture,PubMed
Xingyuan Ma,Researcher,East China University of Science and Technology,"Shanghai 200237, China.",xingyuan.ma@eastchinaeduofscienceandtechnology.com,linkedin.com/in/xingyuanma,Design and evaluation of ionically crosslinked multifunctional ELP-SA composite hydrogels for 3D cel,2025-11,Regenerative biomaterials,41439199,3D cell culture,PubMed
Tong Su,Researcher,School of Life and Health Sciences,"230601, PR China.",tong.su@schooloflifeandhealthsciences.com,linkedin.com/in/tongsu,<i>In vitro</i> 3D models of neuron-astrocyte interactions.,2025-12,Biochemistry and biophysics reports,41438688,3D cell culture,PubMed
Zhixiang Li,Researcher,School of Life and Health Sciences,"230601, PR China.",zhixiang.li@schooloflifeandhealthsciences.com,linkedin.com/in/zhixiangli,<i>In vitro</i> 3D models of neuron-astrocyte interactions.,2025-12,Biochemistry and biophysics reports,41438688,3D cell culture,PubMed
Yujie Yang,Researcher,School of Life and Health Sciences,"230601, PR China.",yujie.yang@schooloflifeandhealthsciences.com,linkedin.com/in/yujieyang,<i>In vitro</i> 3D models of neuron-astrocyte interactions.,2025-12,Biochemistry and biophysics reports,41438688,3D cell culture,PubMed
Yangfan Dai,Researcher,School of Life and Health Sciences,"230601, PR China.",yangfan.dai@schooloflifeandhealthsciences.com,linkedin.com/in/yangfandai,<i>In vitro</i> 3D models of neuron-astrocyte interactions.,2025-12,Biochemistry and biophysics reports,41438688,3D cell culture,PubMed
Yueqi Li,Researcher,School of Life and Health Sciences,"230601, PR China.",yueqi.li@schooloflifeandhealthsciences.com,linkedin.com/in/yueqili,<i>In vitro</i> 3D models of neuron-astrocyte interactions.,2025-12,Biochemistry and biophysics reports,41438688,3D cell culture,PubMed
Huan Zhao,Researcher,School of Life and Health Sciences,"230601, PR China.",huan.zhao@schooloflifeandhealthsciences.com,linkedin.com/in/huanzhao,<i>In vitro</i> 3D models of neuron-astrocyte interactions.,2025-12,Biochemistry and biophysics reports,41438688,3D cell culture,PubMed
Brandhon F Flores-Ibarra,Researcher,Universidad de Sonora,"Sonora, Mexico.",brandhon.flores-ibarra@universidaddesonora.com,linkedin.com/in/brandhonfflores-ibarra,Functionalized peptide hydrogel to generate human insulin-producing cells in vitro.,2025-12,Journal of bioscience and bioengineering,41436341,3D cell culture,PubMed
Andrea I Enríquez-Rodríguez,Researcher,Universidad de Sonora,"Sonora, Mexico.",andrea.enríquez-rodríguez@universidaddesonora.com,linkedin.com/in/andreaienríquez-rodríguez,Functionalized peptide hydrogel to generate human insulin-producing cells in vitro.,2025-12,Journal of bioscience and bioengineering,41436341,3D cell culture,PubMed
Kimberly P Robles-Pablos,Researcher,Universidad de Sonora,"Sonora, Mexico.",kimberly.robles-pablos@universidaddesonora.com,linkedin.com/in/kimberlyprobles-pablos,Functionalized peptide hydrogel to generate human insulin-producing cells in vitro.,2025-12,Journal of bioscience and bioengineering,41436341,3D cell culture,PubMed
Beatriz A Rodas-Junco,Researcher,Universidad Autónoma de Yucatán,"Mérida 97203, Mexico.",beatriz.rodas-junco@universidadautónomadeyucatán.com,linkedin.com/in/beatrizarodas-junco,Functionalized peptide hydrogel to generate human insulin-producing cells in vitro.,2025-12,Journal of bioscience and bioengineering,41436341,3D cell culture,PubMed
Waldo M Argüelles-Monal,Researcher,Hermosillo,"Sonora, Mexico.",waldo.argüelles-monal@hermosillo.com,linkedin.com/in/waldomargüelles-monal,Functionalized peptide hydrogel to generate human insulin-producing cells in vitro.,2025-12,Journal of bioscience and bioengineering,41436341,3D cell culture,PubMed
Luisa L Silva-Gutiérrez,Researcher,Hermosillo,"Sonora, Mexico.",luisa.silva-gutiérrez@hermosillo.com,linkedin.com/in/luisalsilva-gutiérrez,Functionalized peptide hydrogel to generate human insulin-producing cells in vitro.,2025-12,Journal of bioscience and bioengineering,41436341,3D cell culture,PubMed
Refugio Pérez-González,Researcher,Universidad de Sonora,"Sonora, Mexico.",refugio.pérez-gonzález@universidaddesonora.com,linkedin.com/in/refugiopérez-gonzález,Functionalized peptide hydrogel to generate human insulin-producing cells in vitro.,2025-12,Journal of bioscience and bioengineering,41436341,3D cell culture,PubMed
Olga A Patrón-Soberano,Researcher,Instituto Potosino de Investigación Científica y Tecnológica A.C.,"San Luis Potosí, Mexico.",olga.patrón-soberano@institutopotosinodeinvestigacióncientíficaytecnológicaa.c.,linkedin.com/in/olgaapatrón-soberano,Functionalized peptide hydrogel to generate human insulin-producing cells in vitro.,2025-12,Journal of bioscience and bioengineering,41436341,3D cell culture,PubMed
Carmen S Rochín-Wong,Researcher,Universidad de Sonora,"Sonora, Mexico.",carmen.rochín-wong@universidaddesonora.com,linkedin.com/in/carmensrochín-wong,Functionalized peptide hydrogel to generate human insulin-producing cells in vitro.,2025-12,Journal of bioscience and bioengineering,41436341,3D cell culture,PubMed
Luis A Castillo-Díaz,Researcher,Universidad de Sonora,"Sonora, Mexico. Electronic address: luis.castillo@unison.mx.",luis.castillo-díaz@universidaddesonora.com,linkedin.com/in/luisacastillo-díaz,Functionalized peptide hydrogel to generate human insulin-producing cells in vitro.,2025-12,Journal of bioscience and bioengineering,41436341,3D cell culture,PubMed
Hideto Tatsumi,Researcher,Osaka University Graduate School of Dentistry,"Osaka 563-0032, Japan.",hideto.tatsumi@osakaedugraduateschoolofdentistry.com,linkedin.com/in/hidetotatsumi,Spheroid size-induced apoptosis enhances osteogenic differentiation of iPS cells.,2025-12,Journal of bioscience and bioengineering,41423395,3D cell culture,PubMed
Hiroko Okawa,Researcher,Tohoku University Graduate School of Dentistry,"Miyagi 980-8575, Japan.",hiroko.okawa@tohokuedugraduateschoolofdentistry.com,linkedin.com/in/hirokookawa,Spheroid size-induced apoptosis enhances osteogenic differentiation of iPS cells.,2025-12,Journal of bioscience and bioengineering,41423395,3D cell culture,PubMed
Naruephorn Vinaikosol,Researcher,Tohoku University Graduate School of Dentistry,"Miyagi 980-8575, Japan.",naruephorn.vinaikosol@tohokuedugraduateschoolofdentistry.com,linkedin.com/in/naruephornvinaikosol,Spheroid size-induced apoptosis enhances osteogenic differentiation of iPS cells.,2025-12,Journal of bioscience and bioengineering,41423395,3D cell culture,PubMed
Akihito Moribayashi,Researcher,Osaka University Graduate School of Dentistry,"Osaka 530-0001, Japan.",akihito.moribayashi@osakaedugraduateschoolofdentistry.com,linkedin.com/in/akihitomoribayashi,Spheroid size-induced apoptosis enhances osteogenic differentiation of iPS cells.,2025-12,Journal of bioscience and bioengineering,41423395,3D cell culture,PubMed
Hiroki Kayashima,Researcher,Osaka University Graduate School of Dentistry,"Osaka 565-0871, Japan.",hiroki.kayashima@osakaedugraduateschoolofdentistry.com,linkedin.com/in/hirokikayashima,Spheroid size-induced apoptosis enhances osteogenic differentiation of iPS cells.,2025-12,Journal of bioscience and bioengineering,41423395,3D cell culture,PubMed
Hirofumi Yatani,Researcher,Osaka University Graduate School of Dentistry,"Osaka 565-0871, Japan.",hirofumi.yatani@osakaedugraduateschoolofdentistry.com,linkedin.com/in/hirofumiyatani,Spheroid size-induced apoptosis enhances osteogenic differentiation of iPS cells.,2025-12,Journal of bioscience and bioengineering,41423395,3D cell culture,PubMed
Hiroshi Egusa,Researcher,Osaka University Graduate School of Dentistry,"Miyagi 980-8575, Japan. Electronic address: egu@tohoku.ac.jp.",hiroshi.egusa@osakaedugraduateschoolofdentistry.com,linkedin.com/in/hiroshiegusa,Spheroid size-induced apoptosis enhances osteogenic differentiation of iPS cells.,2025-12,Journal of bioscience and bioengineering,41423395,3D cell culture,PubMed
Emily L Pallack,Researcher,Unknown,Unknown,,linkedin.com/in/emilylpallack,"Low-Cost, Rapid Fabrication of Customizable Polyethylene Glycol-Based Cell Culture Devices.",2025-12,bioRxiv : the preprint server for biology,41415374,3D cell culture,PubMed
Maxwell W Oulundsen,Researcher,Unknown,Unknown,,linkedin.com/in/maxwellwoulundsen,"Low-Cost, Rapid Fabrication of Customizable Polyethylene Glycol-Based Cell Culture Devices.",2025-12,bioRxiv : the preprint server for biology,41415374,3D cell culture,PubMed
Hannah R Goldberg,Researcher,Unknown,Unknown,,linkedin.com/in/hannahrgoldberg,"Low-Cost, Rapid Fabrication of Customizable Polyethylene Glycol-Based Cell Culture Devices.",2025-12,bioRxiv : the preprint server for biology,41415374,3D cell culture,PubMed
Yan Kolpakov,Researcher,Unknown,Unknown,,linkedin.com/in/yankolpakov,"Low-Cost, Rapid Fabrication of Customizable Polyethylene Glycol-Based Cell Culture Devices.",2025-12,bioRxiv : the preprint server for biology,41415374,3D cell culture,PubMed
Aneth J Fernandez,Researcher,Unknown,Unknown,,linkedin.com/in/anethjfernandez,"Low-Cost, Rapid Fabrication of Customizable Polyethylene Glycol-Based Cell Culture Devices.",2025-12,bioRxiv : the preprint server for biology,41415374,3D cell culture,PubMed
Noah D Teaney,Researcher,Unknown,Unknown,,linkedin.com/in/noahdteaney,"Low-Cost, Rapid Fabrication of Customizable Polyethylene Glycol-Based Cell Culture Devices.",2025-12,bioRxiv : the preprint server for biology,41415374,3D cell culture,PubMed
Faith E Y Moran,Researcher,Unknown,Unknown,,linkedin.com/in/faitheymoran,"Low-Cost, Rapid Fabrication of Customizable Polyethylene Glycol-Based Cell Culture Devices.",2025-12,bioRxiv : the preprint server for biology,41415374,3D cell culture,PubMed
Nisha R Iyer,Researcher,Unknown,Unknown,,linkedin.com/in/nishariyer,"Low-Cost, Rapid Fabrication of Customizable Polyethylene Glycol-Based Cell Culture Devices.",2025-12,bioRxiv : the preprint server for biology,41415374,3D cell culture,PubMed
David Smith,Researcher,Pentlands Science Park,"Penicuik, United Kingdom.",david.smith@pentlandssciencepark.com,linkedin.com/in/davidsmith,"Lessons on multicellular two- (2D) and three-dimensional (3D) culture in parasitology: Insights, cha",2025-12,International journal for parasitology,41412370,3D cell culture,PubMed
Matias G Perez,Researcher,One Health and Veterinary Medicine,"Glasgow, United Kingdom.",matias.perez@onehealthandveterinarymedicine.com,linkedin.com/in/matiasgperez,"Lessons on multicellular two- (2D) and three-dimensional (3D) culture in parasitology: Insights, cha",2025-12,International journal for parasitology,41412370,3D cell culture,PubMed
Miriam E Garner,Researcher,Pentlands Science Park,"Belfast, United Kingdom.",miriam.garner@pentlandssciencepark.com,linkedin.com/in/miriamegarner,"Lessons on multicellular two- (2D) and three-dimensional (3D) culture in parasitology: Insights, cha",2025-12,International journal for parasitology,41412370,3D cell culture,PubMed
William M Anderson,Researcher,Pentlands Science Park,"Glasgow, United Kingdom.",william.anderson@pentlandssciencepark.com,linkedin.com/in/williammanderson,"Lessons on multicellular two- (2D) and three-dimensional (3D) culture in parasitology: Insights, cha",2025-12,International journal for parasitology,41412370,3D cell culture,PubMed
Collette Britton,Researcher,One Health and Veterinary Medicine,"Glasgow, United Kingdom.",collette.britton@onehealthandveterinarymedicine.com,linkedin.com/in/collettebritton,"Lessons on multicellular two- (2D) and three-dimensional (3D) culture in parasitology: Insights, cha",2025-12,International journal for parasitology,41412370,3D cell culture,PubMed
Maria A Duque-Correa,Researcher,University of Cambridge,"Cambridge, MA",maria.duque-correa@eduofcambridge.com,linkedin.com/in/mariaaduque-correa,"Lessons on multicellular two- (2D) and three-dimensional (3D) culture in parasitology: Insights, cha",2025-12,International journal for parasitology,41412370,3D cell culture,PubMed
Nichola E D Calvani,Researcher,Faculty of Science,"The University of Sydney, Australia. Electronic address: nichola.calvani@sydney.edu.au.",nichola.calvani@facultyofscience.com,linkedin.com/in/nicholaedcalvani,"Lessons on multicellular two- (2D) and three-dimensional (3D) culture in parasitology: Insights, cha",2025-12,International journal for parasitology,41412370,3D cell culture,PubMed
K O Böker,Researcher,Orthopaedics and Plastic Surgery,"Goettingen, Germany.",k.böker@orthopaedicsandplasticsurgery.com,linkedin.com/in/koböker,Influence of Collagen 1 on osteogenesis in a perfused 3D bioreactor system.,2026-01,"Biomedical materials (Bristol, England)",41406600,3D cell culture,PubMed
S Siegk,Researcher,Orthopaedics and Plastic Surgery,"Goettingen, Germany.",s.siegk@orthopaedicsandplasticsurgery.com,linkedin.com/in/ssiegk,Influence of Collagen 1 on osteogenesis in a perfused 3D bioreactor system.,2026-01,"Biomedical materials (Bristol, England)",41406600,3D cell culture,PubMed
J H Wagner,Researcher,Orthopaedics and Plastic Surgery,"Goettingen, Germany.",j.wagner@orthopaedicsandplasticsurgery.com,linkedin.com/in/jhwagner,Influence of Collagen 1 on osteogenesis in a perfused 3D bioreactor system.,2026-01,"Biomedical materials (Bristol, England)",41406600,3D cell culture,PubMed
M Remling,Researcher,Orthopaedics and Plastic Surgery,"Goettingen, Germany.",m.remling@orthopaedicsandplasticsurgery.com,linkedin.com/in/mremling,Influence of Collagen 1 on osteogenesis in a perfused 3D bioreactor system.,2026-01,"Biomedical materials (Bristol, England)",41406600,3D cell culture,PubMed
S Taheri,Researcher,Orthopaedics and Plastic Surgery,"Goettingen, Germany.",s.taheri@orthopaedicsandplasticsurgery.com,linkedin.com/in/staheri,Influence of Collagen 1 on osteogenesis in a perfused 3D bioreactor system.,2026-01,"Biomedical materials (Bristol, England)",41406600,3D cell culture,PubMed
W Lehmann,Researcher,Orthopaedics and Plastic Surgery,"Goettingen, Germany.",w.lehmann@orthopaedicsandplasticsurgery.com,linkedin.com/in/wlehmann,Influence of Collagen 1 on osteogenesis in a perfused 3D bioreactor system.,2026-01,"Biomedical materials (Bristol, England)",41406600,3D cell culture,PubMed
A F Schilling,Researcher,Orthopaedics and Plastic Surgery,"Goettingen, Germany.",a.schilling@orthopaedicsandplasticsurgery.com,linkedin.com/in/afschilling,Influence of Collagen 1 on osteogenesis in a perfused 3D bioreactor system.,2026-01,"Biomedical materials (Bristol, England)",41406600,3D cell culture,PubMed
Stefania Alexandra Iakab,Researcher,Mass Spectrometry and Optical Spectroscopy,"Mannheim, Germany.",stefania.iakab@massspectrometryandopticalspectroscopy.com,linkedin.com/in/stefaniaalexandraiakab,From Sample to Mixed Reality: A Translational 3D MALDI Imaging Platform for Advanced 3D Spatial Omic,2025-12,"Advanced science (Weinheim, Baden-Wurttemberg, Germany)",41405385,3D cell culture,PubMed
Jonas Cordes,Researcher,Mass Spectrometry and Optical Spectroscopy,"Mannheim, Germany.",jonas.cordes@massspectrometryandopticalspectroscopy.com,linkedin.com/in/jonascordes,From Sample to Mixed Reality: A Translational 3D MALDI Imaging Platform for Advanced 3D Spatial Omic,2025-12,"Advanced science (Weinheim, Baden-Wurttemberg, Germany)",41405385,3D cell culture,PubMed
Thomas Enzlein,Researcher,Mass Spectrometry and Optical Spectroscopy,"Mannheim, Germany.",thomas.enzlein@massspectrometryandopticalspectroscopy.com,linkedin.com/in/thomasenzlein,From Sample to Mixed Reality: A Translational 3D MALDI Imaging Platform for Advanced 3D Spatial Omic,2025-12,"Advanced science (Weinheim, Baden-Wurttemberg, Germany)",41405385,3D cell culture,PubMed
Florian Keller,Researcher,3D-Models and Imaging,"Mannheim, Germany.",florian.keller@3d-modelsandimaging.com,linkedin.com/in/floriankeller,From Sample to Mixed Reality: A Translational 3D MALDI Imaging Platform for Advanced 3D Spatial Omic,2025-12,"Advanced science (Weinheim, Baden-Wurttemberg, Germany)",41405385,3D cell culture,PubMed
Kevin Kastner,Researcher,Virtual Engineering,"Mannheim, Germany.",kevin.kastner@virtualengineering.com,linkedin.com/in/kevinkastner,From Sample to Mixed Reality: A Translational 3D MALDI Imaging Platform for Advanced 3D Spatial Omic,2025-12,"Advanced science (Weinheim, Baden-Wurttemberg, Germany)",41405385,3D cell culture,PubMed
Theresa Mulholland,Researcher,German Cancer Research Center (DKFZ),"Heidelberg, Germany.",theresa.mulholland@germancancerresearchcenter(dkfz).com,linkedin.com/in/theresamulholland,From Sample to Mixed Reality: A Translational 3D MALDI Imaging Platform for Advanced 3D Spatial Omic,2025-12,"Advanced science (Weinheim, Baden-Wurttemberg, Germany)",41405385,3D cell culture,PubMed
Björn Christian Fröhlich,Researcher,Mass Spectrometry and Optical Spectroscopy,"Mannheim, Germany.",björn.fröhlich@massspectrometryandopticalspectroscopy.com,linkedin.com/in/björnchristianfröhlich,From Sample to Mixed Reality: A Translational 3D MALDI Imaging Platform for Advanced 3D Spatial Omic,2025-12,"Advanced science (Weinheim, Baden-Wurttemberg, Germany)",41405385,3D cell culture,PubMed
Lars Gruber,Researcher,Mass Spectrometry and Optical Spectroscopy,"Mannheim, Germany.",lars.gruber@massspectrometryandopticalspectroscopy.com,linkedin.com/in/larsgruber,From Sample to Mixed Reality: A Translational 3D MALDI Imaging Platform for Advanced 3D Spatial Omic,2025-12,"Advanced science (Weinheim, Baden-Wurttemberg, Germany)",41405385,3D cell culture,PubMed
James Lucas Cairns,Researcher,Mass Spectrometry and Optical Spectroscopy,"Mannheim, Germany.",james.cairns@massspectrometryandopticalspectroscopy.com,linkedin.com/in/jameslucascairns,From Sample to Mixed Reality: A Translational 3D MALDI Imaging Platform for Advanced 3D Spatial Omic,2025-12,"Advanced science (Weinheim, Baden-Wurttemberg, Germany)",41405385,3D cell culture,PubMed
Stefan Schmidt,Researcher,Mass Spectrometry and Optical Spectroscopy,"Mannheim, Germany.",stefan.schmidt@massspectrometryandopticalspectroscopy.com,linkedin.com/in/stefanschmidt,From Sample to Mixed Reality: A Translational 3D MALDI Imaging Platform for Advanced 3D Spatial Omic,2025-12,"Advanced science (Weinheim, Baden-Wurttemberg, Germany)",41405385,3D cell culture,PubMed
Mathias Hafner,Researcher,3D-Models and Imaging,"Mannheim, Germany.",mathias.hafner@3d-modelsandimaging.com,linkedin.com/in/mathiashafner,From Sample to Mixed Reality: A Translational 3D MALDI Imaging Platform for Advanced 3D Spatial Omic,2025-12,"Advanced science (Weinheim, Baden-Wurttemberg, Germany)",41405385,3D cell culture,PubMed
Richard Schneider,Researcher,Frankfurter Str. 250,"Darmstadt, Germany.",richard.schneider@frankfurterstr.250,linkedin.com/in/richardschneider,From Sample to Mixed Reality: A Translational 3D MALDI Imaging Platform for Advanced 3D Spatial Omic,2025-12,"Advanced science (Weinheim, Baden-Wurttemberg, Germany)",41405385,3D cell culture,PubMed
Johannes Betge,Researcher,German Cancer Research Center (DKFZ),"Heidelberg, Germany.",johannes.betge@germancancerresearchcenter(dkfz).com,linkedin.com/in/johannesbetge,From Sample to Mixed Reality: A Translational 3D MALDI Imaging Platform for Advanced 3D Spatial Omic,2025-12,"Advanced science (Weinheim, Baden-Wurttemberg, Germany)",41405385,3D cell culture,PubMed
Frank Fischer,Researcher,Frankfurter Str. 250,"Darmstadt, Germany.",frank.fischer@frankfurterstr.250,linkedin.com/in/frankfischer,From Sample to Mixed Reality: A Translational 3D MALDI Imaging Platform for Advanced 3D Spatial Omic,2025-12,"Advanced science (Weinheim, Baden-Wurttemberg, Germany)",41405385,3D cell culture,PubMed
Julian Reichwald,Researcher,Virtual Engineering,"Mannheim, Germany.",julian.reichwald@virtualengineering.com,linkedin.com/in/julianreichwald,From Sample to Mixed Reality: A Translational 3D MALDI Imaging Platform for Advanced 3D Spatial Omic,2025-12,"Advanced science (Weinheim, Baden-Wurttemberg, Germany)",41405385,3D cell culture,PubMed
Rüdiger Rudolf,Researcher,3D-Models and Imaging,"Mannheim, Germany.",rüdiger.rudolf@3d-modelsandimaging.com,linkedin.com/in/rüdigerrudolf,From Sample to Mixed Reality: A Translational 3D MALDI Imaging Platform for Advanced 3D Spatial Omic,2025-12,"Advanced science (Weinheim, Baden-Wurttemberg, Germany)",41405385,3D cell culture,PubMed
Carsten Hopf,Researcher,Mass Spectrometry and Optical Spectroscopy,"Mannheim, Germany.",carsten.hopf@massspectrometryandopticalspectroscopy.com,linkedin.com/in/carstenhopf,From Sample to Mixed Reality: A Translational 3D MALDI Imaging Platform for Advanced 3D Spatial Omic,2025-12,"Advanced science (Weinheim, Baden-Wurttemberg, Germany)",41405385,3D cell culture,PubMed
Y F Pan,Researcher,Nanjing Drum Tower Hospital,"Nanjing 210008, China.",y.pan@nanjingdrumtowerhospital.com,linkedin.com/in/yfpan,[Application effects of programmed cell death protein 1 antibody-internalizing Arg-Gly-Asp peptide c,2024-01,Zhonghua yi xue za zhi,41402125,3D cell culture,PubMed
S J Ren,Researcher,Nanjing Drum Tower Hospital,"Nanjing 210008, China.",s.ren@nanjingdrumtowerhospital.com,linkedin.com/in/sjren,[Application effects of programmed cell death protein 1 antibody-internalizing Arg-Gly-Asp peptide c,2024-01,Zhonghua yi xue za zhi,41402125,3D cell culture,PubMed
W Q Liu,Researcher,Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University,"Nanjing 210008, China.",w.liu@nanjingdrumtowerhospitalclinicalcollegeofnanjingmedicaledu.com,linkedin.com/in/wqliu,[Application effects of programmed cell death protein 1 antibody-internalizing Arg-Gly-Asp peptide c,2024-01,Zhonghua yi xue za zhi,41402125,3D cell culture,PubMed
Y R Cai,Researcher,Nanjing Drum Tower Hospital,"Nanjing 210008, China.",y.cai@nanjingdrumtowerhospital.com,linkedin.com/in/yrcai,[Application effects of programmed cell death protein 1 antibody-internalizing Arg-Gly-Asp peptide c,2024-01,Zhonghua yi xue za zhi,41402125,3D cell culture,PubMed
Y T Luo,Researcher,Nanjing Drum Tower Hospital,"Nanjing 210008, China.",y.luo@nanjingdrumtowerhospital.com,linkedin.com/in/ytluo,[Application effects of programmed cell death protein 1 antibody-internalizing Arg-Gly-Asp peptide c,2024-01,Zhonghua yi xue za zhi,41402125,3D cell culture,PubMed
Y N Cao,Researcher,Nanjing Drum Tower Hospital,"Nanjing 210008, China.",y.cao@nanjingdrumtowerhospital.com,linkedin.com/in/yncao,[Application effects of programmed cell death protein 1 antibody-internalizing Arg-Gly-Asp peptide c,2024-01,Zhonghua yi xue za zhi,41402125,3D cell culture,PubMed
H B Wang,Researcher,Nanjing Drum Tower Hospital,"Nanjing 210008, China.",h.wang@nanjingdrumtowerhospital.com,linkedin.com/in/hbwang,[Application effects of programmed cell death protein 1 antibody-internalizing Arg-Gly-Asp peptide c,2024-01,Zhonghua yi xue za zhi,41402125,3D cell culture,PubMed
T Shi,Researcher,Nanjing Drum Tower Hospital,"Nanjing 210008, China.",t.shi@nanjingdrumtowerhospital.com,linkedin.com/in/tshi,[Application effects of programmed cell death protein 1 antibody-internalizing Arg-Gly-Asp peptide c,2024-01,Zhonghua yi xue za zhi,41402125,3D cell culture,PubMed
Y Wang,Researcher,Nanjing Drum Tower Hospital,"Nanjing 210008, China.",y.wang@nanjingdrumtowerhospital.com,linkedin.com/in/ywang,[Application effects of programmed cell death protein 1 antibody-internalizing Arg-Gly-Asp peptide c,2024-01,Zhonghua yi xue za zhi,41402125,3D cell culture,PubMed
B R Liu,Researcher,Nanjing Drum Tower Hospital,"Nanjing 210008, China.",b.liu@nanjingdrumtowerhospital.com,linkedin.com/in/brliu,[Application effects of programmed cell death protein 1 antibody-internalizing Arg-Gly-Asp peptide c,2024-01,Zhonghua yi xue za zhi,41402125,3D cell culture,PubMed
J Wei,Researcher,Nanjing Drum Tower Hospital,"Nanjing 210008, China.",j.wei@nanjingdrumtowerhospital.com,linkedin.com/in/jwei,[Application effects of programmed cell death protein 1 antibody-internalizing Arg-Gly-Asp peptide c,2024-01,Zhonghua yi xue za zhi,41402125,3D cell culture,PubMed
Manzoor Majid,Researcher,Ningbo University,"Ningbo, China.",manzoor.majid@ningboedu.com,linkedin.com/in/manzoormajid,"Skin Organoids for Disease Modelling, Drug Screening and Regenerative Medicine: Recent Advances and ",2024-01,Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society,41480947,organoid,PubMed
Jiani Chen,Researcher,Ningbo University,"Ningbo, China.",jiani.chen@ningboedu.com,linkedin.com/in/jianichen,"Skin Organoids for Disease Modelling, Drug Screening and Regenerative Medicine: Recent Advances and ",2024-01,Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society,41480947,organoid,PubMed
Chunjie Wu,Researcher,Chengdu University of Traditional Chinese Medicine,"Chengdu, China.",chunjie.wu@chengdueduoftraditionalchinesemedicine.com,linkedin.com/in/chunjiewu,"Skin Organoids for Disease Modelling, Drug Screening and Regenerative Medicine: Recent Advances and ",2024-01,Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society,41480947,organoid,PubMed
Yuzong Chen,Researcher,Ningbo University,"Ningbo, China.",yuzong.chen@ningboedu.com,linkedin.com/in/yuzongchen,"Skin Organoids for Disease Modelling, Drug Screening and Regenerative Medicine: Recent Advances and ",2024-01,Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society,41480947,organoid,PubMed
Feng Ni,Researcher,Ningbo University,"Ningbo, China.",feng.ni@ningboedu.com,linkedin.com/in/fengni,"Skin Organoids for Disease Modelling, Drug Screening and Regenerative Medicine: Recent Advances and ",2024-01,Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society,41480947,organoid,PubMed
Sofia Ferreira,Researcher,Department of Radiation Oncology,"California, USA.",sofia.ferreira@departmentofradiationoncology.com,linkedin.com/in/sofiaferreira,Merlin's disappearing act: NF2 loss conjures pancreatic cancer survival in the hostile tumor microen,2026-01,The Journal of clinical investigation,41480769,organoid,PubMed
Laura D Attardi,Researcher,Department of Radiation Oncology,"California, USA.",laura.attardi@departmentofradiationoncology.com,linkedin.com/in/lauradattardi,Merlin's disappearing act: NF2 loss conjures pancreatic cancer survival in the hostile tumor microen,2026-01,The Journal of clinical investigation,41480769,organoid,PubMed
Helene Lacaille,Researcher,Department of Pediatrics,"NY, United States.",helene.lacaille@departmentofpediatrics.com,linkedin.com/in/helenelacaille,Neurosteroid withdrawal disrupts GABAergic system development in human cortical organoids: implicati,2025-12,Frontiers in cellular neuroscience,41480491,organoid,PubMed
Ekaterina Lebayle,Researcher,Stem Cell Core,"NY, United States.",ekaterina.lebayle@stemcellcore.com,linkedin.com/in/ekaterinalebayle,Neurosteroid withdrawal disrupts GABAergic system development in human cortical organoids: implicati,2025-12,Frontiers in cellular neuroscience,41480491,organoid,PubMed
Barbara Corneo,Researcher,Stem Cell Core,"NY, United States.",barbara.corneo@stemcellcore.com,linkedin.com/in/barbaracorneo,Neurosteroid withdrawal disrupts GABAergic system development in human cortical organoids: implicati,2025-12,Frontiers in cellular neuroscience,41480491,organoid,PubMed
Claire-Marie Vacher,Researcher,Department of Pediatrics,"NY, United States.",claire-marie.vacher@departmentofpediatrics.com,linkedin.com/in/claire-marievacher,Neurosteroid withdrawal disrupts GABAergic system development in human cortical organoids: implicati,2025-12,Frontiers in cellular neuroscience,41480491,organoid,PubMed
Anna A Penn,Researcher,Department of Pediatrics,"NY, United States.",anna.penn@departmentofpediatrics.com,linkedin.com/in/annaapenn,Neurosteroid withdrawal disrupts GABAergic system development in human cortical organoids: implicati,2025-12,Frontiers in cellular neuroscience,41480491,organoid,PubMed
Xiao-Ming Zhang,Researcher,Respiratory and Critical Care Medicine,"Beijing 100091, China.",xiao-ming.zhang@respiratoryandcriticalcaremedicine.com,linkedin.com/in/xiao-mingzhang,"Immune therapy-related hyperprogressive disease: Molecular mechanisms, biomarkers, and clinical stra",2024-01,World journal of clinical oncology,41480176,organoid,PubMed
Fei-Yu Zhao,Researcher,The Fifth Medical Center of Chinese PLA General Hospital,"Beijing 100071, China.",fei-yu.zhao@thefifthmedicalcenterofchineseplageneralhospital.com,linkedin.com/in/fei-yuzhao,"Immune therapy-related hyperprogressive disease: Molecular mechanisms, biomarkers, and clinical stra",2024-01,World journal of clinical oncology,41480176,organoid,PubMed
Lin-Feng Gao,Researcher,The 93263 Unit of The Chinese PLA,"Liaoning Province, China.",lin-feng.gao@the93263unitofthechinesepla.com,linkedin.com/in/lin-fenggao,"Immune therapy-related hyperprogressive disease: Molecular mechanisms, biomarkers, and clinical stra",2024-01,World journal of clinical oncology,41480176,organoid,PubMed
Tao Xu,Researcher,Respiratory and Critical Care Medicine,"Beijing 100091, China.",tao.xu@respiratoryandcriticalcaremedicine.com,linkedin.com/in/taoxu,"Immune therapy-related hyperprogressive disease: Molecular mechanisms, biomarkers, and clinical stra",2024-01,World journal of clinical oncology,41480176,organoid,PubMed
Fan Yang,Researcher,The Fifth Medical Center of Chinese PLA General Hospital,"Beijing 100071, China.",fan.yang@thefifthmedicalcenterofchineseplageneralhospital.com,linkedin.com/in/fanyang,"Immune therapy-related hyperprogressive disease: Molecular mechanisms, biomarkers, and clinical stra",2024-01,World journal of clinical oncology,41480176,organoid,PubMed
Nian-Song Qian,Researcher,Respiratory and Critical Care Medicine,"Beijing 100091, China. qianniansong1@163.com.",nian-song.qian@respiratoryandcriticalcaremedicine.com,linkedin.com/in/nian-songqian,"Immune therapy-related hyperprogressive disease: Molecular mechanisms, biomarkers, and clinical stra",2024-01,World journal of clinical oncology,41480176,organoid,PubMed
Finn Dani,Researcher,Centre for Translational Bone Joint and Soft Tissue Research Faculty of Medicine Technische Universität Dresden Dresden Germany.,Unknown,finn.dani@centrefortranslationalbonejointandsofttissueresearchfacultyofmedicinetechnischeuniversitätdresdendresdengermany.,linkedin.com/in/finndani,Combination of Extrusion and Drop-on-Demand Bioprinting in One Process Enables the Local Placement o,2025-12,Engineering in life sciences,41479621,organoid,PubMed
Nieves Cubo-Matteo,Researcher,Universidad Nebrija Madrid Spain.,"Grupo de Investigación ARIES, Universidad Nebrija Madrid Spain.",nieves.cubo-matteo@universidadnebrijamadridspain.,linkedin.com/in/nievescubo-matteo,Combination of Extrusion and Drop-on-Demand Bioprinting in One Process Enables the Local Placement o,2025-12,Engineering in life sciences,41479621,organoid,PubMed
Leonie Schlicht,Researcher,Centre for Translational Bone Joint and Soft Tissue Research Faculty of Medicine Technische Universität Dresden Dresden Germany.,Unknown,leonie.schlicht@centrefortranslationalbonejointandsofttissueresearchfacultyofmedicinetechnischeuniversitätdresdendresdengermany.,linkedin.com/in/leonieschlicht,Combination of Extrusion and Drop-on-Demand Bioprinting in One Process Enables the Local Placement o,2025-12,Engineering in life sciences,41479621,organoid,PubMed
Michael Gelinsky,Researcher,Centre for Translational Bone Joint and Soft Tissue Research Faculty of Medicine Technische Universität Dresden Dresden Germany.,Unknown,michael.gelinsky@centrefortranslationalbonejointandsofttissueresearchfacultyofmedicinetechnischeuniversitätdresdendresdengermany.,linkedin.com/in/michaelgelinsky,Combination of Extrusion and Drop-on-Demand Bioprinting in One Process Enables the Local Placement o,2025-12,Engineering in life sciences,41479621,organoid,PubMed
Anja Lode,Researcher,Centre for Translational Bone Joint and Soft Tissue Research Faculty of Medicine Technische Universität Dresden Dresden Germany.,Unknown,anja.lode@centrefortranslationalbonejointandsofttissueresearchfacultyofmedicinetechnischeuniversitätdresdendresdengermany.,linkedin.com/in/anjalode,Combination of Extrusion and Drop-on-Demand Bioprinting in One Process Enables the Local Placement o,2025-12,Engineering in life sciences,41479621,organoid,PubMed
Noelia Rodriguez Mier,Researcher,Woman and Child Unit,"Leuven, Belgium. Electronic address: noelia.rodriguezmier@kuleuven.be.",noelia.mier@womanandchildunit.com,linkedin.com/in/noeliarodriguezmier,Rethinking CFTR variant responsiveness: Differential responses to vanzacaftor and elexacaftor.,2025-12,Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society,41478784,organoid,PubMed
Isabelle Callebaut,Researcher,UMR CNRS 7590,"Paris F-75005, France.",isabelle.callebaut@umrcnrs7590.com,linkedin.com/in/isabellecallebaut,Rethinking CFTR variant responsiveness: Differential responses to vanzacaftor and elexacaftor.,2025-12,Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society,41478784,organoid,PubMed
Marijke Proesmans,Researcher,Woman and Child Unit,"Leuven, Belgium.",marijke.proesmans@womanandchildunit.com,linkedin.com/in/marijkeproesmans,Rethinking CFTR variant responsiveness: Differential responses to vanzacaftor and elexacaftor.,2025-12,Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society,41478784,organoid,PubMed
Eva Van Braeckel,Researcher,Ghent University Hospital,"Ghent, Belgium.",eva.braeckel@ghenteduhospital.com,linkedin.com/in/evavanbraeckel,Rethinking CFTR variant responsiveness: Differential responses to vanzacaftor and elexacaftor.,2025-12,Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society,41478784,organoid,PubMed
Stephanie Van Biervliet,Researcher,Ghent University,"Ghent, Belgium.",stephanie.biervliet@ghentedu.com,linkedin.com/in/stephanievanbiervliet,Rethinking CFTR variant responsiveness: Differential responses to vanzacaftor and elexacaftor.,2025-12,Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society,41478784,organoid,PubMed
Mieke Boon,Researcher,Woman and Child Unit,"Leuven, Belgium.",mieke.boon@womanandchildunit.com,linkedin.com/in/miekeboon,Rethinking CFTR variant responsiveness: Differential responses to vanzacaftor and elexacaftor.,2025-12,Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society,41478784,organoid,PubMed
Anabela Santo Ramalho,Researcher,Woman and Child Unit,"Leuven, Belgium.",anabela.ramalho@womanandchildunit.com,linkedin.com/in/anabelasantoramalho,Rethinking CFTR variant responsiveness: Differential responses to vanzacaftor and elexacaftor.,2025-12,Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society,41478784,organoid,PubMed
François Vermeulen,Researcher,Woman and Child Unit,"Leuven, Belgium.",françois.vermeulen@womanandchildunit.com,linkedin.com/in/françoisvermeulen,Rethinking CFTR variant responsiveness: Differential responses to vanzacaftor and elexacaftor.,2025-12,Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society,41478784,organoid,PubMed
Dandan Zhong,Researcher,Xuzhou Medical University,"Jiangsu, China.",dandan.zhong@xuzhoumedicaledu.com,linkedin.com/in/dandanzhong,Interplay between aging and metabolic diseases: from molecular mechanisms to therapeutic horizons.,2025-12,Medical review (2021),41477061,organoid,PubMed
Yue Sun,Researcher,Xuzhou Medical University,"Jiangsu, China.",yue.sun@xuzhoumedicaledu.com,linkedin.com/in/yuesun,Interplay between aging and metabolic diseases: from molecular mechanisms to therapeutic horizons.,2025-12,Medical review (2021),41477061,organoid,PubMed
Lanlan Zhao,Researcher,Xuzhou Medical University,"Jiangsu, China.",lanlan.zhao@xuzhoumedicaledu.com,linkedin.com/in/lanlanzhao,Interplay between aging and metabolic diseases: from molecular mechanisms to therapeutic horizons.,2025-12,Medical review (2021),41477061,organoid,PubMed
Zhenchao Hu,Researcher,Xuzhou Medical University,"Jiangsu, China.",zhenchao.hu@xuzhoumedicaledu.com,linkedin.com/in/zhenchaohu,Interplay between aging and metabolic diseases: from molecular mechanisms to therapeutic horizons.,2025-12,Medical review (2021),41477061,organoid,PubMed
Guanming Li,Researcher,Beijing,"Beijing, China.",guanming.li@beijing.com,linkedin.com/in/guanmingli,Interplay between aging and metabolic diseases: from molecular mechanisms to therapeutic horizons.,2025-12,Medical review (2021),41477061,organoid,PubMed
Hao Li,Researcher,University of California San Francisco,"San Francisco, CA",hao.li@eduofcaliforniasanfrancisco.com,linkedin.com/in/haoli,Interplay between aging and metabolic diseases: from molecular mechanisms to therapeutic horizons.,2025-12,Medical review (2021),41477061,organoid,PubMed
Zhengwei Xie,Researcher,School of Basic Medical Sciences,"Beijing, China.",zhengwei.xie@schoolofbasicmedicalsciences.com,linkedin.com/in/zhengweixie,Interplay between aging and metabolic diseases: from molecular mechanisms to therapeutic horizons.,2025-12,Medical review (2021),41477061,organoid,PubMed
Man Luo,Researcher,Affiliated Hospital of North Sichuan Medical College,"Nanchong, China.",man.luo@affiliatedhospitalofnorthsichuanmedicalcollege.com,linkedin.com/in/manluo,Fedratinib reveals chemotherapeutic potential in esophageal squamous cell cancer.,2025-12,Frontiers in pharmacology,41476794,organoid,PubMed
Jiang Zhu,Researcher,Affiliated Hospital of North Sichuan Medical College,"Nanchong, China.",jiang.zhu@affiliatedhospitalofnorthsichuanmedicalcollege.com,linkedin.com/in/jiangzhu,Fedratinib reveals chemotherapeutic potential in esophageal squamous cell cancer.,2025-12,Frontiers in pharmacology,41476794,organoid,PubMed
Yong Yang,Researcher,Affiliated Hospital of North Sichuan Medical College,"Nanchong, China.",yong.yang@affiliatedhospitalofnorthsichuanmedicalcollege.com,linkedin.com/in/yongyang,Fedratinib reveals chemotherapeutic potential in esophageal squamous cell cancer.,2025-12,Frontiers in pharmacology,41476794,organoid,PubMed
Chongbo Liao,Researcher,Affiliated Hospital of North Sichuan Medical College,"Nanchong, China.",chongbo.liao@affiliatedhospitalofnorthsichuanmedicalcollege.com,linkedin.com/in/chongboliao,Fedratinib reveals chemotherapeutic potential in esophageal squamous cell cancer.,2025-12,Frontiers in pharmacology,41476794,organoid,PubMed
Xiao Liu,Researcher,Affiliated Hospital of North Sichuan Medical College,"Nanchong, China.",xiao.liu@affiliatedhospitalofnorthsichuanmedicalcollege.com,linkedin.com/in/xiaoliu,Fedratinib reveals chemotherapeutic potential in esophageal squamous cell cancer.,2025-12,Frontiers in pharmacology,41476794,organoid,PubMed
Maoju Tang,Researcher,Affiliated Hospital of North Sichuan Medical College,"Nanchong, China.",maoju.tang@affiliatedhospitalofnorthsichuanmedicalcollege.com,linkedin.com/in/maojutang,Fedratinib reveals chemotherapeutic potential in esophageal squamous cell cancer.,2025-12,Frontiers in pharmacology,41476794,organoid,PubMed
Lei Xu,Researcher,North Sichuan Medical College,"Nanchong, China.",lei.xu@northsichuanmedicalcollege.com,linkedin.com/in/leixu,Fedratinib reveals chemotherapeutic potential in esophageal squamous cell cancer.,2025-12,Frontiers in pharmacology,41476794,organoid,PubMed
Xiaowu Zhong,Researcher,Affiliated Hospital of North Sichuan Medical College,"Nanchong, China.",xiaowu.zhong@affiliatedhospitalofnorthsichuanmedicalcollege.com,linkedin.com/in/xiaowuzhong,Fedratinib reveals chemotherapeutic potential in esophageal squamous cell cancer.,2025-12,Frontiers in pharmacology,41476794,organoid,PubMed
Qiang Ma,Researcher,Affiliated Hospital of North Sichuan Medical College,"Nanchong, China.",qiang.ma@affiliatedhospitalofnorthsichuanmedicalcollege.com,linkedin.com/in/qiangma,Fedratinib reveals chemotherapeutic potential in esophageal squamous cell cancer.,2025-12,Frontiers in pharmacology,41476794,organoid,PubMed
Xiaolan Guo,Researcher,Affiliated Hospital of North Sichuan Medical College,"Nanchong, China.",xiaolan.guo@affiliatedhospitalofnorthsichuanmedicalcollege.com,linkedin.com/in/xiaolanguo,Fedratinib reveals chemotherapeutic potential in esophageal squamous cell cancer.,2025-12,Frontiers in pharmacology,41476794,organoid,PubMed
Linxue Zhang,Researcher,Peking University School and Hospital of Stomatology & National Center for Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Laboratory for Digital and Material Technology of Stomatology & Beijing Key Laboratory of Digital Stomatology & Research Center of Engineering and Technology for Computerized Dentistry Ministry of Health & NMPA Key Laboratory for Dental Materials,"100081, China.",linxue.zhang@pekingeduschoolandhospitalofstomatology&nationalcenterforstomatology&nationalclinicalresearchcenterfororaldiseases&nationalengineeringlaboratoryfordigitalandmaterialtechnologyofstomatology&beijingkeylaboratoryofdigitalstomatology&researchcenterofengineeringandtechnologyforcomputerizeddentistryministryofhealth&nmpakeylaboratoryfordentalmaterials.com,linkedin.com/in/linxuezhang,Piezo1 mediated scaffold-free rapid generation of self-mineralized bone organoids via activating Wnt,2025-12,Materials today. Bio,41476751,organoid,PubMed
Yunfan Zhang,Researcher,Peking University School and Hospital of Stomatology & National Center for Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Laboratory for Digital and Material Technology of Stomatology & Beijing Key Laboratory of Digital Stomatology & Research Center of Engineering and Technology for Computerized Dentistry Ministry of Health & NMPA Key Laboratory for Dental Materials,"100081, China.",yunfan.zhang@pekingeduschoolandhospitalofstomatology&nationalcenterforstomatology&nationalclinicalresearchcenterfororaldiseases&nationalengineeringlaboratoryfordigitalandmaterialtechnologyofstomatology&beijingkeylaboratoryofdigitalstomatology&researchcenterofengineeringandtechnologyforcomputerizeddentistryministryofhealth&nmpakeylaboratoryfordentalmaterials.com,linkedin.com/in/yunfanzhang,Piezo1 mediated scaffold-free rapid generation of self-mineralized bone organoids via activating Wnt,2025-12,Materials today. Bio,41476751,organoid,PubMed
Zhuo Wan,Researcher,Peking University School and Hospital of Stomatology & National Center for Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Laboratory for Digital and Material Technology of Stomatology & Beijing Key Laboratory of Digital Stomatology & Research Center of Engineering and Technology for Computerized Dentistry Ministry of Health & NMPA Key Laboratory for Dental Materials,"100081, China.",zhuo.wan@pekingeduschoolandhospitalofstomatology&nationalcenterforstomatology&nationalclinicalresearchcenterfororaldiseases&nationalengineeringlaboratoryfordigitalandmaterialtechnologyofstomatology&beijingkeylaboratoryofdigitalstomatology&researchcenterofengineeringandtechnologyforcomputerizeddentistryministryofhealth&nmpakeylaboratoryfordentalmaterials.com,linkedin.com/in/zhuowan,Piezo1 mediated scaffold-free rapid generation of self-mineralized bone organoids via activating Wnt,2025-12,Materials today. Bio,41476751,organoid,PubMed
Xiaojing Yuan,Researcher,Peking University School and Hospital of Stomatology & National Center for Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Laboratory for Digital and Material Technology of Stomatology & Beijing Key Laboratory of Digital Stomatology & Research Center of Engineering and Technology for Computerized Dentistry Ministry of Health & NMPA Key Laboratory for Dental Materials,"100081, China.",xiaojing.yuan@pekingeduschoolandhospitalofstomatology&nationalcenterforstomatology&nationalclinicalresearchcenterfororaldiseases&nationalengineeringlaboratoryfordigitalandmaterialtechnologyofstomatology&beijingkeylaboratoryofdigitalstomatology&researchcenterofengineeringandtechnologyforcomputerizeddentistryministryofhealth&nmpakeylaboratoryfordentalmaterials.com,linkedin.com/in/xiaojingyuan,Piezo1 mediated scaffold-free rapid generation of self-mineralized bone organoids via activating Wnt,2025-12,Materials today. Bio,41476751,organoid,PubMed
Yike Gao,Researcher,Peking University School and Hospital of Stomatology & National Center for Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Laboratory for Digital and Material Technology of Stomatology & Beijing Key Laboratory of Digital Stomatology & Research Center of Engineering and Technology for Computerized Dentistry Ministry of Health & NMPA Key Laboratory for Dental Materials,"100081, China.",yike.gao@pekingeduschoolandhospitalofstomatology&nationalcenterforstomatology&nationalclinicalresearchcenterfororaldiseases&nationalengineeringlaboratoryfordigitalandmaterialtechnologyofstomatology&beijingkeylaboratoryofdigitalstomatology&researchcenterofengineeringandtechnologyforcomputerizeddentistryministryofhealth&nmpakeylaboratoryfordentalmaterials.com,linkedin.com/in/yikegao,Piezo1 mediated scaffold-free rapid generation of self-mineralized bone organoids via activating Wnt,2025-12,Materials today. Bio,41476751,organoid,PubMed
Rui Song,Researcher,Peking University School and Hospital of Stomatology & National Center for Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Laboratory for Digital and Material Technology of Stomatology & Beijing Key Laboratory of Digital Stomatology & Research Center of Engineering and Technology for Computerized Dentistry Ministry of Health & NMPA Key Laboratory for Dental Materials,"100081, China.",rui.song@pekingeduschoolandhospitalofstomatology&nationalcenterforstomatology&nationalclinicalresearchcenterfororaldiseases&nationalengineeringlaboratoryfordigitalandmaterialtechnologyofstomatology&beijingkeylaboratoryofdigitalstomatology&researchcenterofengineeringandtechnologyforcomputerizeddentistryministryofhealth&nmpakeylaboratoryfordentalmaterials.com,linkedin.com/in/ruisong,Piezo1 mediated scaffold-free rapid generation of self-mineralized bone organoids via activating Wnt,2025-12,Materials today. Bio,41476751,organoid,PubMed
Xiya Liu,Researcher,Peking University School and Hospital of Stomatology & National Center for Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Laboratory for Digital and Material Technology of Stomatology & Beijing Key Laboratory of Digital Stomatology & Research Center of Engineering and Technology for Computerized Dentistry Ministry of Health & NMPA Key Laboratory for Dental Materials,"100081, China.",xiya.liu@pekingeduschoolandhospitalofstomatology&nationalcenterforstomatology&nationalclinicalresearchcenterfororaldiseases&nationalengineeringlaboratoryfordigitalandmaterialtechnologyofstomatology&beijingkeylaboratoryofdigitalstomatology&researchcenterofengineeringandtechnologyforcomputerizeddentistryministryofhealth&nmpakeylaboratoryfordentalmaterials.com,linkedin.com/in/xiyaliu,Piezo1 mediated scaffold-free rapid generation of self-mineralized bone organoids via activating Wnt,2025-12,Materials today. Bio,41476751,organoid,PubMed
Jingyi Sang,Researcher,Peking University School and Hospital of Stomatology & National Center for Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Laboratory for Digital and Material Technology of Stomatology & Beijing Key Laboratory of Digital Stomatology & Research Center of Engineering and Technology for Computerized Dentistry Ministry of Health & NMPA Key Laboratory for Dental Materials,"100081, China.",jingyi.sang@pekingeduschoolandhospitalofstomatology&nationalcenterforstomatology&nationalclinicalresearchcenterfororaldiseases&nationalengineeringlaboratoryfordigitalandmaterialtechnologyofstomatology&beijingkeylaboratoryofdigitalstomatology&researchcenterofengineeringandtechnologyforcomputerizeddentistryministryofhealth&nmpakeylaboratoryfordentalmaterials.com,linkedin.com/in/jingyisang,Piezo1 mediated scaffold-free rapid generation of self-mineralized bone organoids via activating Wnt,2025-12,Materials today. Bio,41476751,organoid,PubMed
Jiagui Song,Researcher,Institute of Medical Innovation and Research,"100191, China.",jiagui.song@orgofmedicalinnovationandresearch.com,linkedin.com/in/jiaguisong,Piezo1 mediated scaffold-free rapid generation of self-mineralized bone organoids via activating Wnt,2025-12,Materials today. Bio,41476751,organoid,PubMed
Yuming Zhao,Researcher,Peking University School and Hospital of Stomatology & National Center for Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Laboratory for Digital and Material Technology of Stomatology & Beijing Key Laboratory of Digital Stomatology & Research Center of Engineering and Technology for Computerized Dentistry Ministry of Health & NMPA Key Laboratory for Dental Materials,"100081, China.",yuming.zhao@pekingeduschoolandhospitalofstomatology&nationalcenterforstomatology&nationalclinicalresearchcenterfororaldiseases&nationalengineeringlaboratoryfordigitalandmaterialtechnologyofstomatology&beijingkeylaboratoryofdigitalstomatology&researchcenterofengineeringandtechnologyforcomputerizeddentistryministryofhealth&nmpakeylaboratoryfordentalmaterials.com,linkedin.com/in/yumingzhao,Piezo1 mediated scaffold-free rapid generation of self-mineralized bone organoids via activating Wnt,2025-12,Materials today. Bio,41476751,organoid,PubMed
Zuoying Yuan,Researcher,Institute of Medical Innovation and Research,"100191, China.",zuoying.yuan@orgofmedicalinnovationandresearch.com,linkedin.com/in/zuoyingyuan,Piezo1 mediated scaffold-free rapid generation of self-mineralized bone organoids via activating Wnt,2025-12,Materials today. Bio,41476751,organoid,PubMed
Shuyue Hao,Researcher,Organoid Research Center Institute of Translational Medicine Shanghai University Shanghai China.,Unknown,shuyue.hao@organoidresearchcenterorgoftranslationalmedicineshanghaiedushanghaichina.,linkedin.com/in/shuyuehao,Periosteum Organoid: Biomimetic Design Inspired From the Bone Healing Process.,2025-12,"Exploration (Beijing, China)",41476644,organoid,PubMed
Fuxiao Wang,Researcher,Organoid Research Center Institute of Translational Medicine Shanghai University Shanghai China.,Unknown,fuxiao.wang@organoidresearchcenterorgoftranslationalmedicineshanghaiedushanghaichina.,linkedin.com/in/fuxiaowang,Periosteum Organoid: Biomimetic Design Inspired From the Bone Healing Process.,2025-12,"Exploration (Beijing, China)",41476644,organoid,PubMed
Jingtao Huang,Researcher,Department of Orthopedics Shanghai Zhongye Hospital Shanghai China.,Unknown,jingtao.huang@departmentoforthopedicsshanghaizhongyehospitalshanghaichina.,linkedin.com/in/jingtaohuang,Periosteum Organoid: Biomimetic Design Inspired From the Bone Healing Process.,2025-12,"Exploration (Beijing, China)",41476644,organoid,PubMed
Zhidao Xia,Researcher,Centre For Nanohealth ILS2 Medical School Swansea University Swansea UK.,Unknown,zhidao.xia@centrefornanohealthils2medicalschoolswanseaeduswanseauk.,linkedin.com/in/zhidaoxia,Periosteum Organoid: Biomimetic Design Inspired From the Bone Healing Process.,2025-12,"Exploration (Beijing, China)",41476644,organoid,PubMed
James T Triffitt,Researcher,Nuffield Department of Orthopaedics Rheumatology and Musculoskeletal Sciences The Oxford University Institute of Musculoskeletal Sciences The Botnar Research Centre Nuffield Orthopaedic Centre Oxford UK.,"Oxford, UK",james.triffitt@nuffielddepartmentoforthopaedicsrheumatologyandmusculoskeletalsciencestheoxfordeduorgofmusculoskeletalsciencesthebotnarresearchcentrenuffieldorthopaediccentreoxforduk.,linkedin.com/in/jamesttriffitt,Periosteum Organoid: Biomimetic Design Inspired From the Bone Healing Process.,2025-12,"Exploration (Beijing, China)",41476644,organoid,PubMed
Chenjie Xu,Researcher,Department of Biomedical Engineering City University of Hong Kong Hong Kong SAR China.,Unknown,chenjie.xu@departmentofbiomedicalengineeringcityeduofhongkonghongkongsarchina.,linkedin.com/in/chenjiexu,Periosteum Organoid: Biomimetic Design Inspired From the Bone Healing Process.,2025-12,"Exploration (Beijing, China)",41476644,organoid,PubMed
Long Bai,Researcher,Organoid Research Center Institute of Translational Medicine Shanghai University Shanghai China.,Unknown,long.bai@organoidresearchcenterorgoftranslationalmedicineshanghaiedushanghaichina.,linkedin.com/in/longbai,Periosteum Organoid: Biomimetic Design Inspired From the Bone Healing Process.,2025-12,"Exploration (Beijing, China)",41476644,organoid,PubMed
Jiacan Su,Researcher,Organoid Research Center Institute of Translational Medicine Shanghai University Shanghai China.,Unknown,jiacan.su@organoidresearchcenterorgoftranslationalmedicineshanghaiedushanghaichina.,linkedin.com/in/jiacansu,Periosteum Organoid: Biomimetic Design Inspired From the Bone Healing Process.,2025-12,"Exploration (Beijing, China)",41476644,organoid,PubMed
Giovannino Silvestri,Researcher,Baltimore,"MD, USA.",giovannino.silvestri@baltimore.com,linkedin.com/in/giovanninosilvestri,HIV-1 and Artificial Intelligence: From Molecular Insight to Population Impact.,2024-01,Journal of AIDS and HIV treatment,41473133,organoid,PubMed
Aditi Chatterjee,Researcher,Baltimore,"MD, USA.",aditi.chatterjee@baltimore.com,linkedin.com/in/aditichatterjee,HIV-1 and Artificial Intelligence: From Molecular Insight to Population Impact.,2024-01,Journal of AIDS and HIV treatment,41473133,organoid,PubMed
Xuan Zhang,Researcher,Affiliated Stomatological Hospital of Southwest Medical University,"Sichuan, China.",xuan.zhang@affiliatedstomatologicalhospitalofsouthwestmedicaledu.com,linkedin.com/in/xuanzhang,Vascularized Homeostasis: The Key to Orofacial Tissue-Engineered Organoid Construction.,2025-12,"Tissue engineering. Part B, Reviews",41472623,organoid,PubMed
Zhaohong Li,Researcher,Affiliated Stomatological Hospital of Southwest Medical University,"Sichuan, China.",zhaohong.li@affiliatedstomatologicalhospitalofsouthwestmedicaledu.com,linkedin.com/in/zhaohongli,Vascularized Homeostasis: The Key to Orofacial Tissue-Engineered Organoid Construction.,2025-12,"Tissue engineering. Part B, Reviews",41472623,organoid,PubMed
Qiuyue Mou,Researcher,Affiliated Stomatological Hospital of Southwest Medical University,"Sichuan, China.",qiuyue.mou@affiliatedstomatologicalhospitalofsouthwestmedicaledu.com,linkedin.com/in/qiuyuemou,Vascularized Homeostasis: The Key to Orofacial Tissue-Engineered Organoid Construction.,2025-12,"Tissue engineering. Part B, Reviews",41472623,organoid,PubMed
Lingxiao He,Researcher,Luzhou,"Luzhou, China.",lingxiao.he@luzhou.com,linkedin.com/in/lingxiaohe,Vascularized Homeostasis: The Key to Orofacial Tissue-Engineered Organoid Construction.,2025-12,"Tissue engineering. Part B, Reviews",41472623,organoid,PubMed
Jiao Long,Researcher,Affiliated Stomatological Hospital of Southwest Medical University,"Sichuan, China.",jiao.long@affiliatedstomatologicalhospitalofsouthwestmedicaledu.com,linkedin.com/in/jiaolong,Vascularized Homeostasis: The Key to Orofacial Tissue-Engineered Organoid Construction.,2025-12,"Tissue engineering. Part B, Reviews",41472623,organoid,PubMed
Zheng Ma,Researcher,Luzhou,"Luzhou, China.",zheng.ma@luzhou.com,linkedin.com/in/zhengma,Vascularized Homeostasis: The Key to Orofacial Tissue-Engineered Organoid Construction.,2025-12,"Tissue engineering. Part B, Reviews",41472623,organoid,PubMed
Xuqian Liu,Researcher,Affiliated Stomatological Hospital of Southwest Medical University,"Sichuan, China.",xuqian.liu@affiliatedstomatologicalhospitalofsouthwestmedicaledu.com,linkedin.com/in/xuqianliu,Vascularized Homeostasis: The Key to Orofacial Tissue-Engineered Organoid Construction.,2025-12,"Tissue engineering. Part B, Reviews",41472623,organoid,PubMed
Alexandra D Avera,Researcher,The University of Alabama,"AL 35487, USA.",alexandra.avera@theeduofalabama.com,linkedin.com/in/alexandradavera,Bioengineering Stem Cell-Derived Glioblastoma Organoids: A Comprehensive Review.,2025-12,"Pharmaceuticals (Basel, Switzerland)",41471318,organoid,PubMed
Yonghyun Kim,Researcher,The University of Alabama,"AL 35487, USA.",yonghyun.kim@theeduofalabama.com,linkedin.com/in/yonghyunkim,Bioengineering Stem Cell-Derived Glioblastoma Organoids: A Comprehensive Review.,2025-12,"Pharmaceuticals (Basel, Switzerland)",41471318,organoid,PubMed
Andrea Marfoglia,Researcher,Surgical and Health Sciences,"34139 Trieste, Italy.",andrea.marfoglia@surgicalandhealthsciences.com,linkedin.com/in/andreamarfoglia,Next-Generation Hydrogels for Biliary Organoid Engineering.,2025-11,"Pharmaceuticals (Basel, Switzerland)",41471270,organoid,PubMed
Giovanni Sorrentino,Researcher,Surgical and Health Sciences,"34139 Trieste, Italy.",giovanni.sorrentino@surgicalandhealthsciences.com,linkedin.com/in/giovannisorrentino,Next-Generation Hydrogels for Biliary Organoid Engineering.,2025-11,"Pharmaceuticals (Basel, Switzerland)",41471270,organoid,PubMed
Crina Elena Tiron,Researcher,Regional Institute of Oncology,"700483 Iasi, Romania.",crina.tiron@regionalorgofoncology.com,linkedin.com/in/crinaelenatiron,Trastuzumab-Conjugated pH-Sensitive Micelles Exhibit Antitumor Activity and Induce Mesenchymal-to-Ep,2025-12,Pharmaceutics,41471069,organoid,PubMed
Gabriel Luta,Researcher,Regional Institute of Oncology,"700483 Iasi, Romania.",gabriel.luta@regionalorgofoncology.com,linkedin.com/in/gabrielluta,Trastuzumab-Conjugated pH-Sensitive Micelles Exhibit Antitumor Activity and Induce Mesenchymal-to-Ep,2025-12,Pharmaceutics,41471069,organoid,PubMed
Razvan Ghiarasim,Researcher,"""Petru Poni"" Institute of Macromolecular Chemistry","700487 Iasi, Romania.","razvan.ghiarasim@""petruponi""orgofmacromolecularchemistry.com",linkedin.com/in/razvanghiarasim,Trastuzumab-Conjugated pH-Sensitive Micelles Exhibit Antitumor Activity and Induce Mesenchymal-to-Ep,2025-12,Pharmaceutics,41471069,organoid,PubMed
Adrian Tiron,Researcher,Regional Institute of Oncology,"700483 Iasi, Romania.",adrian.tiron@regionalorgofoncology.com,linkedin.com/in/adriantiron,Trastuzumab-Conjugated pH-Sensitive Micelles Exhibit Antitumor Activity and Induce Mesenchymal-to-Ep,2025-12,Pharmaceutics,41471069,organoid,PubMed
Valentin Nastasa,Researcher,Iasi,"700489 Iasi, Romania.",valentin.nastasa@iasi.com,linkedin.com/in/valentinnastasa,Trastuzumab-Conjugated pH-Sensitive Micelles Exhibit Antitumor Activity and Induce Mesenchymal-to-Ep,2025-12,Pharmaceutics,41471069,organoid,PubMed
Dragos Constantin Anita,Researcher,Iasi,"700489 Iasi, Romania.",dragos.anita@iasi.com,linkedin.com/in/dragosconstantinanita,Trastuzumab-Conjugated pH-Sensitive Micelles Exhibit Antitumor Activity and Induce Mesenchymal-to-Ep,2025-12,Pharmaceutics,41471069,organoid,PubMed
Tore Geir Iversen,Researcher,Institute for Cancer Research,"0379 Oslo, Norway.",tore.iversen@orgforcancerresearch.com,linkedin.com/in/toregeiriversen,Trastuzumab-Conjugated pH-Sensitive Micelles Exhibit Antitumor Activity and Induce Mesenchymal-to-Ep,2025-12,Pharmaceutics,41471069,organoid,PubMed
Tore Skotland,Researcher,Institute for Cancer Research,"0379 Oslo, Norway.",tore.skotland@orgforcancerresearch.com,linkedin.com/in/toreskotland,Trastuzumab-Conjugated pH-Sensitive Micelles Exhibit Antitumor Activity and Induce Mesenchymal-to-Ep,2025-12,Pharmaceutics,41471069,organoid,PubMed
Kirsten Sandvig,Researcher,Institute for Cancer Research,"0379 Oslo, Norway.",kirsten.sandvig@orgforcancerresearch.com,linkedin.com/in/kirstensandvig,Trastuzumab-Conjugated pH-Sensitive Micelles Exhibit Antitumor Activity and Induce Mesenchymal-to-Ep,2025-12,Pharmaceutics,41471069,organoid,PubMed
Mihai Mares,Researcher,Iasi,"700489 Iasi, Romania.",mihai.mares@iasi.com,linkedin.com/in/mihaimares,Trastuzumab-Conjugated pH-Sensitive Micelles Exhibit Antitumor Activity and Induce Mesenchymal-to-Ep,2025-12,Pharmaceutics,41471069,organoid,PubMed
Mihail-Gabriel Dimofte,Researcher,Regional Institute of Oncology,"700483 Iasi, Romania.",mihail-gabriel.dimofte@regionalorgofoncology.com,linkedin.com/in/mihail-gabrieldimofte,Trastuzumab-Conjugated pH-Sensitive Micelles Exhibit Antitumor Activity and Induce Mesenchymal-to-Ep,2025-12,Pharmaceutics,41471069,organoid,PubMed
Wen Tong,Researcher,Shandong First Medical University,"250117, China.",wen.tong@shandongfirstmedicaledu.com,linkedin.com/in/wentong,Individualized drug screening in cholangiocarcinoma using organoid models and patient-derived tumor ,2025-12,BMC cancer,41469951,organoid,PubMed
Tianze Wang,Researcher,Nankai University,"300071, China.",tianze.wang@nankaiedu.com,linkedin.com/in/tianzewang,Individualized drug screening in cholangiocarcinoma using organoid models and patient-derived tumor ,2025-12,BMC cancer,41469951,organoid,PubMed
Yu Miao,Researcher,Tianjin Institute of Pharmaceutical Research,"300301, China.",yu.miao@tianjinorgofpharmaceuticalresearch.com,linkedin.com/in/yumiao,Individualized drug screening in cholangiocarcinoma using organoid models and patient-derived tumor ,2025-12,BMC cancer,41469951,organoid,PubMed
Hao Chi,Researcher,Tianjin,"300192, China.",hao.chi@tianjin.com,linkedin.com/in/haochi,Individualized drug screening in cholangiocarcinoma using organoid models and patient-derived tumor ,2025-12,BMC cancer,41469951,organoid,PubMed
Yamin Zhang,Researcher,School of Medicine,"300384, China. 5020200824@nankai.edu.cn.",yamin.zhang@schoolofmedicine.com,linkedin.com/in/yaminzhang,Individualized drug screening in cholangiocarcinoma using organoid models and patient-derived tumor ,2025-12,BMC cancer,41469951,organoid,PubMed
Xuan Pan,Researcher,Nanjing Drum Tower Hospital,"Jiangsu Province, China.",xuan.pan@nanjingdrumtowerhospital.com,linkedin.com/in/xuanpan,"Mechanisms, efficacy, and future perspectives of cellular-based therapies for liver fibrosis/cirrhos",2025-12,Cell & bioscience,41469927,organoid,PubMed
Tianyun Gao,Researcher,Nanjing Drum Tower Hospital,"Jiangsu Province, China.",tianyun.gao@nanjingdrumtowerhospital.com,linkedin.com/in/tianyungao,"Mechanisms, efficacy, and future perspectives of cellular-based therapies for liver fibrosis/cirrhos",2025-12,Cell & bioscience,41469927,organoid,PubMed
Bin Wang,Researcher,Nanjing Drum Tower Hospital,"Jiangsu Province, China. wangbin022800@126.com.",bin.wang@nanjingdrumtowerhospital.com,linkedin.com/in/binwang,"Mechanisms, efficacy, and future perspectives of cellular-based therapies for liver fibrosis/cirrhos",2025-12,Cell & bioscience,41469927,organoid,PubMed
Katharina Wansch,Researcher,Oncology and Tumor Immunology,"Berlin, Germany.",katharina.wansch@oncologyandtumorimmunology.com,linkedin.com/in/katharinawansch,Identifying Factors of Organoid Establishment in Pancreatic Cancer: A Prospective Observational Stud,2024-01,Cancer medicine,41469727,organoid,PubMed
François Schneider,Researcher,Oncology and Tumor Immunology,"Berlin, Germany.",françois.schneider@oncologyandtumorimmunology.com,linkedin.com/in/françoisschneider,Identifying Factors of Organoid Establishment in Pancreatic Cancer: A Prospective Observational Stud,2024-01,Cancer medicine,41469727,organoid,PubMed
Florian Dölvers,Researcher,Oncology and Tumor Immunology,"Berlin, Germany.",florian.dölvers@oncologyandtumorimmunology.com,linkedin.com/in/floriandölvers,Identifying Factors of Organoid Establishment in Pancreatic Cancer: A Prospective Observational Stud,2024-01,Cancer medicine,41469727,organoid,PubMed
Anna Kühn,Researcher,Oncology and Tumor Immunology,"Berlin, Germany.",anna.kühn@oncologyandtumorimmunology.com,linkedin.com/in/annakühn,Identifying Factors of Organoid Establishment in Pancreatic Cancer: A Prospective Observational Stud,2024-01,Cancer medicine,41469727,organoid,PubMed
Mihnea P Dragomir,Researcher,Charité-Universitätsmedizin Berlin,"Berlin, Germany.",mihnea.dragomir@charité-universitätsmedizinberlin.com,linkedin.com/in/mihneapdragomir,Identifying Factors of Organoid Establishment in Pancreatic Cancer: A Prospective Observational Stud,2024-01,Cancer medicine,41469727,organoid,PubMed
Maria Joosten,Researcher,Charité-Universitätsmedizin Berlin,"Berlin, Germany.",maria.joosten@charité-universitätsmedizinberlin.com,linkedin.com/in/mariajoosten,Identifying Factors of Organoid Establishment in Pancreatic Cancer: A Prospective Observational Stud,2024-01,Cancer medicine,41469727,organoid,PubMed
Georg Hilfenhaus,Researcher,Oncology and Tumor Immunology,"Berlin, Germany.",georg.hilfenhaus@oncologyandtumorimmunology.com,linkedin.com/in/georghilfenhaus,Identifying Factors of Organoid Establishment in Pancreatic Cancer: A Prospective Observational Stud,2024-01,Cancer medicine,41469727,organoid,PubMed
Loredana Vecchione,Researcher,Oncology and Tumor Immunology,"Berlin, Germany.",loredana.vecchione@oncologyandtumorimmunology.com,linkedin.com/in/loredanavecchione,Identifying Factors of Organoid Establishment in Pancreatic Cancer: A Prospective Observational Stud,2024-01,Cancer medicine,41469727,organoid,PubMed
Matthäus Felsenstein,Researcher,Charité-Universitätsmedizin Berlin,"Berlin, Germany.",matthäus.felsenstein@charité-universitätsmedizinberlin.com,linkedin.com/in/matthäusfelsenstein,Identifying Factors of Organoid Establishment in Pancreatic Cancer: A Prospective Observational Stud,2024-01,Cancer medicine,41469727,organoid,PubMed
Markus Lerchbaumer,Researcher,Charité-Universitätsmedizin Berlin,"Berlin, Germany.",markus.lerchbaumer@charité-universitätsmedizinberlin.com,linkedin.com/in/markuslerchbaumer,Identifying Factors of Organoid Establishment in Pancreatic Cancer: A Prospective Observational Stud,2024-01,Cancer medicine,41469727,organoid,PubMed
Christian Jürgensen,Researcher,Charité-Universitätsmedizin Berlin,"Berlin, Germany.",christian.jürgensen@charité-universitätsmedizinberlin.com,linkedin.com/in/christianjürgensen,Identifying Factors of Organoid Establishment in Pancreatic Cancer: A Prospective Observational Stud,2024-01,Cancer medicine,41469727,organoid,PubMed
Marcus Bahra,Researcher,Krankenhaus Waldfriede,"Berlin, Germany.",marcus.bahra@krankenhauswaldfriede.com,linkedin.com/in/marcusbahra,Identifying Factors of Organoid Establishment in Pancreatic Cancer: A Prospective Observational Stud,2024-01,Cancer medicine,41469727,organoid,PubMed
Gregor Duwe,Researcher,University Medical Center Johannes Gutenberg University,"Mainz, Germany.",gregor.duwe@edumedicalcenterjohannesgutenbergedu.com,linkedin.com/in/gregorduwe,Identifying Factors of Organoid Establishment in Pancreatic Cancer: A Prospective Observational Stud,2024-01,Cancer medicine,41469727,organoid,PubMed
Reinhold Schäfer,Researcher,Charité-Universitätsmedizin Berlin,"Berlin, Germany.",reinhold.schäfer@charité-universitätsmedizinberlin.com,linkedin.com/in/reinholdschäfer,Identifying Factors of Organoid Establishment in Pancreatic Cancer: A Prospective Observational Stud,2024-01,Cancer medicine,41469727,organoid,PubMed
Sebastian Stintzing,Researcher,Oncology and Tumor Immunology,"Berlin, Germany.",sebastian.stintzing@oncologyandtumorimmunology.com,linkedin.com/in/sebastianstintzing,Identifying Factors of Organoid Establishment in Pancreatic Cancer: A Prospective Observational Stud,2024-01,Cancer medicine,41469727,organoid,PubMed
Ulrich Keilholz,Researcher,Charité-Universitätsmedizin Berlin,"Berlin, Germany.",ulrich.keilholz@charité-universitätsmedizinberlin.com,linkedin.com/in/ulrichkeilholz,Identifying Factors of Organoid Establishment in Pancreatic Cancer: A Prospective Observational Stud,2024-01,Cancer medicine,41469727,organoid,PubMed
Christopher C M Neumann,Researcher,Oncology and Tumor Immunology,"Berlin, Germany.",christopher.neumann@oncologyandtumorimmunology.com,linkedin.com/in/christophercmneumann,Identifying Factors of Organoid Establishment in Pancreatic Cancer: A Prospective Observational Stud,2024-01,Cancer medicine,41469727,organoid,PubMed
Uwe Pelzer,Researcher,Oncology and Tumor Immunology,"Berlin, Germany.",uwe.pelzer@oncologyandtumorimmunology.com,linkedin.com/in/uwepelzer,Identifying Factors of Organoid Establishment in Pancreatic Cancer: A Prospective Observational Stud,2024-01,Cancer medicine,41469727,organoid,PubMed
Nan-Nan Zhou,Researcher,School of Life Sciences,"Shanghai 200241, China.",nan-nan.zhou@schooloflifesciences.com,linkedin.com/in/nan-nanzhou,Cetobacterium somerae ZNN-1 promotes goblet cell differentiation through glutamine-mediated Notch si,2025-12,Journal of advanced research,41468963,organoid,PubMed
Jun-Xi Liu,Researcher,School of Life Sciences,"Shanghai 200241, China.",jun-xi.liu@schooloflifesciences.com,linkedin.com/in/jun-xiliu,Cetobacterium somerae ZNN-1 promotes goblet cell differentiation through glutamine-mediated Notch si,2025-12,Journal of advanced research,41468963,organoid,PubMed
Tong Wang,Researcher,School of Life Sciences,"Shanghai 200241, China.",tong.wang@schooloflifesciences.com,linkedin.com/in/tongwang,Cetobacterium somerae ZNN-1 promotes goblet cell differentiation through glutamine-mediated Notch si,2025-12,Journal of advanced research,41468963,organoid,PubMed
Zhe Wang,Researcher,School of Life Sciences,"Shanghai 200241, China.",zhe.wang@schooloflifesciences.com,linkedin.com/in/zhewang,Cetobacterium somerae ZNN-1 promotes goblet cell differentiation through glutamine-mediated Notch si,2025-12,Journal of advanced research,41468963,organoid,PubMed
Lu-Kuan Li,Researcher,School of Life Sciences,"Shanghai 200241, China.",lu-kuan.li@schooloflifesciences.com,linkedin.com/in/lu-kuanli,Cetobacterium somerae ZNN-1 promotes goblet cell differentiation through glutamine-mediated Notch si,2025-12,Journal of advanced research,41468963,organoid,PubMed
Fang Qiao,Researcher,School of Life Sciences,"Shanghai 200241, China.",fang.qiao@schooloflifesciences.com,linkedin.com/in/fangqiao,Cetobacterium somerae ZNN-1 promotes goblet cell differentiation through glutamine-mediated Notch si,2025-12,Journal of advanced research,41468963,organoid,PubMed
Zhen-Yu Du,Researcher,School of Life Sciences,"Shanghai 200241, China.",zhen-yu.du@schooloflifesciences.com,linkedin.com/in/zhen-yudu,Cetobacterium somerae ZNN-1 promotes goblet cell differentiation through glutamine-mediated Notch si,2025-12,Journal of advanced research,41468963,organoid,PubMed
Mei-Ling Zhang,Researcher,School of Life Sciences,"Shanghai 200241, China. Electronic address: mlzhang@bio.ecnu.edu.cn.",mei-ling.zhang@schooloflifesciences.com,linkedin.com/in/mei-lingzhang,Cetobacterium somerae ZNN-1 promotes goblet cell differentiation through glutamine-mediated Notch si,2025-12,Journal of advanced research,41468963,organoid,PubMed
Nattida Kampuang,Researcher,Faculty of Allied Health Sciences,"Chonburi, Thailand.",nattida.kampuang@facultyofalliedhealthsciences.com,linkedin.com/in/nattidakampuang,Transient receptor potential melastatin 6 and transient receptor potential melastatin 6/7 antagonist,2024-01,World journal of gastrointestinal oncology,41480213,spheroid,PubMed
Siriporn Chamniansawat,Researcher,Faculty of Allied Health Sciences,"Chonburi, Thailand.",siriporn.chamniansawat@facultyofalliedhealthsciences.com,linkedin.com/in/siripornchamniansawat,Transient receptor potential melastatin 6 and transient receptor potential melastatin 6/7 antagonist,2024-01,World journal of gastrointestinal oncology,41480213,spheroid,PubMed
Pawin Pongkorpsakol,Researcher,Chulabhorn Royal Academy,"Bangkok, Thailand.",pawin.pongkorpsakol@chulabhornroyalacademy.com,linkedin.com/in/pawinpongkorpsakol,Transient receptor potential melastatin 6 and transient receptor potential melastatin 6/7 antagonist,2024-01,World journal of gastrointestinal oncology,41480213,spheroid,PubMed
Supisara Treveeravoot,Researcher,Chulabhorn Royal Academy,"Bangkok, Thailand.",supisara.treveeravoot@chulabhornroyalacademy.com,linkedin.com/in/supisaratreveeravoot,Transient receptor potential melastatin 6 and transient receptor potential melastatin 6/7 antagonist,2024-01,World journal of gastrointestinal oncology,41480213,spheroid,PubMed
Narongrit Thongon,Researcher,Faculty of Allied Health Sciences,"Chonburi, Thailand. narongritt@buu.ac.th.",narongrit.thongon@facultyofalliedhealthsciences.com,linkedin.com/in/narongritthongon,Transient receptor potential melastatin 6 and transient receptor potential melastatin 6/7 antagonist,2024-01,World journal of gastrointestinal oncology,41480213,spheroid,PubMed
Ceren Sari,Researcher,Health Institutes of Türkiye,"Ankara, Türkiye.",ceren.sari@healthorgsoftürkiye.com,linkedin.com/in/cerensari,Evaluation of the Combined Effects of Rosmarinic Acid and Cisplatin in Gastric Cancer Cells.,2024-01,Medeniyet medical journal,41479170,spheroid,PubMed
Ceren Sumer,Researcher,Health Institutes of Türkiye,"Ankara, Türkiye.",ceren.sumer@healthorgsoftürkiye.com,linkedin.com/in/cerensumer,Evaluation of the Combined Effects of Rosmarinic Acid and Cisplatin in Gastric Cancer Cells.,2024-01,Medeniyet medical journal,41479170,spheroid,PubMed
Saniye Koc Ada,Researcher,Department of Medical Biochemistry,"Istanbul, Türkiye.",saniye.ada@departmentofmedicalbiochemistry.com,linkedin.com/in/saniyekocada,Evaluation of the Combined Effects of Rosmarinic Acid and Cisplatin in Gastric Cancer Cells.,2024-01,Medeniyet medical journal,41479170,spheroid,PubMed
Burcu Yucel,Researcher,Department of Medical Biology,"Istanbul, Türkiye.",burcu.yucel@departmentofmedicalbiology.com,linkedin.com/in/burcuyucel,Evaluation of the Combined Effects of Rosmarinic Acid and Cisplatin in Gastric Cancer Cells.,2024-01,Medeniyet medical journal,41479170,spheroid,PubMed
Madita Wandrey,Researcher,Head and Neck Surgery,"Mainz, Germany.",madita.wandrey@headandnecksurgery.com,linkedin.com/in/maditawandrey,A Head and Neck Cancer Spheroid Model for Phenotypic High-Content Screening of Chemoresistance.,2024-01,"Methods in molecular biology (Clifton, N.J.)",41479057,spheroid,PubMed
Aya Khamis Hassan,Researcher,University Medical Center,"Mainz, Germany.",aya.hassan@edumedicalcenter.com,linkedin.com/in/ayakhamishassan,A Head and Neck Cancer Spheroid Model for Phenotypic High-Content Screening of Chemoresistance.,2024-01,"Methods in molecular biology (Clifton, N.J.)",41479057,spheroid,PubMed
Roland H Stauber,Researcher,Head and Neck Surgery,"Mainz, Germany.",roland.stauber@headandnecksurgery.com,linkedin.com/in/rolandhstauber,A Head and Neck Cancer Spheroid Model for Phenotypic High-Content Screening of Chemoresistance.,2024-01,"Methods in molecular biology (Clifton, N.J.)",41479057,spheroid,PubMed
Désirée Gül,Researcher,Head and Neck Surgery,"Mainz, Germany. guel@uni-mainz.de.",désirée.gül@headandnecksurgery.com,linkedin.com/in/désiréegül,A Head and Neck Cancer Spheroid Model for Phenotypic High-Content Screening of Chemoresistance.,2024-01,"Methods in molecular biology (Clifton, N.J.)",41479057,spheroid,PubMed
Danielle C Rouse,Researcher,College of Pharmacy and Health Sciences,"NY, USA.",danielle.rouse@collegeofpharmacyandhealthsciences.com,linkedin.com/in/daniellecrouse,3D Spheroid Model: A Methodological Approach for Advancing Cancer and Immunology Research.,2024-01,"Methods in molecular biology (Clifton, N.J.)",41478971,spheroid,PubMed
Saurabh Agarwal,Researcher,College of Pharmacy and Health Sciences,"NY, USA. agarwals@stjohns.edu.",saurabh.agarwal@collegeofpharmacyandhealthsciences.com,linkedin.com/in/saurabhagarwal,3D Spheroid Model: A Methodological Approach for Advancing Cancer and Immunology Research.,2024-01,"Methods in molecular biology (Clifton, N.J.)",41478971,spheroid,PubMed
Hathaichanok Impheng,Researcher,Faculty of Medical Science,"Phitsanulok 65000, Thailand.",hathaichanok.impheng@facultyofmedicalscience.com,linkedin.com/in/hathaichanokimpheng,Peptide-based covalent inhibitor of tubulin detyrosination promotes mesenchymal-to-epithelial transi,2025-12,Proceedings of the National Academy of Sciences of the United States of America,41474745,spheroid,PubMed
Ghislain Gillard,Researcher,IGH (Institute of Human Genetics) UMR 9002,"Montpellier 34090, France.",ghislain.gillard@igh(orgofhumangenetics)umr9002.com,linkedin.com/in/ghislaingillard,Peptide-based covalent inhibitor of tubulin detyrosination promotes mesenchymal-to-epithelial transi,2025-12,Proceedings of the National Academy of Sciences of the United States of America,41474745,spheroid,PubMed
Nuttanid Numnoi,Researcher,Faculty of Medical Science,"Phitsanulok 65000, Thailand.",nuttanid.numnoi@facultyofmedicalscience.com,linkedin.com/in/nuttanidnumnoi,Peptide-based covalent inhibitor of tubulin detyrosination promotes mesenchymal-to-epithelial transi,2025-12,Proceedings of the National Academy of Sciences of the United States of America,41474745,spheroid,PubMed
Anthony Feral,Researcher,Amino Acids,"Montpellier 34293, France.",anthony.feral@aminoacids.com,linkedin.com/in/anthonyferal,Peptide-based covalent inhibitor of tubulin detyrosination promotes mesenchymal-to-epithelial transi,2025-12,Proceedings of the National Academy of Sciences of the United States of America,41474745,spheroid,PubMed
Matthieu Simon,Researcher,Amino Acids,"Montpellier 34293, France.",matthieu.simon@aminoacids.com,linkedin.com/in/matthieusimon,Peptide-based covalent inhibitor of tubulin detyrosination promotes mesenchymal-to-epithelial transi,2025-12,Proceedings of the National Academy of Sciences of the United States of America,41474745,spheroid,PubMed
Maxime Louet,Researcher,Amino Acids,"Montpellier 34293, France.",maxime.louet@aminoacids.com,linkedin.com/in/maximelouet,Peptide-based covalent inhibitor of tubulin detyrosination promotes mesenchymal-to-epithelial transi,2025-12,Proceedings of the National Academy of Sciences of the United States of America,41474745,spheroid,PubMed
Muriel Amblard,Researcher,Amino Acids,"Montpellier 34293, France.",muriel.amblard@aminoacids.com,linkedin.com/in/murielamblard,Peptide-based covalent inhibitor of tubulin detyrosination promotes mesenchymal-to-epithelial transi,2025-12,Proceedings of the National Academy of Sciences of the United States of America,41474745,spheroid,PubMed
François Juge,Researcher,IGH (Institute of Human Genetics) UMR 9002,"Montpellier 34090, France.",françois.juge@igh(orgofhumangenetics)umr9002.com,linkedin.com/in/françoisjuge,Peptide-based covalent inhibitor of tubulin detyrosination promotes mesenchymal-to-epithelial transi,2025-12,Proceedings of the National Academy of Sciences of the United States of America,41474745,spheroid,PubMed
Lubomir Vezenkov,Researcher,Amino Acids,"Montpellier 34293, France.",lubomir.vezenkov@aminoacids.com,linkedin.com/in/lubomirvezenkov,Peptide-based covalent inhibitor of tubulin detyrosination promotes mesenchymal-to-epithelial transi,2025-12,Proceedings of the National Academy of Sciences of the United States of America,41474745,spheroid,PubMed
Krzysztof Rogowski,Researcher,IGH (Institute of Human Genetics) UMR 9002,"Montpellier 34090, France.",krzysztof.rogowski@igh(orgofhumangenetics)umr9002.com,linkedin.com/in/krzysztofrogowski,Peptide-based covalent inhibitor of tubulin detyrosination promotes mesenchymal-to-epithelial transi,2025-12,Proceedings of the National Academy of Sciences of the United States of America,41474745,spheroid,PubMed
Apurva Mishra,Researcher,College of Dentistry,"Ajman, United Arab Emirates.",apurva.mishra@collegeofdentistry.com,linkedin.com/in/apurvamishra,Advancements in Light-Sheet Fluorescence Microscopy for Three Dimensional Cellular Spheroid Imaging.,2025-12,"Tissue engineering. Part B, Reviews",41472627,spheroid,PubMed
Varuni Arora,Researcher,National University of Singapore,"Singapore, Singapore.",varuni.arora@nationaleduofsingapore.com,linkedin.com/in/varuniarora,Advancements in Light-Sheet Fluorescence Microscopy for Three Dimensional Cellular Spheroid Imaging.,2025-12,"Tissue engineering. Part B, Reviews",41472627,spheroid,PubMed
Kristina A Feizer,Researcher,Federal Research Center KSC SB RAS,"Krasnoyarsk 660036, Russia.",kristina.feizer@federalresearchcenterkscsbras.com,linkedin.com/in/kristinaafeizer,Orientational Structure and Electro-Optical Properties of Chiral Nematic Droplets with Conical Ancho,2025-12,"Molecules (Basel, Switzerland)",41471785,spheroid,PubMed
Mikhail N Krakhalev,Researcher,Federal Research Center KSC SB RAS,"Krasnoyarsk 660036, Russia.",mikhail.krakhalev@federalresearchcenterkscsbras.com,linkedin.com/in/mikhailnkrakhalev,Orientational Structure and Electro-Optical Properties of Chiral Nematic Droplets with Conical Ancho,2025-12,"Molecules (Basel, Switzerland)",41471785,spheroid,PubMed
Vladimir Yu Rudyak,Researcher,School of Physics and Astronomy,"Tel Aviv 69978, Israel.",vladimir.rudyak@schoolofphysicsandastronomy.com,linkedin.com/in/vladimiryurudyak,Orientational Structure and Electro-Optical Properties of Chiral Nematic Droplets with Conical Ancho,2025-12,"Molecules (Basel, Switzerland)",41471785,spheroid,PubMed
Victor Ya Zyryanov,Researcher,Federal Research Center KSC SB RAS,"Krasnoyarsk 660036, Russia.",victor.zyryanov@federalresearchcenterkscsbras.com,linkedin.com/in/victoryazyryanov,Orientational Structure and Electro-Optical Properties of Chiral Nematic Droplets with Conical Ancho,2025-12,"Molecules (Basel, Switzerland)",41471785,spheroid,PubMed
Maria Veronica Lipreri,Researcher,Technologies,"40136 Bologna, Italy.",maria.lipreri@technologies.com,linkedin.com/in/mariaveronicalipreri,From Spheroids to Tumor-on-a-Chip for Cancer Modeling and Therapeutic Testing.,2025-11,Micromachines,41470509,spheroid,PubMed
Marilina Tamara Totaro,Researcher,University of Bologna,"40138 Bologna, Italy.",marilina.totaro@eduofbologna.com,linkedin.com/in/marilinatamaratotaro,From Spheroids to Tumor-on-a-Chip for Cancer Modeling and Therapeutic Testing.,2025-11,Micromachines,41470509,spheroid,PubMed
Nicola Baldini,Researcher,Technologies,"40136 Bologna, Italy.",nicola.baldini@technologies.com,linkedin.com/in/nicolabaldini,From Spheroids to Tumor-on-a-Chip for Cancer Modeling and Therapeutic Testing.,2025-11,Micromachines,41470509,spheroid,PubMed
Sofia Avnet,Researcher,University of Bologna,"40138 Bologna, Italy.",sofia.avnet@eduofbologna.com,linkedin.com/in/sofiaavnet,From Spheroids to Tumor-on-a-Chip for Cancer Modeling and Therapeutic Testing.,2025-11,Micromachines,41470509,spheroid,PubMed
Mattie Hartauer,Researcher,UNC Eshelman School of Pharmacy,"27599-7569, USA.",mattie.hartauer@unceshelmanschoolofpharmacy.com,linkedin.com/in/mattiehartauer,Evaluation of a human 3D multicellular hepatic spheroid model as a platform for studying hepatic tra,2025-12,Cellular and molecular life sciences : CMLS,41467945,spheroid,PubMed
Henry Ho,Researcher,UNC Eshelman School of Pharmacy,"27599-7569, USA.",henry.ho@unceshelmanschoolofpharmacy.com,linkedin.com/in/henryho,Evaluation of a human 3D multicellular hepatic spheroid model as a platform for studying hepatic tra,2025-12,Cellular and molecular life sciences : CMLS,41467945,spheroid,PubMed
Meimei Wan,Researcher,Winston-Salem,"NC, USA.",meimei.wan@winston-salem.com,linkedin.com/in/meimeiwan,Evaluation of a human 3D multicellular hepatic spheroid model as a platform for studying hepatic tra,2025-12,Cellular and molecular life sciences : CMLS,41467945,spheroid,PubMed
William A Murphy,Researcher,UNC Eshelman School of Pharmacy,"27599-7569, USA.",william.murphy@unceshelmanschoolofpharmacy.com,linkedin.com/in/williamamurphy,Evaluation of a human 3D multicellular hepatic spheroid model as a platform for studying hepatic tra,2025-12,Cellular and molecular life sciences : CMLS,41467945,spheroid,PubMed
Jacqueline B Tiley,Researcher,UNC Eshelman School of Pharmacy,"27599-7569, USA.",jacqueline.tiley@unceshelmanschoolofpharmacy.com,linkedin.com/in/jacquelinebtiley,Evaluation of a human 3D multicellular hepatic spheroid model as a platform for studying hepatic tra,2025-12,Cellular and molecular life sciences : CMLS,41467945,spheroid,PubMed
John K Fallon,Researcher,UNC Eshelman School of Pharmacy,"27599-7569, USA.",john.fallon@unceshelmanschoolofpharmacy.com,linkedin.com/in/johnkfallon,Evaluation of a human 3D multicellular hepatic spheroid model as a platform for studying hepatic tra,2025-12,Cellular and molecular life sciences : CMLS,41467945,spheroid,PubMed
Colin E Bishop,Researcher,Winston-Salem,"NC, USA.",colin.bishop@winston-salem.com,linkedin.com/in/colinebishop,Evaluation of a human 3D multicellular hepatic spheroid model as a platform for studying hepatic tra,2025-12,Cellular and molecular life sciences : CMLS,41467945,spheroid,PubMed
Kim L R Brouwer,Researcher,UNC Eshelman School of Pharmacy,"27599-7569, USA. kbrouwer@unc.edu.",kim.brouwer@unceshelmanschoolofpharmacy.com,linkedin.com/in/kimlrbrouwer,Evaluation of a human 3D multicellular hepatic spheroid model as a platform for studying hepatic tra,2025-12,Cellular and molecular life sciences : CMLS,41467945,spheroid,PubMed
Raffaella Daniele,Researcher,University of Padova,"Padova, Italy.",raffaella.daniele@eduofpadova.com,linkedin.com/in/raffaelladaniele,Folate-targeted gold nanoparticles for doxorubicin delivery in tumor spheroids.,2025-12,Drug delivery,41467876,spheroid,PubMed
Agnese Fragassi,Researcher,University of Padova,"Padova, Italy.",agnese.fragassi@eduofpadova.com,linkedin.com/in/agnesefragassi,Folate-targeted gold nanoparticles for doxorubicin delivery in tumor spheroids.,2025-12,Drug delivery,41467876,spheroid,PubMed
Cristiano Pesce,Researcher,University of Padova,"Padova, Italy.",cristiano.pesce@eduofpadova.com,linkedin.com/in/cristianopesce,Folate-targeted gold nanoparticles for doxorubicin delivery in tumor spheroids.,2025-12,Drug delivery,41467876,spheroid,PubMed
Francesco Tognetti,Researcher,University of Padova,"Padova, Italy.",francesco.tognetti@eduofpadova.com,linkedin.com/in/francescotognetti,Folate-targeted gold nanoparticles for doxorubicin delivery in tumor spheroids.,2025-12,Drug delivery,41467876,spheroid,PubMed
Marco Verona,Researcher,University of Padova,"Padova, Italy.",marco.verona@eduofpadova.com,linkedin.com/in/marcoverona,Folate-targeted gold nanoparticles for doxorubicin delivery in tumor spheroids.,2025-12,Drug delivery,41467876,spheroid,PubMed
Giovanni Marzaro,Researcher,University of Verona,"Verona, Italy.",giovanni.marzaro@eduofverona.com,linkedin.com/in/giovannimarzaro,Folate-targeted gold nanoparticles for doxorubicin delivery in tumor spheroids.,2025-12,Drug delivery,41467876,spheroid,PubMed
Stefano Salmaso,Researcher,University of Padova,"Padova, Italy.",stefano.salmaso@eduofpadova.com,linkedin.com/in/stefanosalmaso,Folate-targeted gold nanoparticles for doxorubicin delivery in tumor spheroids.,2025-12,Drug delivery,41467876,spheroid,PubMed
Paolo Caliceti,Researcher,University of Padova,"Padova, Italy.",paolo.caliceti@eduofpadova.com,linkedin.com/in/paolocaliceti,Folate-targeted gold nanoparticles for doxorubicin delivery in tumor spheroids.,2025-12,Drug delivery,41467876,spheroid,PubMed
Xiao Wu,Researcher,Chengdu University of Traditional Chinese Medicine,"Chengdu 611137, China.",xiao.wu@chengdueduoftraditionalchinesemedicine.com,linkedin.com/in/xiaowu,Adenosine Triggers an ADK-Dependent Intracellular Signaling Pathway Interacts PFKFB3-Mediated Glycol,2025-12,International journal of molecular sciences,41465609,spheroid,PubMed
Dawei Zeng,Researcher,Chengdu University of Traditional Chinese Medicine,"Chengdu 611137, China.",dawei.zeng@chengdueduoftraditionalchinesemedicine.com,linkedin.com/in/daweizeng,Adenosine Triggers an ADK-Dependent Intracellular Signaling Pathway Interacts PFKFB3-Mediated Glycol,2025-12,International journal of molecular sciences,41465609,spheroid,PubMed
Baojia Wang,Researcher,Chengdu University of Traditional Chinese Medicine,"Chengdu 611137, China.",baojia.wang@chengdueduoftraditionalchinesemedicine.com,linkedin.com/in/baojiawang,Adenosine Triggers an ADK-Dependent Intracellular Signaling Pathway Interacts PFKFB3-Mediated Glycol,2025-12,International journal of molecular sciences,41465609,spheroid,PubMed
Jie Liu,Researcher,Chengdu University of Traditional Chinese Medicine,"Chengdu 611137, China.",jie.liu@chengdueduoftraditionalchinesemedicine.com,linkedin.com/in/jieliu,Adenosine Triggers an ADK-Dependent Intracellular Signaling Pathway Interacts PFKFB3-Mediated Glycol,2025-12,International journal of molecular sciences,41465609,spheroid,PubMed
Yue Zhang,Researcher,Chengdu University of Traditional Chinese Medicine,"Chengdu 611137, China.",yue.zhang@chengdueduoftraditionalchinesemedicine.com,linkedin.com/in/yuezhang,Adenosine Triggers an ADK-Dependent Intracellular Signaling Pathway Interacts PFKFB3-Mediated Glycol,2025-12,International journal of molecular sciences,41465609,spheroid,PubMed
Cong Huang,Researcher,Chengdu University of Traditional Chinese Medicine,"Chengdu 611137, China.",cong.huang@chengdueduoftraditionalchinesemedicine.com,linkedin.com/in/conghuang,Adenosine Triggers an ADK-Dependent Intracellular Signaling Pathway Interacts PFKFB3-Mediated Glycol,2025-12,International journal of molecular sciences,41465609,spheroid,PubMed
Qian Nie,Researcher,School of Clinical Medicine,"Chengdu 610075, China.",qian.nie@schoolofclinicalmedicine.com,linkedin.com/in/qiannie,Adenosine Triggers an ADK-Dependent Intracellular Signaling Pathway Interacts PFKFB3-Mediated Glycol,2025-12,International journal of molecular sciences,41465609,spheroid,PubMed
Liangqin Shi,Researcher,Chengdu University of Traditional Chinese Medicine,"Chengdu 611137, China.",liangqin.shi@chengdueduoftraditionalchinesemedicine.com,linkedin.com/in/liangqinshi,Adenosine Triggers an ADK-Dependent Intracellular Signaling Pathway Interacts PFKFB3-Mediated Glycol,2025-12,International journal of molecular sciences,41465609,spheroid,PubMed
Yong Wang,Researcher,Chengdu University of Traditional Chinese Medicine,"Chengdu 611137, China.",yong.wang@chengdueduoftraditionalchinesemedicine.com,linkedin.com/in/yongwang,Adenosine Triggers an ADK-Dependent Intracellular Signaling Pathway Interacts PFKFB3-Mediated Glycol,2025-12,International journal of molecular sciences,41465609,spheroid,PubMed
E Cate Wisdom,Researcher,Department of Radiology and Bioengineering,"MD 20814, USA.",e.wisdom@departmentofradiologyandbioengineering.com,linkedin.com/in/ecatewisdom,A Novel Approach to Pattern Dermal Papilla Spheroids in Dermal-Epidermal Composites Using Non-Adhere,2025-11,"Bioengineering (Basel, Switzerland)",41463578,spheroid,PubMed
Donald C Aduba,Researcher,Uniformed Services University,"MD 20814, USA.",donald.aduba@uniformedservicesedu.com,linkedin.com/in/donaldcaduba,A Novel Approach to Pattern Dermal Papilla Spheroids in Dermal-Epidermal Composites Using Non-Adhere,2025-11,"Bioengineering (Basel, Switzerland)",41463578,spheroid,PubMed
Owen Lewis,Researcher,Department of Radiology and Bioengineering,"MD 20814, USA.",owen.lewis@departmentofradiologyandbioengineering.com,linkedin.com/in/owenlewis,A Novel Approach to Pattern Dermal Papilla Spheroids in Dermal-Epidermal Composites Using Non-Adhere,2025-11,"Bioengineering (Basel, Switzerland)",41463578,spheroid,PubMed
Sandhya Xavier,Researcher,Uniformed Services University,"MD 20814, USA.",sandhya.xavier@uniformedservicesedu.com,linkedin.com/in/sandhyaxavier,A Novel Approach to Pattern Dermal Papilla Spheroids in Dermal-Epidermal Composites Using Non-Adhere,2025-11,"Bioengineering (Basel, Switzerland)",41463578,spheroid,PubMed
Ernest O N Phillips,Researcher,Uniformed Services University,"MD 20814, USA.",ernest.phillips@uniformedservicesedu.com,linkedin.com/in/ernestonphillips,A Novel Approach to Pattern Dermal Papilla Spheroids in Dermal-Epidermal Composites Using Non-Adhere,2025-11,"Bioengineering (Basel, Switzerland)",41463578,spheroid,PubMed
Kristin H Gilchrist,Researcher,Department of Radiology and Bioengineering,"MD 20814, USA.",kristin.gilchrist@departmentofradiologyandbioengineering.com,linkedin.com/in/kristinhgilchrist,A Novel Approach to Pattern Dermal Papilla Spheroids in Dermal-Epidermal Composites Using Non-Adhere,2025-11,"Bioengineering (Basel, Switzerland)",41463578,spheroid,PubMed
Ira M Herman,Researcher,Molecular,"Boston, MA",ira.herman@molecular.com,linkedin.com/in/iramherman,A Novel Approach to Pattern Dermal Papilla Spheroids in Dermal-Epidermal Composites Using Non-Adhere,2025-11,"Bioengineering (Basel, Switzerland)",41463578,spheroid,PubMed
Vincent B Ho,Researcher,Department of Radiology and Bioengineering,"MD 20814, USA.",vincent.ho@departmentofradiologyandbioengineering.com,linkedin.com/in/vincentbho,A Novel Approach to Pattern Dermal Papilla Spheroids in Dermal-Epidermal Composites Using Non-Adhere,2025-11,"Bioengineering (Basel, Switzerland)",41463578,spheroid,PubMed
Thomas N Darling,Researcher,Uniformed Services University,"MD 20814, USA.",thomas.darling@uniformedservicesedu.com,linkedin.com/in/thomasndarling,A Novel Approach to Pattern Dermal Papilla Spheroids in Dermal-Epidermal Composites Using Non-Adhere,2025-11,"Bioengineering (Basel, Switzerland)",41463578,spheroid,PubMed
George J Klarmann,Researcher,Department of Radiology and Bioengineering,"MD 20814, USA.",george.klarmann@departmentofradiologyandbioengineering.com,linkedin.com/in/georgejklarmann,A Novel Approach to Pattern Dermal Papilla Spheroids in Dermal-Epidermal Composites Using Non-Adhere,2025-11,"Bioengineering (Basel, Switzerland)",41463578,spheroid,PubMed
Lele Wang,Researcher,School of Dentistry and Dental Research Institute,"Seoul 03080, Republic of Korea.",lele.wang@schoolofdentistryanddentalresearchorg.com,linkedin.com/in/lelewang,Biomimetic Salivary Gland Cancer Spheroid Platform for In Vitro Recapitulation of Three-Dimensional ,2025-11,Biomolecules,41463290,spheroid,PubMed
Seokjun Kwon,Researcher,School of Dentistry and Dental Research Institute,"Seoul 03080, Republic of Korea.",seokjun.kwon@schoolofdentistryanddentalresearchorg.com,linkedin.com/in/seokjunkwon,Biomimetic Salivary Gland Cancer Spheroid Platform for In Vitro Recapitulation of Three-Dimensional ,2025-11,Biomolecules,41463290,spheroid,PubMed
Sujin Park,Researcher,School of Dentistry and Dental Research Institute,"Seoul 03080, Republic of Korea.",sujin.park@schoolofdentistryanddentalresearchorg.com,linkedin.com/in/sujinpark,Biomimetic Salivary Gland Cancer Spheroid Platform for In Vitro Recapitulation of Three-Dimensional ,2025-11,Biomolecules,41463290,spheroid,PubMed
Eun Namkoong,Researcher,School of Dentistry and Dental Research Institute,"Seoul 03080, Republic of Korea.",eun.namkoong@schoolofdentistryanddentalresearchorg.com,linkedin.com/in/eunnamkoong,Biomimetic Salivary Gland Cancer Spheroid Platform for In Vitro Recapitulation of Three-Dimensional ,2025-11,Biomolecules,41463290,spheroid,PubMed
Junchul Kim,Researcher,School of Dentistry and Dental Research Institute,"Seoul 03080, Republic of Korea.",junchul.kim@schoolofdentistryanddentalresearchorg.com,linkedin.com/in/junchulkim,Biomimetic Salivary Gland Cancer Spheroid Platform for In Vitro Recapitulation of Three-Dimensional ,2025-11,Biomolecules,41463290,spheroid,PubMed
Hye-Young Sim,Researcher,School of Dentistry and Dental Research Institute,"Seoul 03080, Republic of Korea.",hye-young.sim@schoolofdentistryanddentalresearchorg.com,linkedin.com/in/hye-youngsim,Biomimetic Salivary Gland Cancer Spheroid Platform for In Vitro Recapitulation of Three-Dimensional ,2025-11,Biomolecules,41463290,spheroid,PubMed
Shazid Md Sharker,Researcher,North South University,"Dhaka 1229, Bangladesh.",shazid.sharker@northsouthedu.com,linkedin.com/in/shazidmdsharker,Biomimetic Salivary Gland Cancer Spheroid Platform for In Vitro Recapitulation of Three-Dimensional ,2025-11,Biomolecules,41463290,spheroid,PubMed
Sang-Woo Lee,Researcher,School of Dentistry and Dental Research Institute,"Seoul 03080, Republic of Korea.",sang-woo.lee@schoolofdentistryanddentalresearchorg.com,linkedin.com/in/sang-woolee,Biomimetic Salivary Gland Cancer Spheroid Platform for In Vitro Recapitulation of Three-Dimensional ,2025-11,Biomolecules,41463290,spheroid,PubMed
Ting Wu,Researcher,Institut Convergence Plascan,"CEDEX 08 Lyon, France.",ting.wu@institutconvergenceplascan.com,linkedin.com/in/tingwu,Fibrillarin Contributes to the Oncogenic Characteristics of Colorectal Cancer Cells and Reduces Sens,2025-12,Cancers,41463151,spheroid,PubMed
Mounira Chalabi-Dchar,Researcher,Institut Convergence Plascan,"CEDEX 08 Lyon, France.",mounira.chalabi-dchar@institutconvergenceplascan.com,linkedin.com/in/mounirachalabi-dchar,Fibrillarin Contributes to the Oncogenic Characteristics of Colorectal Cancer Cells and Reduces Sens,2025-12,Cancers,41463151,spheroid,PubMed
Wei Xiong,Researcher,Institut Convergence Plascan,"CEDEX 08 Lyon, France.",wei.xiong@institutconvergenceplascan.com,linkedin.com/in/weixiong,Fibrillarin Contributes to the Oncogenic Characteristics of Colorectal Cancer Cells and Reduces Sens,2025-12,Cancers,41463151,spheroid,PubMed
Lucie Arnould,Researcher,Institut Convergence Plascan,"CEDEX 08 Lyon, France.",lucie.arnould@institutconvergenceplascan.com,linkedin.com/in/luciearnould,Fibrillarin Contributes to the Oncogenic Characteristics of Colorectal Cancer Cells and Reduces Sens,2025-12,Cancers,41463151,spheroid,PubMed
Eliezer Aimontche,Researcher,Institut Convergence Plascan,"CEDEX 08 Lyon, France.",eliezer.aimontche@institutconvergenceplascan.com,linkedin.com/in/eliezeraimontche,Fibrillarin Contributes to the Oncogenic Characteristics of Colorectal Cancer Cells and Reduces Sens,2025-12,Cancers,41463151,spheroid,PubMed
Sabine Beaumel,Researcher,Institut Convergence Plascan,"CEDEX 08 Lyon, France.",sabine.beaumel@institutconvergenceplascan.com,linkedin.com/in/sabinebeaumel,Fibrillarin Contributes to the Oncogenic Characteristics of Colorectal Cancer Cells and Reduces Sens,2025-12,Cancers,41463151,spheroid,PubMed
Charles Dumontet,Researcher,Institut Convergence Plascan,"CEDEX 08 Lyon, France.",charles.dumontet@institutconvergenceplascan.com,linkedin.com/in/charlesdumontet,Fibrillarin Contributes to the Oncogenic Characteristics of Colorectal Cancer Cells and Reduces Sens,2025-12,Cancers,41463151,spheroid,PubMed
Virginie Marcel,Researcher,Institut Convergence Plascan,"CEDEX 08 Lyon, France.",virginie.marcel@institutconvergenceplascan.com,linkedin.com/in/virginiemarcel,Fibrillarin Contributes to the Oncogenic Characteristics of Colorectal Cancer Cells and Reduces Sens,2025-12,Cancers,41463151,spheroid,PubMed
Tanguy Fenouil,Researcher,Institut Convergence Plascan,"CEDEX 08 Lyon, France.",tanguy.fenouil@institutconvergenceplascan.com,linkedin.com/in/tanguyfenouil,Fibrillarin Contributes to the Oncogenic Characteristics of Colorectal Cancer Cells and Reduces Sens,2025-12,Cancers,41463151,spheroid,PubMed
Jean-Jacques Diaz,Researcher,Institut Convergence Plascan,"CEDEX 08 Lyon, France.",jean-jacques.diaz@institutconvergenceplascan.com,linkedin.com/in/jean-jacquesdiaz,Fibrillarin Contributes to the Oncogenic Characteristics of Colorectal Cancer Cells and Reduces Sens,2025-12,Cancers,41463151,spheroid,PubMed
Marie Alexandra Albaret,Researcher,Institut Convergence Plascan,"CEDEX 08 Lyon, France.",marie.albaret@institutconvergenceplascan.com,linkedin.com/in/mariealexandraalbaret,Fibrillarin Contributes to the Oncogenic Characteristics of Colorectal Cancer Cells and Reduces Sens,2025-12,Cancers,41463151,spheroid,PubMed
Hichem Claude Mertani,Researcher,Institut Convergence Plascan,"CEDEX 08 Lyon, France.",hichem.mertani@institutconvergenceplascan.com,linkedin.com/in/hichemclaudemertani,Fibrillarin Contributes to the Oncogenic Characteristics of Colorectal Cancer Cells and Reduces Sens,2025-12,Cancers,41463151,spheroid,PubMed
Yin Ye,Researcher,Anatomy and Cell Biology,"TN 37208, USA.",yin.ye@anatomyandcellbiology.com,linkedin.com/in/yinye,E-Cadherin Regulates HIF1-α In Vitro in Induced 3D Spheroid Models of Human Breast Cancer Through Bo,2025-11,Biomedicines,41462905,spheroid,PubMed
Dollada Srisai,Researcher,Anatomy and Cell Biology,"TN 37208, USA.",dollada.srisai@anatomyandcellbiology.com,linkedin.com/in/dolladasrisai,E-Cadherin Regulates HIF1-α In Vitro in Induced 3D Spheroid Models of Human Breast Cancer Through Bo,2025-11,Biomedicines,41462905,spheroid,PubMed
Sanford H Barsky,Researcher,Anatomy and Cell Biology,"TN 37208, USA.",sanford.barsky@anatomyandcellbiology.com,linkedin.com/in/sanfordhbarsky,E-Cadherin Regulates HIF1-α In Vitro in Induced 3D Spheroid Models of Human Breast Cancer Through Bo,2025-11,Biomedicines,41462905,spheroid,PubMed
Zongzhe Xuan,Researcher,Department of Health Science and Technology,"9260, Denmark.",zongzhe.xuan@departmentofhealthscienceandtechnology.com,linkedin.com/in/zongzhexuan,Development of a sustainable strategy for cultured fat production based on serum-free 3D culture of ,2025-12,Scientific reports,41461685,spheroid,PubMed
Qiuyue Peng,Researcher,Department of Health Science and Technology,"9260, Denmark.",qiuyue.peng@departmentofhealthscienceandtechnology.com,linkedin.com/in/qiuyuepeng,Development of a sustainable strategy for cultured fat production based on serum-free 3D culture of ,2025-12,Scientific reports,41461685,spheroid,PubMed
Mariia Borsuk,Researcher,Herdernstrasse 71,"8004, Switzerland.",mariia.borsuk@herdernstrasse71.com,linkedin.com/in/mariiaborsuk,Development of a sustainable strategy for cultured fat production based on serum-free 3D culture of ,2025-12,Scientific reports,41461685,spheroid,PubMed
Rupali Prasad,Researcher,Herdernstrasse 71,"8004, Switzerland.",rupali.prasad@herdernstrasse71.com,linkedin.com/in/rupaliprasad,Development of a sustainable strategy for cultured fat production based on serum-free 3D culture of ,2025-12,Scientific reports,41461685,spheroid,PubMed
Vladimir Zachar,Researcher,Department of Health Science and Technology,"9260, Denmark.",vladimir.zachar@departmentofhealthscienceandtechnology.com,linkedin.com/in/vladimirzachar,Development of a sustainable strategy for cultured fat production based on serum-free 3D culture of ,2025-12,Scientific reports,41461685,spheroid,PubMed
Suman Kumar Das,Researcher,Herdernstrasse 71,"8004, Switzerland.",suman.das@herdernstrasse71.com,linkedin.com/in/sumankumardas,Development of a sustainable strategy for cultured fat production based on serum-free 3D culture of ,2025-12,Scientific reports,41461685,spheroid,PubMed
Cristian Pablo Pennisi,Researcher,Department of Health Science and Technology,"9260, Denmark. cpennisi@hst.aau.dk.",cristian.pennisi@departmentofhealthscienceandtechnology.com,linkedin.com/in/cristianpablopennisi,Development of a sustainable strategy for cultured fat production based on serum-free 3D culture of ,2025-12,Scientific reports,41461685,spheroid,PubMed
Alicja Zalecińska,Researcher,Warsaw University of Life Sciences,"02-797 Warsaw, Poland.",alicja.zalecińska@warsaweduoflifesciences.com,linkedin.com/in/alicjazalecińska,Clinical Outcomes of Oat Beta-Glucan Nutritional Intervention in Ulcerative Colitis: Case Reports of,2025-12,Nutrients,41470757,in vitro toxicity,PubMed
Joanna Harasym,Researcher,Faculty of Production Engineering,"53-345 Wrocław, Poland.",joanna.harasym@facultyofproductionengineering.com,linkedin.com/in/joannaharasym,Clinical Outcomes of Oat Beta-Glucan Nutritional Intervention in Ulcerative Colitis: Case Reports of,2025-12,Nutrients,41470757,in vitro toxicity,PubMed
Katarzyna Dziendzikowska,Researcher,Institute of Human Nutrition,"02-797 Warsaw, Poland.",katarzyna.dziendzikowska@orgofhumannutrition.com,linkedin.com/in/katarzynadziendzikowska,Clinical Outcomes of Oat Beta-Glucan Nutritional Intervention in Ulcerative Colitis: Case Reports of,2025-12,Nutrients,41470757,in vitro toxicity,PubMed
Katarzyna Sikorska,Researcher,Institute of Nuclear Chemistry and Technology,"03-195 Warsaw, Poland.",katarzyna.sikorska@orgofnuclearchemistryandtechnology.com,linkedin.com/in/katarzynasikorska,Clinical Outcomes of Oat Beta-Glucan Nutritional Intervention in Ulcerative Colitis: Case Reports of,2025-12,Nutrients,41470757,in vitro toxicity,PubMed
Joanna Gromadzka-Ostrowska,Researcher,Institute of Human Nutrition,"02-797 Warsaw, Poland.",joanna.gromadzka-ostrowska@orgofhumannutrition.com,linkedin.com/in/joannagromadzka-ostrowska,Clinical Outcomes of Oat Beta-Glucan Nutritional Intervention in Ulcerative Colitis: Case Reports of,2025-12,Nutrients,41470757,in vitro toxicity,PubMed
Kyle S Burns,Researcher,Oregon State University,"OR 97331, USA.",kyle.burns@oregonstateedu.com,linkedin.com/in/kylesburns,Co-Culture of Primary Human Bronchial Epithelial Cells at the Air-Liquid Interface and THP-1 Macroph,2025-12,Toxics,41441286,in vitro toxicity,PubMed
Audrey G Biggerstaff,Researcher,Oregon State University,"OR 97331, USA.",audrey.biggerstaff@oregonstateedu.com,linkedin.com/in/audreygbiggerstaff,Co-Culture of Primary Human Bronchial Epithelial Cells at the Air-Liquid Interface and THP-1 Macroph,2025-12,Toxics,41441286,in vitro toxicity,PubMed
Jamie M Pennington,Researcher,Oregon State University,"OR 97331, USA.",jamie.pennington@oregonstateedu.com,linkedin.com/in/jamiempennington,Co-Culture of Primary Human Bronchial Epithelial Cells at the Air-Liquid Interface and THP-1 Macroph,2025-12,Toxics,41441286,in vitro toxicity,PubMed
Susan C Tilton,Researcher,Oregon State University,"OR 97331, USA.",susan.tilton@oregonstateedu.com,linkedin.com/in/susanctilton,Co-Culture of Primary Human Bronchial Epithelial Cells at the Air-Liquid Interface and THP-1 Macroph,2025-12,Toxics,41441286,in vitro toxicity,PubMed
Xuefei Cao,Researcher,Richmond,"VA, United States.",xuefei.cao@richmond.com,linkedin.com/in/xuefeicao,Comparative evaluation of artificial saliva and complete artificial saliva as solvent vehicles for <,2025-12,Frontiers in toxicology,41438570,in vitro toxicity,PubMed
Mariana T Farcas,Researcher,Richmond,"VA, United States.",mariana.farcas@richmond.com,linkedin.com/in/marianatfarcas,Comparative evaluation of artificial saliva and complete artificial saliva as solvent vehicles for <,2025-12,Frontiers in toxicology,41438570,in vitro toxicity,PubMed
Yevgeniya V Prepelitskaya,Researcher,Richmond,"VA, United States.",yevgeniya.prepelitskaya@richmond.com,linkedin.com/in/yevgeniyavprepelitskaya,Comparative evaluation of artificial saliva and complete artificial saliva as solvent vehicles for <,2025-12,Frontiers in toxicology,41438570,in vitro toxicity,PubMed
Abaigeal Ritzenthaler,Researcher,Richmond,"VA, United States.",abaigeal.ritzenthaler@richmond.com,linkedin.com/in/abaigealritzenthaler,Comparative evaluation of artificial saliva and complete artificial saliva as solvent vehicles for <,2025-12,Frontiers in toxicology,41438570,in vitro toxicity,PubMed
Jennifer Molignano,Researcher,Ashland,"MA, United States.",jennifer.molignano@ashland.com,linkedin.com/in/jennifermolignano,Comparative evaluation of artificial saliva and complete artificial saliva as solvent vehicles for <,2025-12,Frontiers in toxicology,41438570,in vitro toxicity,PubMed
Jonathan Oldach,Researcher,Ashland,"MA, United States.",jonathan.oldach@ashland.com,linkedin.com/in/jonathanoldach,Comparative evaluation of artificial saliva and complete artificial saliva as solvent vehicles for <,2025-12,Frontiers in toxicology,41438570,in vitro toxicity,PubMed
Marisol M Gutierrez,Researcher,Richmond,"VA, United States.",marisol.gutierrez@richmond.com,linkedin.com/in/marisolmgutierrez,Comparative evaluation of artificial saliva and complete artificial saliva as solvent vehicles for <,2025-12,Frontiers in toxicology,41438570,in vitro toxicity,PubMed
Asmae Mahtal,Researcher,Natural Substances,"Taza, Morocco.",asmae.mahtal@naturalsubstances.com,linkedin.com/in/asmaemahtal,"<i>Morchella esculenta</i> (L.) Pers. Wild of the Province of Taza, Morocco: Toxicity Assessment in ",2025-12,Biochemistry research international,41425864,in vitro toxicity,PubMed
Fatima Lamchouri,Researcher,Natural Substances,"Taza, Morocco.",fatima.lamchouri@naturalsubstances.com,linkedin.com/in/fatimalamchouri,"<i>Morchella esculenta</i> (L.) Pers. Wild of the Province of Taza, Morocco: Toxicity Assessment in ",2025-12,Biochemistry research international,41425864,in vitro toxicity,PubMed
Nacima Lachkar,Researcher,Natural Substances,"Taza, Morocco.",nacima.lachkar@naturalsubstances.com,linkedin.com/in/nacimalachkar,"<i>Morchella esculenta</i> (L.) Pers. Wild of the Province of Taza, Morocco: Toxicity Assessment in ",2025-12,Biochemistry research international,41425864,in vitro toxicity,PubMed
Hafida Bouhazama,Researcher,Natural Substances,"Taza, Morocco.",hafida.bouhazama@naturalsubstances.com,linkedin.com/in/hafidabouhazama,"<i>Morchella esculenta</i> (L.) Pers. Wild of the Province of Taza, Morocco: Toxicity Assessment in ",2025-12,Biochemistry research international,41425864,in vitro toxicity,PubMed
Hamid Toufik,Researcher,Natural Substances,"Taza, Morocco.",hamid.toufik@naturalsubstances.com,linkedin.com/in/hamidtoufik,"<i>Morchella esculenta</i> (L.) Pers. Wild of the Province of Taza, Morocco: Toxicity Assessment in ",2025-12,Biochemistry research international,41425864,in vitro toxicity,PubMed
Bozhena Tsyupa,Researcher,"Materials and Chemical Engineering ""G. Natta""","Stezzano, Italy. Electronic address: bozhena.tsyupa@polimi.it.","bozhena.tsyupa@materialsandchemicalengineering""g.natta""",linkedin.com/in/bozhenatsyupa,On-site ALI versus submerged culture: Chemical and toxicological investigation of brake wear sub-mic,2025-12,Environmental toxicology and pharmacology,41419189,in vitro toxicity,PubMed
Chiara Emma Campiglio,Researcher,Information and Production Engineering,"Bergamo, Italy.",chiara.campiglio@informationandproductionengineering.com,linkedin.com/in/chiaraemmacampiglio,On-site ALI versus submerged culture: Chemical and toxicological investigation of brake wear sub-mic,2025-12,Environmental toxicology and pharmacology,41419189,in vitro toxicity,PubMed
Elena Carrara,Researcher,Istituto di Ricerche Farmacologiche Mario Negri IRCCS,"Bergamo, Italy.",elena.carrara@istitutodiricerchefarmacologichemarionegriirccs.com,linkedin.com/in/elenacarrara,On-site ALI versus submerged culture: Chemical and toxicological investigation of brake wear sub-mic,2025-12,Environmental toxicology and pharmacology,41419189,in vitro toxicity,PubMed
Marta Ripamonti,Researcher,Istituto di Ricerche Farmacologiche Mario Negri IRCCS,"Bergamo, Italy.",marta.ripamonti@istitutodiricerchefarmacologichemarionegriirccs.com,linkedin.com/in/martaripamonti,On-site ALI versus submerged culture: Chemical and toxicological investigation of brake wear sub-mic,2025-12,Environmental toxicology and pharmacology,41419189,in vitro toxicity,PubMed
Alessandro Mancini,Researcher,GCF Research & Development,"Stezzano, Italy.",alessandro.mancini@gcfresearch&development.com,linkedin.com/in/alessandromancini,On-site ALI versus submerged culture: Chemical and toxicological investigation of brake wear sub-mic,2025-12,Environmental toxicology and pharmacology,41419189,in vitro toxicity,PubMed
Andrea Bonfanti,Researcher,GCF Research & Development,"Stezzano, Italy.",andrea.bonfanti@gcfresearch&development.com,linkedin.com/in/andreabonfanti,On-site ALI versus submerged culture: Chemical and toxicological investigation of brake wear sub-mic,2025-12,Environmental toxicology and pharmacology,41419189,in vitro toxicity,PubMed
Micol Introna,Researcher,Stockholm University,"Stockholm, Sweden.",micol.introna@stockholmedu.com,linkedin.com/in/micolintrona,On-site ALI versus submerged culture: Chemical and toxicological investigation of brake wear sub-mic,2025-12,Environmental toxicology and pharmacology,41419189,in vitro toxicity,PubMed
Ana Teresa Juarez-Facio,Researcher,Stockholm University,"Stockholm, Sweden.",ana.juarez-facio@stockholmedu.com,linkedin.com/in/anateresajuarez-facio,On-site ALI versus submerged culture: Chemical and toxicological investigation of brake wear sub-mic,2025-12,Environmental toxicology and pharmacology,41419189,in vitro toxicity,PubMed
Karine Elihn,Researcher,Stockholm University,"Stockholm, Sweden.",karine.elihn@stockholmedu.com,linkedin.com/in/karineelihn,On-site ALI versus submerged culture: Chemical and toxicological investigation of brake wear sub-mic,2025-12,Environmental toxicology and pharmacology,41419189,in vitro toxicity,PubMed
Manuela Teresa Raimondi,Researcher,"Materials and Chemical Engineering ""G. Natta""","Politecnico di Milano, Italy.","manuela.raimondi@materialsandchemicalengineering""g.natta""",linkedin.com/in/manuelateresaraimondi,On-site ALI versus submerged culture: Chemical and toxicological investigation of brake wear sub-mic,2025-12,Environmental toxicology and pharmacology,41419189,in vitro toxicity,PubMed
Andrea Remuzzi,Researcher,Information and Production Engineering,"Bergamo, Italy. Electronic address: andrea.remuzzi@unibg.it.",andrea.remuzzi@informationandproductionengineering.com,linkedin.com/in/andrearemuzzi,On-site ALI versus submerged culture: Chemical and toxicological investigation of brake wear sub-mic,2025-12,Environmental toxicology and pharmacology,41419189,in vitro toxicity,PubMed
Pratistha Singh,Researcher,Institute of Science,"Uttar Pradesh, 221005 India.",pratistha.singh@orgofscience.com,linkedin.com/in/pratisthasingh,Targeting myeloid cell leukemia-1 protein to identify potential compounds for chronic myeloid leukem,2025-12,Biochemical and biophysical research communications,41418352,in vitro toxicity,PubMed
Vinay Kumar Singh,Researcher,Institute of Science,"Uttar Pradesh, 221005 India.",vinay.singh@orgofscience.com,linkedin.com/in/vinaykumarsingh,Targeting myeloid cell leukemia-1 protein to identify potential compounds for chronic myeloid leukem,2025-12,Biochemical and biophysical research communications,41418352,in vitro toxicity,PubMed
Malkhey Verma,Researcher,Institute of Science,"Uttar Pradesh, 221005 India. Electronic address: malkhey@bhu.ac.in.",malkhey.verma@orgofscience.com,linkedin.com/in/malkheyverma,Targeting myeloid cell leukemia-1 protein to identify potential compounds for chronic myeloid leukem,2025-12,Biochemical and biophysical research communications,41418352,in vitro toxicity,PubMed
Andrey Amosov,Researcher,Far Eastern Branch,"Vladivostok 690041, Russia.",andrey.amosov@fareasternbranch.com,linkedin.com/in/andreyamosov,Ultrafast laser synthesis of NIR-absorbing Au-TiO<sub>2</sub> nanoagents for photothermal theranosti,2025-12,"Colloids and surfaces. B, Biointerfaces",41406682,in vitro toxicity,PubMed
Stanislav O Gurbatov,Researcher,Far Eastern Branch,"Vladivostok 690922, Russia.",stanislav.gurbatov@fareasternbranch.com,linkedin.com/in/stanislavogurbatov,Ultrafast laser synthesis of NIR-absorbing Au-TiO<sub>2</sub> nanoagents for photothermal theranosti,2025-12,"Colloids and surfaces. B, Biointerfaces",41406682,in vitro toxicity,PubMed
Aleksandr V Shevlyagin,Researcher,Far Eastern Branch,"Vladivostok 690041, Russia.",aleksandr.shevlyagin@fareasternbranch.com,linkedin.com/in/aleksandrvshevlyagin,Ultrafast laser synthesis of NIR-absorbing Au-TiO<sub>2</sub> nanoagents for photothermal theranosti,2025-12,"Colloids and surfaces. B, Biointerfaces",41406682,in vitro toxicity,PubMed
Andrei Pilnik,Researcher,Far Eastern Branch,"Vladivostok 690041, Russia.",andrei.pilnik@fareasternbranch.com,linkedin.com/in/andreipilnik,Ultrafast laser synthesis of NIR-absorbing Au-TiO<sub>2</sub> nanoagents for photothermal theranosti,2025-12,"Colloids and surfaces. B, Biointerfaces",41406682,in vitro toxicity,PubMed
Evgeny Modin,Researcher,Avda Tolosa 76,"Donostia-San Sebastian 20018, Spain.",evgeny.modin@avdatolosa76.com,linkedin.com/in/evgenymodin,Ultrafast laser synthesis of NIR-absorbing Au-TiO<sub>2</sub> nanoagents for photothermal theranosti,2025-12,"Colloids and surfaces. B, Biointerfaces",41406682,in vitro toxicity,PubMed
Soslan Khubezhov,Researcher,Harbin Engineering University,"Qingdao 266500, China.",soslan.khubezhov@harbinengineeringedu.com,linkedin.com/in/soslankhubezhov,Ultrafast laser synthesis of NIR-absorbing Au-TiO<sub>2</sub> nanoagents for photothermal theranosti,2025-12,"Colloids and surfaces. B, Biointerfaces",41406682,in vitro toxicity,PubMed
Ekaterina S Menchinskaya,Researcher,Far Eastern Branch,"Vladivostok 690022, Russia.",ekaterina.menchinskaya@fareasternbranch.com,linkedin.com/in/ekaterinasmenchinskaya,Ultrafast laser synthesis of NIR-absorbing Au-TiO<sub>2</sub> nanoagents for photothermal theranosti,2025-12,"Colloids and surfaces. B, Biointerfaces",41406682,in vitro toxicity,PubMed
Tatiana Yu Gorpenchenko,Researcher,Far Eastern Branch of the Russian Academy of Sciences,"Vladivostok 690022, Russia.",tatiana.gorpenchenko@fareasternbranchoftherussianacademyofsciences.com,linkedin.com/in/tatianayugorpenchenko,Ultrafast laser synthesis of NIR-absorbing Au-TiO<sub>2</sub> nanoagents for photothermal theranosti,2025-12,"Colloids and surfaces. B, Biointerfaces",41406682,in vitro toxicity,PubMed
Dmitry L Aminin,Researcher,Far Eastern Branch,"Vladivostok 690022, Russia.",dmitry.aminin@fareasternbranch.com,linkedin.com/in/dmitrylaminin,Ultrafast laser synthesis of NIR-absorbing Au-TiO<sub>2</sub> nanoagents for photothermal theranosti,2025-12,"Colloids and surfaces. B, Biointerfaces",41406682,in vitro toxicity,PubMed
Aleksandr A Kuchmizhak,Researcher,Far Eastern Branch,"Vladivostok 690041, Russia. Electronic address: alex.iacp.dvo@mail.ru.",aleksandr.kuchmizhak@fareasternbranch.com,linkedin.com/in/aleksandrakuchmizhak,Ultrafast laser synthesis of NIR-absorbing Au-TiO<sub>2</sub> nanoagents for photothermal theranosti,2025-12,"Colloids and surfaces. B, Biointerfaces",41406682,in vitro toxicity,PubMed
Carine El Hajjar,Researcher,ABTE UR 4651,"F-14000 Caen, France. Electronic address: carine.el-hajjar@univ-grenoble-alpes.fr.",carine.hajjar@abteur4651.com,linkedin.com/in/carineelhajjar,Biological responses of human tracheobronchial mucociliary pseudo-epithelium repeatedly exposed at t,2025-12,Toxicology,41389869,in vitro toxicity,PubMed
Ivannah Pottier,Researcher,ABTE UR 4651,"F-14000 Caen, France. Electronic address: ivannah.pottier@unicaen.fr.",ivannah.pottier@abteur4651.com,linkedin.com/in/ivannahpottier,Biological responses of human tracheobronchial mucociliary pseudo-epithelium repeatedly exposed at t,2025-12,Toxicology,41389869,in vitro toxicity,PubMed
Marie Lelong,Researcher,IRSET,"Rennes 35000, France. Electronic address: marie.lelong@univ-rennes.fr.",marie.lelong@irset.com,linkedin.com/in/marielelong,Biological responses of human tracheobronchial mucociliary pseudo-epithelium repeatedly exposed at t,2025-12,Toxicology,41389869,in vitro toxicity,PubMed
Valérie Lecureur,Researcher,IRSET,"Rennes 35000, France. Electronic address: valerie.lecureur@univ-rennes.fr.",valérie.lecureur@irset.com,linkedin.com/in/valérielecureur,Biological responses of human tracheobronchial mucociliary pseudo-epithelium repeatedly exposed at t,2025-12,Toxicology,41389869,in vitro toxicity,PubMed
Véronique André,Researcher,ABTE UR 4651,"F-14000 Caen, France. Electronic address: veronique.andre@unicaen.fr.",véronique.andré@abteur4651.com,linkedin.com/in/véroniqueandré,Biological responses of human tracheobronchial mucociliary pseudo-epithelium repeatedly exposed at t,2025-12,Toxicology,41389869,in vitro toxicity,PubMed
Arpamas Vachiraarunwong,Researcher,Osaka Metropolitan University Graduate School of Medicine,"Osaka, Japan.",arpamas.vachiraarunwong@osakametropolitanedugraduateschoolofmedicine.com,linkedin.com/in/arpamasvachiraarunwong,Developing a novel in vitro toxicity assay for predicting inhalation toxicity in rats.,2025-12,Toxicology letters,41386503,in vitro toxicity,PubMed
Masaki Fujioka,Researcher,Osaka Metropolitan University Graduate School of Medicine,"Osaka, Japan.",masaki.fujioka@osakametropolitanedugraduateschoolofmedicine.com,linkedin.com/in/masakifujioka,Developing a novel in vitro toxicity assay for predicting inhalation toxicity in rats.,2025-12,Toxicology letters,41386503,in vitro toxicity,PubMed
David B Alexander,Researcher,Nagoya City University Graduate School of Medical Sciences,"Nagoya, Japan.",david.alexander@nagoyacityedugraduateschoolofmedicalsciences.com,linkedin.com/in/davidbalexander,Developing a novel in vitro toxicity assay for predicting inhalation toxicity in rats.,2025-12,Toxicology letters,41386503,in vitro toxicity,PubMed
Shugo Suzuki,Researcher,Osaka Metropolitan University Graduate School of Medicine,"Osaka, Japan.",shugo.suzuki@osakametropolitanedugraduateschoolofmedicine.com,linkedin.com/in/shugosuzuki,Developing a novel in vitro toxicity assay for predicting inhalation toxicity in rats.,2025-12,Toxicology letters,41386503,in vitro toxicity,PubMed
Runjie Guo,Researcher,Osaka Metropolitan University Graduate School of Medicine,"Osaka, Japan.",runjie.guo@osakametropolitanedugraduateschoolofmedicine.com,linkedin.com/in/runjieguo,Developing a novel in vitro toxicity assay for predicting inhalation toxicity in rats.,2025-12,Toxicology letters,41386503,in vitro toxicity,PubMed
Guiyu Qiu,Researcher,Osaka Metropolitan University Graduate School of Medicine,"Osaka, Japan.",guiyu.qiu@osakametropolitanedugraduateschoolofmedicine.com,linkedin.com/in/guiyuqiu,Developing a novel in vitro toxicity assay for predicting inhalation toxicity in rats.,2025-12,Toxicology letters,41386503,in vitro toxicity,PubMed
Yurina Kawamura,Researcher,Osaka Metropolitan University Graduate School of Medicine,"Osaka, Japan.",yurina.kawamura@osakametropolitanedugraduateschoolofmedicine.com,linkedin.com/in/yurinakawamura,Developing a novel in vitro toxicity assay for predicting inhalation toxicity in rats.,2025-12,Toxicology letters,41386503,in vitro toxicity,PubMed
Kana Shibano,Researcher,Osaka Metropolitan University Graduate School of Medicine,"Osaka, Japan.",kana.shibano@osakametropolitanedugraduateschoolofmedicine.com,linkedin.com/in/kanashibano,Developing a novel in vitro toxicity assay for predicting inhalation toxicity in rats.,2025-12,Toxicology letters,41386503,in vitro toxicity,PubMed
Ikue Noura,Researcher,Osaka Metropolitan University Graduate School of Medicine,"Osaka, Japan.",ikue.noura@osakametropolitanedugraduateschoolofmedicine.com,linkedin.com/in/ikuenoura,Developing a novel in vitro toxicity assay for predicting inhalation toxicity in rats.,2025-12,Toxicology letters,41386503,in vitro toxicity,PubMed
Kwanchanok Praseatsook,Researcher,Osaka Metropolitan University Graduate School of Medicine,"Chiang Mai, Thailand.",kwanchanok.praseatsook@osakametropolitanedugraduateschoolofmedicine.com,linkedin.com/in/kwanchanokpraseatsook,Developing a novel in vitro toxicity assay for predicting inhalation toxicity in rats.,2025-12,Toxicology letters,41386503,in vitro toxicity,PubMed
Hirotoshi Akane,Researcher,National Institute of Health Sciences,"Kawasaki, Japan.",hirotoshi.akane@nationalorgofhealthsciences.com,linkedin.com/in/hirotoshiakane,Developing a novel in vitro toxicity assay for predicting inhalation toxicity in rats.,2025-12,Toxicology letters,41386503,in vitro toxicity,PubMed
Shinji Takasu,Researcher,National Institute of Health Sciences,"Kawasaki, Japan.",shinji.takasu@nationalorgofhealthsciences.com,linkedin.com/in/shinjitakasu,Developing a novel in vitro toxicity assay for predicting inhalation toxicity in rats.,2025-12,Toxicology letters,41386503,in vitro toxicity,PubMed
Hiroyuki Tsuda,Researcher,Nagoya City University Graduate School of Medical Sciences,"Nagoya, Japan.",hiroyuki.tsuda@nagoyacityedugraduateschoolofmedicalsciences.com,linkedin.com/in/hiroyukitsuda,Developing a novel in vitro toxicity assay for predicting inhalation toxicity in rats.,2025-12,Toxicology letters,41386503,in vitro toxicity,PubMed
Kumiko Ogawa,Researcher,National Institute of Health Sciences,"Tokyo, Japan.",kumiko.ogawa@nationalorgofhealthsciences.com,linkedin.com/in/kumikoogawa,Developing a novel in vitro toxicity assay for predicting inhalation toxicity in rats.,2025-12,Toxicology letters,41386503,in vitro toxicity,PubMed
Hideki Wanibuchi,Researcher,Osaka Metropolitan University Graduate School of Medicine,"Osaka, Japan.",hideki.wanibuchi@osakametropolitanedugraduateschoolofmedicine.com,linkedin.com/in/hidekiwanibuchi,Developing a novel in vitro toxicity assay for predicting inhalation toxicity in rats.,2025-12,Toxicology letters,41386503,in vitro toxicity,PubMed
Min Gi,Researcher,Osaka Metropolitan University Graduate School of Medicine,"Osaka, Japan. Electronic address: mwei@omu.ac.jp.",min.gi@osakametropolitanedugraduateschoolofmedicine.com,linkedin.com/in/mingi,Developing a novel in vitro toxicity assay for predicting inhalation toxicity in rats.,2025-12,Toxicology letters,41386503,in vitro toxicity,PubMed
Jaume Reverté,Researcher,Marine and Continental Waters (AMiC),"Reus, Spain.",jaume.reverté@marineandcontinentalwaters(amic).com,linkedin.com/in/jaumereverté,Mechanistic insights into antibody recognition of tetrodotoxin analogues: Implications for neurotoxi,2025-12,Chemico-biological interactions,41386469,in vitro toxicity,PubMed
Mounira Alkassar,Researcher,Marine and Continental Waters (AMiC),"Reus, Spain.",mounira.alkassar@marineandcontinentalwaters(amic).com,linkedin.com/in/mouniraalkassar,Mechanistic insights into antibody recognition of tetrodotoxin analogues: Implications for neurotoxi,2025-12,Chemico-biological interactions,41386469,in vitro toxicity,PubMed
Maria Rambla-Alegre,Researcher,Marine and Continental Waters (AMiC),"Catalonia, Spain.",maria.rambla-alegre@marineandcontinentalwaters(amic).com,linkedin.com/in/mariarambla-alegre,Mechanistic insights into antibody recognition of tetrodotoxin analogues: Implications for neurotoxi,2025-12,Chemico-biological interactions,41386469,in vitro toxicity,PubMed
Andres Sanchez-Henao,Researcher,Marine and Continental Waters (AMiC),"Arucas, Spain.",andres.sanchez-henao@marineandcontinentalwaters(amic).com,linkedin.com/in/andressanchez-henao,Mechanistic insights into antibody recognition of tetrodotoxin analogues: Implications for neurotoxi,2025-12,Chemico-biological interactions,41386469,in vitro toxicity,PubMed
Manolis Mandalakis,Researcher,Biotechnology and Aquaculture,"Heraklion, Greece.",manolis.mandalakis@biotechnologyandaquaculture.com,linkedin.com/in/manolismandalakis,Mechanistic insights into antibody recognition of tetrodotoxin analogues: Implications for neurotoxi,2025-12,Chemico-biological interactions,41386469,in vitro toxicity,PubMed
Panagiota Peristeraki,Researcher,Hellenic Centre for Marine Research (HCMR),"Heraklion, Greece.",panagiota.peristeraki@helleniccentreformarineresearch(hcmr).com,linkedin.com/in/panagiotaperisteraki,Mechanistic insights into antibody recognition of tetrodotoxin analogues: Implications for neurotoxi,2025-12,Chemico-biological interactions,41386469,in vitro toxicity,PubMed
Francesc X Sureda,Researcher,Facultat de Medicina i Ciències de la Salut,"Reus, Spain.",francesc.sureda@facultatdemedicinaiciènciesdelasalut.com,linkedin.com/in/francescxsureda,Mechanistic insights into antibody recognition of tetrodotoxin analogues: Implications for neurotoxi,2025-12,Chemico-biological interactions,41386469,in vitro toxicity,PubMed
Jorge Diogène,Researcher,Marine and Continental Waters (AMiC),"Catalonia, Spain.",jorge.diogène@marineandcontinentalwaters(amic).com,linkedin.com/in/jorgediogène,Mechanistic insights into antibody recognition of tetrodotoxin analogues: Implications for neurotoxi,2025-12,Chemico-biological interactions,41386469,in vitro toxicity,PubMed
Mònica Campàs,Researcher,Marine and Continental Waters (AMiC),"Catalonia, Spain. Electronic address: monica.campas@irta.cat.",mònica.campàs@marineandcontinentalwaters(amic).com,linkedin.com/in/mònicacampàs,Mechanistic insights into antibody recognition of tetrodotoxin analogues: Implications for neurotoxi,2025-12,Chemico-biological interactions,41386469,in vitro toxicity,PubMed
Sujie Liu,Researcher,Harbin/150040,"Heilongjiang, China.",sujie.liu@harbin/150040.com,linkedin.com/in/sujieliu,Elucidation of Cortex Dictamni hepatotoxicity mechanism by integrated serum pharmacochemistry and me,2025-11,Phytomedicine : international journal of phytotherapy and phytopharmacology,41380413,in vitro toxicity,PubMed
Jiaxin Ruan,Researcher,Harbin/150040,"Heilongjiang, China.",jiaxin.ruan@harbin/150040.com,linkedin.com/in/jiaxinruan,Elucidation of Cortex Dictamni hepatotoxicity mechanism by integrated serum pharmacochemistry and me,2025-11,Phytomedicine : international journal of phytotherapy and phytopharmacology,41380413,in vitro toxicity,PubMed
Chen Wang,Researcher,Harbin/150040,"Heilongjiang, China.",chen.wang@harbin/150040.com,linkedin.com/in/chenwang,Elucidation of Cortex Dictamni hepatotoxicity mechanism by integrated serum pharmacochemistry and me,2025-11,Phytomedicine : international journal of phytotherapy and phytopharmacology,41380413,in vitro toxicity,PubMed
Xiaofan Wang,Researcher,Harbin/150040,"Heilongjiang, China.",xiaofan.wang@harbin/150040.com,linkedin.com/in/xiaofanwang,Elucidation of Cortex Dictamni hepatotoxicity mechanism by integrated serum pharmacochemistry and me,2025-11,Phytomedicine : international journal of phytotherapy and phytopharmacology,41380413,in vitro toxicity,PubMed
Jiahe Yan,Researcher,Harbin/150040,"Heilongjiang, China.",jiahe.yan@harbin/150040.com,linkedin.com/in/jiaheyan,Elucidation of Cortex Dictamni hepatotoxicity mechanism by integrated serum pharmacochemistry and me,2025-11,Phytomedicine : international journal of phytotherapy and phytopharmacology,41380413,in vitro toxicity,PubMed
Donghua Yu,Researcher,Heilongjiang University of Chinese Medicine,"Heilongjiang, China.",donghua.yu@heilongjiangeduofchinesemedicine.com,linkedin.com/in/donghuayu,Elucidation of Cortex Dictamni hepatotoxicity mechanism by integrated serum pharmacochemistry and me,2025-11,Phytomedicine : international journal of phytotherapy and phytopharmacology,41380413,in vitro toxicity,PubMed
Zhang Na,Researcher,Heilongjiang University of Chinese Medicine,"Heilongjiang University of Chinese Medicine, China.",zhang.na@heilongjiangeduofchinesemedicine.com,linkedin.com/in/zhangna,Elucidation of Cortex Dictamni hepatotoxicity mechanism by integrated serum pharmacochemistry and me,2025-11,Phytomedicine : international journal of phytotherapy and phytopharmacology,41380413,in vitro toxicity,PubMed
Pingping Chen,Researcher,Heilongjiang University of Chinese Medicine,"Heilongjiang, China.",pingping.chen@heilongjiangeduofchinesemedicine.com,linkedin.com/in/pingpingchen,Elucidation of Cortex Dictamni hepatotoxicity mechanism by integrated serum pharmacochemistry and me,2025-11,Phytomedicine : international journal of phytotherapy and phytopharmacology,41380413,in vitro toxicity,PubMed
Yu Wang,Researcher,Heilongjiang University of Chinese Medicine,"Heilongjiang, China.",yu.wang@heilongjiangeduofchinesemedicine.com,linkedin.com/in/yuwang,Elucidation of Cortex Dictamni hepatotoxicity mechanism by integrated serum pharmacochemistry and me,2025-11,Phytomedicine : international journal of phytotherapy and phytopharmacology,41380413,in vitro toxicity,PubMed
Fang Lu,Researcher,Heilongjiang University of Chinese Medicine,"Heilongjiang, China.",fang.lu@heilongjiangeduofchinesemedicine.com,linkedin.com/in/fanglu,Elucidation of Cortex Dictamni hepatotoxicity mechanism by integrated serum pharmacochemistry and me,2025-11,Phytomedicine : international journal of phytotherapy and phytopharmacology,41380413,in vitro toxicity,PubMed
Shumin Liu,Researcher,Heilongjiang University of Chinese Medicine,"Heilongjiang, China. Electronic address: keji-liu@163.com.",shumin.liu@heilongjiangeduofchinesemedicine.com,linkedin.com/in/shuminliu,Elucidation of Cortex Dictamni hepatotoxicity mechanism by integrated serum pharmacochemistry and me,2025-11,Phytomedicine : international journal of phytotherapy and phytopharmacology,41380413,in vitro toxicity,PubMed
Emily C Davies,Researcher,Murdoch University,"Perth, Australia.",emily.davies@murdochedu.com,linkedin.com/in/emilycdavies,Evaluation of in vitro toxicity of common phytochemicals included in weight loss supplements using <,2025-12,FEBS open bio,41364907,in vitro toxicity,PubMed
Garth L Maker,Researcher,Murdoch University,"Perth, Australia.",garth.maker@murdochedu.com,linkedin.com/in/garthlmaker,Evaluation of in vitro toxicity of common phytochemicals included in weight loss supplements using <,2025-12,FEBS open bio,41364907,in vitro toxicity,PubMed
Ian F Musgrave,Researcher,The University of Adelaide,"The University of Adelaide, Australia.",ian.musgrave@theeduofadelaide.com,linkedin.com/in/ianfmusgrave,Evaluation of in vitro toxicity of common phytochemicals included in weight loss supplements using <,2025-12,FEBS open bio,41364907,in vitro toxicity,PubMed
Samantha Lodge,Researcher,Murdoch University,"Perth, Australia.",samantha.lodge@murdochedu.com,linkedin.com/in/samanthalodge,Evaluation of in vitro toxicity of common phytochemicals included in weight loss supplements using <,2025-12,FEBS open bio,41364907,in vitro toxicity,PubMed
Vaibhavi Srivastava,Researcher,Biomedical Technology,"India, gujaratuniversity.org.in.",vaibhavi.srivastava@biomedicaltechnology.com,linkedin.com/in/vaibhavisrivastava,Comparative Metabolomic and Pharmacognostic Analysis of <i>Ocimum basilicum</i> L. Extracts: Insight,2025-12,International journal of food science,41356576,in vitro toxicity,PubMed
Ann Maria Joseph,Researcher,Biomedical Technology,"India, gujaratuniversity.org.in.",ann.joseph@biomedicaltechnology.com,linkedin.com/in/annmariajoseph,Comparative Metabolomic and Pharmacognostic Analysis of <i>Ocimum basilicum</i> L. Extracts: Insight,2025-12,International journal of food science,41356576,in vitro toxicity,PubMed
Priyesh Kumar,Researcher,Biomedical Technology,"India, gujaratuniversity.org.in.",priyesh.kumar@biomedicaltechnology.com,linkedin.com/in/priyeshkumar,Comparative Metabolomic and Pharmacognostic Analysis of <i>Ocimum basilicum</i> L. Extracts: Insight,2025-12,International journal of food science,41356576,in vitro toxicity,PubMed
Khairah Ansari,Researcher,Biomedical Technology,"India, gujaratuniversity.org.in.",khairah.ansari@biomedicaltechnology.com,linkedin.com/in/khairahansari,Comparative Metabolomic and Pharmacognostic Analysis of <i>Ocimum basilicum</i> L. Extracts: Insight,2025-12,International journal of food science,41356576,in vitro toxicity,PubMed
Krupali Trivedi,Researcher,Biomedical Technology,"India, gujaratuniversity.org.in.",krupali.trivedi@biomedicaltechnology.com,linkedin.com/in/krupalitrivedi,Comparative Metabolomic and Pharmacognostic Analysis of <i>Ocimum basilicum</i> L. Extracts: Insight,2025-12,International journal of food science,41356576,in vitro toxicity,PubMed
Nilam Parmar,Researcher,University School of Sciences,"India, gujaratuniversity.org.in.",nilam.parmar@eduschoolofsciences.com,linkedin.com/in/nilamparmar,Comparative Metabolomic and Pharmacognostic Analysis of <i>Ocimum basilicum</i> L. Extracts: Insight,2025-12,International journal of food science,41356576,in vitro toxicity,PubMed
Bhakti Patel,Researcher,Hemchandracharya North Gujarat University,"India, ngu.ac.in.",bhakti.patel@hemchandracharyanorthgujaratedu.com,linkedin.com/in/bhaktipatel,Comparative Metabolomic and Pharmacognostic Analysis of <i>Ocimum basilicum</i> L. Extracts: Insight,2025-12,International journal of food science,41356576,in vitro toxicity,PubMed
Ashish Patel,Researcher,Hemchandracharya North Gujarat University,"India, ngu.ac.in.",ashish.patel@hemchandracharyanorthgujaratedu.com,linkedin.com/in/ashishpatel,Comparative Metabolomic and Pharmacognostic Analysis of <i>Ocimum basilicum</i> L. Extracts: Insight,2025-12,International journal of food science,41356576,in vitro toxicity,PubMed
Dipak Kumar Sahoo,Researcher,College of Veterinary Medicine,"USA, iastate.edu.",dipak.sahoo@collegeofveterinarymedicine.com,linkedin.com/in/dipakkumarsahoo,Comparative Metabolomic and Pharmacognostic Analysis of <i>Ocimum basilicum</i> L. Extracts: Insight,2025-12,International journal of food science,41356576,in vitro toxicity,PubMed
Devendrasinh Jhala,Researcher,Biomedical Technology,"India, gujaratuniversity.org.in.",devendrasinh.jhala@biomedicaltechnology.com,linkedin.com/in/devendrasinhjhala,Comparative Metabolomic and Pharmacognostic Analysis of <i>Ocimum basilicum</i> L. Extracts: Insight,2025-12,International journal of food science,41356576,in vitro toxicity,PubMed
Johnson Marimuthu Alias Antonysamy,Researcher,Department of Botany,"Palayamkottai, India.",johnson.antonysamy@departmentofbotany.com,linkedin.com/in/johnsonmarimuthualiasantonysamy,"Chemical Profiling, In Silico and In Vitro Studies to Identify Potential CDK2 and mTOR Inhibitor Fro",2025-11,Chemistry & biodiversity,41317009,in vitro toxicity,PubMed
Sivaraman Arumugam,Researcher,Department of Botany,"Palayamkottai, India.",sivaraman.arumugam@departmentofbotany.com,linkedin.com/in/sivaramanarumugam,"Chemical Profiling, In Silico and In Vitro Studies to Identify Potential CDK2 and mTOR Inhibitor Fro",2025-11,Chemistry & biodiversity,41317009,in vitro toxicity,PubMed
Robin Charles Antony Arulraj,Researcher,Department of Botany,"Palayamkottai, India.",robin.arulraj@departmentofbotany.com,linkedin.com/in/robincharlesantonyarulraj,"Chemical Profiling, In Silico and In Vitro Studies to Identify Potential CDK2 and mTOR Inhibitor Fro",2025-11,Chemistry & biodiversity,41317009,in vitro toxicity,PubMed
Anne Wincy Jacob Thomas,Researcher,Alagar Nagar,"Tirunelveli, India.",anne.thomas@alagarnagar.com,linkedin.com/in/annewincyjacobthomas,"Chemical Profiling, In Silico and In Vitro Studies to Identify Potential CDK2 and mTOR Inhibitor Fro",2025-11,Chemistry & biodiversity,41317009,in vitro toxicity,PubMed
Henrique D M Coutinho,Researcher,Regional University of Cariri,"Crato, Brazil.",henrique.coutinho@regionaleduofcariri.com,linkedin.com/in/henriquedmcoutinho,"Chemical Profiling, In Silico and In Vitro Studies to Identify Potential CDK2 and mTOR Inhibitor Fro",2025-11,Chemistry & biodiversity,41317009,in vitro toxicity,PubMed
Oana Catalina Bute,Researcher,Valahia University of Târgoviște,"130004 Târgoviște, Romania.",oana.bute@valahiaeduoftârgoviște.com,linkedin.com/in/oanacatalinabute,Potential Toxicological Risk Associated with the Oral Use of Colloidal Silver Dietary Supplements.,2025-11,Toxics,41304544,in vitro toxicity,PubMed
Anca-Irina Gheboianu,Researcher,Valahia University of Târgoviște,"130004 Târgoviște, Romania.",anca-irina.gheboianu@valahiaeduoftârgoviște.com,linkedin.com/in/anca-irinagheboianu,Potential Toxicological Risk Associated with the Oral Use of Colloidal Silver Dietary Supplements.,2025-11,Toxics,41304544,in vitro toxicity,PubMed
Bogdan Trica,Researcher,202 Splaiul Independentei,"060021 Bucharest, Romania.",bogdan.trica@202splaiulindependentei.com,linkedin.com/in/bogdantrica,Potential Toxicological Risk Associated with the Oral Use of Colloidal Silver Dietary Supplements.,2025-11,Toxics,41304544,in vitro toxicity,PubMed
Ana-Maria Hossu,Researcher,Valahia University of Târgoviște,"130004 Târgoviște, Romania.",ana-maria.hossu@valahiaeduoftârgoviște.com,linkedin.com/in/ana-mariahossu,Potential Toxicological Risk Associated with the Oral Use of Colloidal Silver Dietary Supplements.,2025-11,Toxics,41304544,in vitro toxicity,PubMed
Jeanne d'arc Bacha,Researcher,Jinan University,"Tripoli, Lebanon.",jeanne.bacha@jinanedu.com,linkedin.com/in/jeanned'arcbacha,Catalase Gene Variants and Oxidative Stress in Autism Spectrum Disorder: A Northern Lebanon Cohort a,2024-01,International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience,41277029,in vitro toxicity,PubMed
Nawal El Zoebi,Researcher,Jinan University,"Tripoli, Lebanon.",nawal.zoebi@jinanedu.com,linkedin.com/in/nawalelzoebi,Catalase Gene Variants and Oxidative Stress in Autism Spectrum Disorder: A Northern Lebanon Cohort a,2024-01,International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience,41277029,in vitro toxicity,PubMed
Houssein Al-Attrache,Researcher,Jinan University,"Tripoli, Lebanon.",houssein.al-attrache@jinanedu.com,linkedin.com/in/housseinal-attrache,Catalase Gene Variants and Oxidative Stress in Autism Spectrum Disorder: A Northern Lebanon Cohort a,2024-01,International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience,41277029,in vitro toxicity,PubMed
Xinyi Wang,Researcher,School of the Environment,"Jiangsu, China.",xinyi.wang@schooloftheenvironment.com,linkedin.com/in/xinyiwang,Identification of priority organophosphate esters and priority control areas based on toxic effects ,2025-11,Water research,41273912,in vitro toxicity,PubMed
Aimin Li,Researcher,School of the Environment,"Jiangsu, China. Electronic address: liaimingroup@nju.edu.cn.",aimin.li@schooloftheenvironment.com,linkedin.com/in/aiminli,Identification of priority organophosphate esters and priority control areas based on toxic effects ,2025-11,Water research,41273912,in vitro toxicity,PubMed
Yizhou Tu,Researcher,School of the Environment,"Ltd. Jiangsu Nanjing 210036, China.",yizhou.tu@schooloftheenvironment.com,linkedin.com/in/yizhoutu,Identification of priority organophosphate esters and priority control areas based on toxic effects ,2025-11,Water research,41273912,in vitro toxicity,PubMed
Min Hu,Researcher,School of the Environment,"Jiangsu, China.",min.hu@schooloftheenvironment.com,linkedin.com/in/minhu,Identification of priority organophosphate esters and priority control areas based on toxic effects ,2025-11,Water research,41273912,in vitro toxicity,PubMed
Gabriel Sousa,Researcher,Instituto Superior de Engenharia Do Porto,"Porto, Portugal.",gabriel.sousa@institutosuperiordeengenhariadoporto.com,linkedin.com/in/gabrielsousa,Impact of Fire Emissions and Tobacco Consumption on the Salivary Content of Metal(loid)s and PAHs: E,2025-11,Biological trace element research,41251926,in vitro toxicity,PubMed
Joana Teixeira,Researcher,Instituto Superior de Engenharia Do Porto,"Porto, Portugal.",joana.teixeira@institutosuperiordeengenhariadoporto.com,linkedin.com/in/joanateixeira,Impact of Fire Emissions and Tobacco Consumption on the Salivary Content of Metal(loid)s and PAHs: E,2025-11,Biological trace element research,41251926,in vitro toxicity,PubMed
Maria João Bessa,Researcher,Instituto Universitário de Ciências da Saúde (IUCS),"Gandra, Portugal.",maria.bessa@institutouniversitáriodeciênciasdasaúde(iucs).com,linkedin.com/in/mariajoãobessa,Impact of Fire Emissions and Tobacco Consumption on the Salivary Content of Metal(loid)s and PAHs: E,2025-11,Biological trace element research,41251926,in vitro toxicity,PubMed
Cristina Delerue-Matos,Researcher,Instituto Superior de Engenharia Do Porto,"Porto, Portugal.",cristina.delerue-matos@institutosuperiordeengenhariadoporto.com,linkedin.com/in/cristinadelerue-matos,Impact of Fire Emissions and Tobacco Consumption on the Salivary Content of Metal(loid)s and PAHs: E,2025-11,Biological trace element research,41251926,in vitro toxicity,PubMed
Bruno Sarmento,Researcher,Instituto Universitário de Ciências da Saúde (IUCS),"Gandra, Portugal.",bruno.sarmento@institutouniversitáriodeciênciasdasaúde(iucs).com,linkedin.com/in/brunosarmento,Impact of Fire Emissions and Tobacco Consumption on the Salivary Content of Metal(loid)s and PAHs: E,2025-11,Biological trace element research,41251926,in vitro toxicity,PubMed
Marta Oliveira,Researcher,Instituto Superior de Engenharia Do Porto,"Porto, Portugal.",marta.oliveira@institutosuperiordeengenhariadoporto.com,linkedin.com/in/martaoliveira,Impact of Fire Emissions and Tobacco Consumption on the Salivary Content of Metal(loid)s and PAHs: E,2025-11,Biological trace element research,41251926,in vitro toxicity,PubMed
Francisca Rodrigues,Researcher,Instituto Superior de Engenharia Do Porto,"Porto, Portugal. frodrigues@ff.up.pt.",francisca.rodrigues@institutosuperiordeengenhariadoporto.com,linkedin.com/in/franciscarodrigues,Impact of Fire Emissions and Tobacco Consumption on the Salivary Content of Metal(loid)s and PAHs: E,2025-11,Biological trace element research,41251926,in vitro toxicity,PubMed
Huimin Ma,Researcher,Guangzhou Institute of Geochemistry,"Guangzhou 510640, China. Electronic address: mahuimin@gig.ac.cn.",huimin.ma@guangzhouorgofgeochemistry.com,linkedin.com/in/huiminma,Polycyclic nitroaromatic compounds in HULIS as dominant pro-apoptotic agents in PM<sub>2.5</sub>: Bi,2025-11,Ecotoxicology and environmental safety,41240573,in vitro toxicity,PubMed
Haonan Jie,Researcher,Guangzhou Institute of Geochemistry,"Beijing 100049, China.",haonan.jie@guangzhouorgofgeochemistry.com,linkedin.com/in/haonanjie,Polycyclic nitroaromatic compounds in HULIS as dominant pro-apoptotic agents in PM<sub>2.5</sub>: Bi,2025-11,Ecotoxicology and environmental safety,41240573,in vitro toxicity,PubMed
Qianyu Zhang,Researcher,Guangzhou Institute of Geochemistry,"Guangzhou 510640, China.",qianyu.zhang@guangzhouorgofgeochemistry.com,linkedin.com/in/qianyuzhang,Polycyclic nitroaromatic compounds in HULIS as dominant pro-apoptotic agents in PM<sub>2.5</sub>: Bi,2025-11,Ecotoxicology and environmental safety,41240573,in vitro toxicity,PubMed
Cong Wan,Researcher,Guangzhou Institute of Geochemistry,"Guangzhou 510640, China.",cong.wan@guangzhouorgofgeochemistry.com,linkedin.com/in/congwan,Polycyclic nitroaromatic compounds in HULIS as dominant pro-apoptotic agents in PM<sub>2.5</sub>: Bi,2025-11,Ecotoxicology and environmental safety,41240573,in vitro toxicity,PubMed
Jing You,Researcher,School of Environment,"Guangzhou 511443, China.",jing.you@schoolofenvironment.com,linkedin.com/in/jingyou,Polycyclic nitroaromatic compounds in HULIS as dominant pro-apoptotic agents in PM<sub>2.5</sub>: Bi,2025-11,Ecotoxicology and environmental safety,41240573,in vitro toxicity,PubMed
Guanghui Dong,Researcher,School of Public Health,"Guangzhou 510080, China.",guanghui.dong@schoolofpublichealth.com,linkedin.com/in/guanghuidong,Polycyclic nitroaromatic compounds in HULIS as dominant pro-apoptotic agents in PM<sub>2.5</sub>: Bi,2025-11,Ecotoxicology and environmental safety,41240573,in vitro toxicity,PubMed
Xinyu Liu,Researcher,Pearl River Water Resources Commission of Ministry of Water Resources,"Guangzhou 510611, China.",xinyu.liu@pearlriverwaterresourcescommissionofministryofwaterresources.com,linkedin.com/in/xinyuliu,Polycyclic nitroaromatic compounds in HULIS as dominant pro-apoptotic agents in PM<sub>2.5</sub>: Bi,2025-11,Ecotoxicology and environmental safety,41240573,in vitro toxicity,PubMed
Zhiqiang Yu,Researcher,Guangzhou Institute of Geochemistry,"Guangzhou 510640, China.",zhiqiang.yu@guangzhouorgofgeochemistry.com,linkedin.com/in/zhiqiangyu,Polycyclic nitroaromatic compounds in HULIS as dominant pro-apoptotic agents in PM<sub>2.5</sub>: Bi,2025-11,Ecotoxicology and environmental safety,41240573,in vitro toxicity,PubMed
Jun Li,Researcher,Guangzhou Institute of Geochemistry,"Guangzhou 510640, China.",jun.li@guangzhouorgofgeochemistry.com,linkedin.com/in/junli,Polycyclic nitroaromatic compounds in HULIS as dominant pro-apoptotic agents in PM<sub>2.5</sub>: Bi,2025-11,Ecotoxicology and environmental safety,41240573,in vitro toxicity,PubMed
Gan Zhang,Researcher,Guangzhou Institute of Geochemistry,"Guangzhou 510640, China.",gan.zhang@guangzhouorgofgeochemistry.com,linkedin.com/in/ganzhang,Polycyclic nitroaromatic compounds in HULIS as dominant pro-apoptotic agents in PM<sub>2.5</sub>: Bi,2025-11,Ecotoxicology and environmental safety,41240573,in vitro toxicity,PubMed
Zhuoli Chen,Researcher,Fujian Medical University,"Fujian 350108, China.",zhuoli.chen@fujianmedicaledu.com,linkedin.com/in/zhuolichen,Near-Infrared Light-Driven Photocatalytic Antibacterial Activity of CaCO<sub>3</sub>/C/PDA Nanocompo,2025-11,ACS applied bio materials,41234140,in vitro toxicity,PubMed
Lingying Chen,Researcher,The Second Clinical Medical College of Fujian Medical University,"Fujian 362000, China.",lingying.chen@thesecondclinicalmedicalcollegeoffujianmedicaledu.com,linkedin.com/in/lingyingchen,Near-Infrared Light-Driven Photocatalytic Antibacterial Activity of CaCO<sub>3</sub>/C/PDA Nanocompo,2025-11,ACS applied bio materials,41234140,in vitro toxicity,PubMed
Xiaozhi Zheng,Researcher,The Second Clinical Medical College of Fujian Medical University,"Fujian 362000, China.",xiaozhi.zheng@thesecondclinicalmedicalcollegeoffujianmedicaledu.com,linkedin.com/in/xiaozhizheng,Near-Infrared Light-Driven Photocatalytic Antibacterial Activity of CaCO<sub>3</sub>/C/PDA Nanocompo,2025-11,ACS applied bio materials,41234140,in vitro toxicity,PubMed
Junlin Li,Researcher,The Second Clinical Medical College of Fujian Medical University,"Fujian 362000, China.",junlin.li@thesecondclinicalmedicalcollegeoffujianmedicaledu.com,linkedin.com/in/junlinli,Near-Infrared Light-Driven Photocatalytic Antibacterial Activity of CaCO<sub>3</sub>/C/PDA Nanocompo,2025-11,ACS applied bio materials,41234140,in vitro toxicity,PubMed
Jiankun Ding,Researcher,The Second Clinical Medical College of Fujian Medical University,"Fujian 362000, China.",jiankun.ding@thesecondclinicalmedicalcollegeoffujianmedicaledu.com,linkedin.com/in/jiankunding,Near-Infrared Light-Driven Photocatalytic Antibacterial Activity of CaCO<sub>3</sub>/C/PDA Nanocompo,2025-11,ACS applied bio materials,41234140,in vitro toxicity,PubMed
Chen Cai,Researcher,The Second Clinical Medical College of Fujian Medical University,"Fujian 362000, China.",chen.cai@thesecondclinicalmedicalcollegeoffujianmedicaledu.com,linkedin.com/in/chencai,Near-Infrared Light-Driven Photocatalytic Antibacterial Activity of CaCO<sub>3</sub>/C/PDA Nanocompo,2025-11,ACS applied bio materials,41234140,in vitro toxicity,PubMed
Haiming Yu,Researcher,The Second Clinical Medical College of Fujian Medical University,"Fujian 362000, China.",haiming.yu@thesecondclinicalmedicalcollegeoffujianmedicaledu.com,linkedin.com/in/haimingyu,Near-Infrared Light-Driven Photocatalytic Antibacterial Activity of CaCO<sub>3</sub>/C/PDA Nanocompo,2025-11,ACS applied bio materials,41234140,in vitro toxicity,PubMed
